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Clinical	  Significance	  of	  Psychotic	  Experiences	  in	  the	  General	  Population	  
Jordan	  DeVylder	  
	  
Epidemiological	  studies	  have	  demonstrated	  that	  the	  prevalence	  of	  psychotic	  disorders	  is	  
exceeded	  by	  that	  of	  sub-­‐threshold	  psychotic	  experiences,	  which	  are	  phenomenologically	  
similar	  to	  threshold	  psychosis	  but	  of	  less	  intensity	  or	  associated	  impairment.	  Recent	  
research	  has	  highlighted	  the	  potential	  clinical	  significance	  of	  psychotic	  experiences	  with	  
regards	  to	  psychological	  distress,	  service	  utilization,	  psychiatric	  comorbidities,	  and	  suicide	  
risk.	  The	  aims	  of	  this	  three	  paper	  dissertation	  are	  to:	  1)	  determine	  risk	  for	  suicidal	  
behavior	  among	  respondents	  with	  psychotic	  experiences;	  2)	  examine	  the	  prevalence	  of	  
psychotic	  experiences	  among	  respondents	  with	  common	  mental	  disorders,	  and	  describe	  
the	  clinical	  significance	  of	  these	  symptoms	  when	  occurring	  in	  the	  context	  of	  common	  
mental	  disorders;	  and	  3)	  evaluate	  factors	  associated	  with	  the	  persistence	  or	  remission	  of	  
psychotic	  experiences	  in	  the	  general	  population.	  For	  all	  three	  papers,	  data	  were	  drawn	  
from	  the	  Collaborative	  Psychiatric	  Epidemiology	  Surveys	  (n=20,013),	  composed	  of	  the	  
National	  Comorbidity	  Survey-­‐Replication,	  National	  Latino	  and	  Asian	  American	  Study,	  and	  
National	  Survey	  of	  American	  Life.	  Psychotic	  experiences	  and	  other	  clinical	  variables	  were	  
assessed	  using	  the	  World	  Health	  Organization	  Composite	  International	  Diagnostic	  
Interview,	  version	  3.0.	  Analyses	  consisted	  primarily	  of	  logistic	  regression	  models,	  with	  
effect	  sizes	  calculated	  as	  adjusted	  odds	  ratios.	  Psychotic	  experiences	  were	  found	  to	  be	  
associated	  with	  elevated	  risk	  for	  suicidal	  ideation	  and	  suicide	  attempts,	  and	  with	  multiple	  
co-­‐morbidities	  with	  common	  mental	  health	  conditions.	  The	  persistence	  of	  psychotic	  
	  
	  
experiences	  over	  time	  was	  primarily	  associated	  with	  the	  type	  of	  symptom	  experienced	  (i.e.	  
hearing	  voices)	  and	  with	  marital	  status.	  Co-­‐morbid	  mental	  health	  conditions,	  although	  
extensive,	  did	  not	  predict	  the	  persistence	  of	  psychotic	  experiences,	  although	  persistent	  
psychotic	  experiences	  were	  associated	  with	  ongoing	  suicide	  risk.	  Together,	  these	  data	  
support	  the	  clinical	  significance	  of	  sub-­‐threshold	  psychotic	  experiences	  among	  a	  large	  
general	  population	  sample	  of	  adults	  in	  the	  United	  States.	  The	  most	  clinically	  notable	  
features	  of	  psychotic	  experiences	  are	  that	  they	  indicate	  drastically	  elevated	  risk	  for	  suicide	  
attempts	  (particularly	  severe	  attempts	  with	  intent	  to	  die)	  and	  the	  presence	  of	  multiple	  co-­‐
morbid	  mental	  health	  conditions.	  These	  findings	  will	  have	  clinical	  utility	  in	  highlighting	  
unique	  needs	  of	  individuals	  with	  sub-­‐threshold	  psychotic	  symptoms,	  and	  will	  have	  public	  
health	  value	  in	  identifying	  a	  significant	  risk	  factor	  for	  severe	  suicidal	  behavior	  that	  may	  be	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Introduction:	  Psychotic	  Experiences	  
As	  early	  as	  1969,	  John	  S.	  Strauss	  proposed	  that	  hallucinations	  and	  delusions,	  the	  
characteristic	  positive	  symptoms	  of	  psychosis,	  occur	  along	  a	  continuum	  in	  the	  population	  
(Strauss,	  1969).	  Schizophrenia	  and	  other	  psychotic	  disorders	  nonetheless	  continue	  to	  be	  
diagnosed	  as	  discrete	  entities.	  However,	  the	  continuum	  model	  of	  psychosis	  has	  received	  
considerable	  attention	  and	  renewed	  interest	  since	  being	  revisited	  (van	  Os	  et	  al.,	  2000),	  and	  
has	  subsequently	  received	  extensive	  empirical	  support	  (Linscott	  &	  van	  Os,	  2010;	  2013).	  
Lifetime	  prevalence	  rates	  of	  ‘sub-­‐threshold’	  psychotic	  experiences	  (i.e.	  below	  threshold	  
required	  for	  a	  diagnosis	  of	  a	  psychotic	  disorder	  in	  terms	  of	  intensity,	  frequency,	  or	  insight;	  
American	  Psychiatric	  Association,	  2013)	  have	  been	  estimated	  to	  be	  approximately	  8%,	  
compared	  to	  an	  estimated	  3%	  for	  full	  psychotic	  disorders,	  with	  symptoms	  among	  
psychosis-­‐prone	  individuals	  either	  remitting,	  persisting,	  or	  developing	  into	  a	  full	  disorder	  
over	  time	  (van	  Os,	  Linscott,	  Myin-­‐Germeys,	  Delespaul,	  &	  Krabbendam,	  2009).	  	  
Psychotic	  experiences	  as	  clinical	  phenomena	  
Psychotic	  experiences	  resemble	  the	  symptoms	  of	  schizophrenia	  and	  other	  psychotic	  
disorders,	  but	  are	  more	  common	  in	  the	  general	  population	  and	  believed	  to	  be	  of	  lesser	  
intensity,	  duration,	  and	  associated	  impairment	  (van	  Os	  et	  al.,	  2009).	  “Sub-­‐threshold”	  does	  
not	  necessarily	  denote	  an	  absence	  of	  clinical	  significance,	  but	  rather	  that	  the	  particular	  
symptoms	  are	  below	  the	  categorical	  thresholds	  used	  to	  identify	  the	  presence	  of	  psychotic	  
disorder.	  Several	  meta-­‐analyses	  confirm	  the	  value	  of	  epidemiological	  studies	  of	  these	  
experiences	  in	  elucidating	  the	  etiology	  of	  psychosis	  and	  its	  pattern	  of	  occurrence	  in	  the	  
population	  (Linscott	  &	  van	  Os,	  2010;	  2013).	  Less	  attention	  has	  been	  given	  to	  the	  clinical	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significance	  of	  these	  sub-­‐threshold	  experiences,	  although	  recent	  studies	  have	  suggested	  
that	  they	  may	  be	  precursors	  to	  threshold	  psychotic	  disorder	  (Dominguez,	  Wichers,	  Lieb,	  
Wittchen,	  &	  van	  Os,	  2011;	  Fisher	  et	  al.,	  2013;	  Hanssen,	  Bak,	  Bijl,	  Vollebergh,	  &	  van	  Os,	  2005;	  
Poulton	  et	  al.,	  2000;	  Werbeloff	  et	  al.,	  2012),	  useful	  indicators	  of	  co-­‐morbidity	  (van	  Nierop	  et	  
al.,	  2012;	  Varghese	  et	  al.,	  2011;	  Wigman	  et	  al.,	  2012)	  and	  suicidality	  (Fisher	  et	  al.,	  2013;	  
Kelleher	  et	  al.,	  2012a;	  Nishida	  et	  al.,	  2010;	  Saha	  et	  al.,	  2011a),	  and	  clinically	  impairing	  in	  
their	  own	  right	  (Armando	  et	  al.,	  2010;	  Bak	  et	  al.,	  2003;	  2005;	  DeVylder,	  Oh,	  Corcoran,	  &	  
Lukens,	  in	  press;	  Murphy,	  Shevlin,	  Houston,	  &	  Adamson,	  2012;	  Yung	  et	  al.,	  2006;	  2009).	  	  
It	  would	  be	  consistent	  with	  a	  continuum	  model	  of	  psychosis	  to	  assume	  that	  need	  for	  
care	  and	  clinical	  significance	  associated	  with	  psychosis	  is	  likewise	  continuous.	  That	  is,	  
clinical	  need	  may	  be	  associated	  with	  the	  entire	  range	  of	  psychotic	  experiences	  rather	  than	  
solely	  with	  diagnosable	  psychotic	  disorders.	  Alternatively,	  it	  is	  possible	  that	  the	  purported	  
clinical	  significance	  is	  due	  to	  confounding	  given	  that	  psychotic	  experiences	  are	  associated	  
with	  many	  risk	  factors	  for	  psychopathology	  in	  general,	  and	  that	  common	  mental	  health	  
conditions	  such	  as	  affective,	  anxiety,	  and	  substance	  use	  disorders	  are	  frequently	  present	  in	  
people	  who	  report	  psychotic	  experiences.	  In	  this	  scenario,	  the	  psychotic	  experiences	  may	  
be	  a	  clinically	  insignificant	  artifact	  that	  manifests	  more	  commonly	  in	  individuals	  who	  are	  
otherwise	  at	  greater	  risk	  for	  psychopathology	  and	  in	  greater	  need	  for	  clinical	  treatment.	  	  
	   The	  goal	  of	  this	  dissertation	  is	  to	  further	  explore	  the	  clinical	  significance	  of	  
psychotic	  experiences	  in	  the	  general	  population,	  using	  data	  from	  the	  Collaborative	  
Psychiatric	  Epidemiology	  Surveys	  (CPES;	  Alegría,	  Jackson,	  Kessler,	  &	  Takeuchi,	  2007a).	  
CPES	  is	  a	  national	  household	  survey	  of	  20,013	  adults,	  age	  18	  and	  over.	  CPES	  data	  is	  
assembled	  from	  three	  constituent	  surveys	  conducted	  in	  the	  United	  States:	  1)	  the	  National	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Comorbidity	  Survey-­‐Replication,	  a	  nationally	  representative	  sample	  (Alegría,	  Jackson,	  
Kessler,	  &	  Takeuchi,	  2007b;	  Kessler	  et	  al.,	  2004),	  2)	  the	  National	  Latino	  and	  Asian	  American	  
Study,	  a	  national	  area	  probability	  sample	  with	  supplements	  for	  adults	  of	  Latino	  and	  Asian	  
national	  origin	  (Alegría	  et	  al.,	  2004;	  Alegría	  &	  Takeuchi,	  2007),	  and	  3)	  the	  National	  Survey	  
of	  American	  Life,	  a	  nationally	  representative	  sample	  of	  African-­‐Americans,	  with	  Afro-­‐
Caribbean	  and	  non-­‐Hispanic	  white	  adults	  drawn	  from	  the	  same	  source	  population	  and	  of	  
similar	  socioeconomic	  status	  (Jackson	  et	  al.,	  2004;	  2007).	  This	  publicly	  available	  data	  set	  
has	  several	  features	  that	  make	  it	  particularly	  amenable	  to	  these	  research	  questions,	  in	  that	  
it	  assesses	  psychotic	  experiences	  and	  psychiatric	  diagnoses	  using	  the	  reliable	  World	  Health	  
Organization	  Composite	  International	  Diagnostic	  Interview	  (WHO-­‐CIDI;	  Kessler	  &	  Üstün,	  
2004)	  assessment,	  in	  that	  it	  assesses	  not	  only	  current	  (12-­‐month)	  but	  also	  lifetime	  
prevalence	  of	  disorders	  as	  well	  as	  suicidality,	  in	  that	  it	  assesses	  numerous	  potential	  
environmental	  and	  psychosocial	  risk	  factors,	  and	  finally	  in	  that	  it	  assesses	  clinical	  
treatment,	  help-­‐seeking	  behavior,	  and	  need	  for	  care.	  
Dissertation	  aims	  and	  hypotheses	  
This	  three-­‐paper	  dissertation	  explores	  the	  clinical	  significance	  of	  psychotic	  
experiences	  in	  the	  general	  population	  in	  terms	  of	  suicidality,	  co-­‐morbidities	  with	  common	  
mental	  health	  conditions,	  and	  persistence	  of	  symptoms	  over	  time,	  with	  a	  precursor	  paper	  
exploring	  the	  validity	  of	  the	  measurement	  of	  psychotic	  experiences	  in	  this	  sample.	  The	  
hypothesis	  of	  the	  first	  paper	  is	  that	  psychotic	  experiences	  will	  be	  associated	  with	  increased	  
risk	  for	  suicidal	  thoughts	  and	  behavior,	  based	  on	  prior	  studies	  of	  psychotic	  experiences	  in	  
adolescents,	  with	  the	  competing	  null	  hypothesis	  that	  associations	  with	  suicidality	  arise	  
following	  clinical	  onset	  of	  schizophrenia	  and	  other	  psychotic	  disorders,	  and	  therefore	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would	  not	  be	  found	  for	  population-­‐level	  psychotic	  experiences.	  	  The	  hypothesis	  of	  the	  
second	  paper	  is	  that	  psychotic	  experiences	  will	  be	  associated	  with	  a	  range	  of	  common	  
mental	  disorders,	  and	  particularly	  multi-­‐comorbidity,	  although	  limited	  prior	  research	  
suggests	  that	  these	  associations	  may	  be	  limited	  exclusively	  to	  post-­‐traumatic	  stress	  
disorder.	  The	  third	  study	  is	  more	  exploratory	  in	  nature,	  predicting	  that	  persistence	  of	  
psychotic	  experience	  will	  be	  related	  to	  sociodemographic	  and	  clinical	  factors,	  with	  
particular	  attention	  given	  to	  the	  role	  of	  co-­‐morbidities	  and	  suicidal	  behaviors	  analyzed	  in	  
the	  primary	  two	  papers.	  	  
Sub-­‐threshold	  psychotic	  experiences	  are	  likely	  highly	  prevalent	  among	  recipients	  of	  
social	  work	  services,	  as	  they	  are	  in	  the	  population	  as	  a	  whole,	  but	  their	  clinical	  meaning	  has	  
been	  largely	  unexplored,	  particularly	  from	  a	  social	  work	  perspective.	  These	  papers	  
together	  will	  expand	  our	  current	  knowledge	  base	  on	  the	  clinical	  significance	  of	  sub-­‐
threshold	  psychotic	  experiences,	  and	  will	  guide	  social	  work	  and	  public	  health	  efforts	  to	  
appropriately	  respond	  to	  such	  experiences.	  
	  




Descriptive	  Data,	  Cultural	  Validity,	  and	  Social	  Desirability	  Biases	  
Epidemiological	  studies	  have	  shown	  that	  the	  prevalence	  of	  psychotic	  disorders	  is	  far	  
exceeded	  by	  that	  of	  sub-­‐threshold	  psychotic	  experiences,	  which	  are	  phenomenologically	  
similar	  to	  threshold	  psychosis	  but	  of	  less	  intensity	  or	  associated	  impairment	  (Linscott	  &	  
van	  Os	  2010;	  2013;	  van	  Os	  et	  al.,	  2009).	  The	  most	  recent	  meta-­‐analytic	  estimates	  report	  
that	  psychotic	  experiences	  occur	  with	  a	  lifetime	  prevalence	  of	  7.2%	  and	  median	  annual	  
incidence	  of	  2.5%	  in	  the	  general	  population,	  with	  substantial	  variance	  in	  prevalence	  
estimates	  reflecting	  methodological	  differences	  between	  studies	  (Linscott	  &	  van	  Os,	  2013).	  
Despite	  this	  wide	  methodological	  variance	  there	  have	  been	  very	  few	  attempts	  to	  formally	  
assess	  the	  validity	  of	  measures	  of	  psychotic	  experiences,	  although	  the	  limited	  existent	  
research	  has	  supported	  the	  use	  of	  self-­‐report	  screens	  as	  valid	  measures	  of	  clinician-­‐
assessed	  psychotic	  or	  psychosis-­‐like	  experiences	  (Kelleher,	  Harley,	  Murtagh,	  &	  Cannon,	  
2011).	  It	  is	  crucial	  to	  have	  clinically	  and	  culturally	  valid	  measures	  of	  psychotic	  experiences	  
given	  their	  importance	  as	  significant	  phenomena	  that	  may	  further	  indicate	  the	  incipient	  
onset	  of	  more	  severe	  mental	  health	  conditions.	  	  	  
This	  dissertation	  measures	  sub-­‐threshold	  psychotic	  experiences	  using	  the	  psychosis	  
screen	  from	  the	  World	  Health	  Organization	  Composite	  International	  Diagnostic	  Interview	  
(WHO-­‐CIDI),	  version	  3.0	  (Kessler	  &	  Üstun,	  2004).	  Information	  on	  the	  validity	  of	  this	  
measure	  primarily	  comes	  from	  analysis	  of	  its	  validity	  through	  reassessment	  of	  positive	  
screens	  with	  clinical	  interview	  in	  the	  predominantly	  European-­‐American	  NCS-­‐R.	  In	  this	  
analysis,	  clinicians	  classified	  16.8%	  of	  respondents	  endorsing	  psychotic	  experiences	  as	  
“probable”	  cases	  of	  non-­‐affective	  psychosis,	  with	  non-­‐affective	  psychosis	  diagnoses	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disproportionately	  applied	  in	  greater	  numbers	  to	  individuals	  with	  delusional	  experiences,	  
as	  opposed	  to	  visual	  or	  auditory	  hallucinations	  (Kessler	  et	  al.,	  2005a).	  Remaining	  positive	  
screens	  were	  identified	  by	  clinicians	  primarily	  as	  either	  “possible”	  cases	  (19.2%),	  culturally	  
appropriate	  (32.1%),	  or	  “odd	  but	  not	  psychotic”	  (26.6%).	  	  
It	  is	  not	  known	  how	  these	  findings	  would	  generalize	  to	  the	  NLAAS	  (Asians	  and	  
Latinos	  in	  the	  United	  States)	  and	  NSAL	  (African	  Americans	  and	  Afro-­‐Caribbeans	  in	  the	  
United	  States)	  samples,	  which	  vary	  from	  the	  NCS-­‐R	  primarily	  in	  terms	  of	  ethnicity	  and	  did	  
not	  include	  the	  clinical	  reappraisal	  interviews.	  The	  frequency	  with	  which	  clinicians	  
determined	  psychotic	  experiences	  to	  be	  “culturally	  appropriate”	  in	  the	  NCS-­‐R	  would	  
suggest	  that	  cultural	  and	  possibly	  ethnic	  differences	  may	  influence	  responses	  to	  screen	  
items.	  Several	  studies	  have	  shown	  ethnic	  difference	  in	  prevalence	  of	  psychotic	  experiences	  
(Johns	  et	  al.,	  2002;	  2004;	  King	  et	  al.,	  2005;	  Morgan	  et	  al.,	  2009)	  but	  it	  is	  not	  known	  if	  this	  is	  
due	  to	  true	  prevalence	  differences	  or	  due	  to	  cross-­‐cultural	  variance	  in	  the	  validity	  of	  
psychosis	  screens.	  Of	  note,	  prevalence	  of	  schizophrenia	  likewise	  varies	  by	  ethnicity	  even	  
when	  assessed	  using	  clinical	  interview,	  with	  African-­‐Americans	  in	  particular	  at	  greatest	  
risk	  for	  schizophrenia	  in	  the	  United	  States	  (Bresnahan	  et	  al.,	  2007).	  Nuevo	  and	  colleagues	  
(2009)	  found	  a	  wide	  range	  of	  prevalence	  estimates	  across	  countries	  (from	  0.8%	  to	  31.4%)	  
using	  the	  WHO-­‐CIDI	  psychosis	  screen,	  version	  3.0,	  although	  these	  symptoms	  were	  
uniformly	  associated	  with	  poorer	  health	  status	  regardless	  of	  overall	  prevalence.	  This	  
suggests	  a	  similar	  level	  of	  clinical	  significance	  across	  the	  nations	  studied,	  although	  similar	  
analyses	  have	  not	  yet	  been	  published	  across	  ethnicities	  within	  a	  single	  nation.	  	  
The	  validity	  of	  psychosis	  screens	  may	  also	  be	  influenced	  by	  social	  desirability	  bias,	  
the	  tendency	  of	  respondents	  to	  answer	  questions	  in	  a	  way	  that	  may	  be	  viewed	  favorably	  by	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others	  (Crowne	  &	  Marlowe,	  1960;	  King	  &	  Bruner,	  2000).	  Social	  desirability	  bias	  is	  common	  
in	  research	  on	  mental	  health	  (e.g.	  Davis,	  Thake,	  &	  Vilhena,	  2010;	  Soubelet	  &	  Salthouse,	  
2011),	  and	  can	  produce	  false	  positive	  associations	  or	  obscure	  true	  relationships	  (Ganster,	  
Hennesseey,	  &	  Luthans,	  1983;	  Podsakoff,	  MacKenzie,	  Lee,	  &	  Podsakoff,	  2003).	  	  Psychotic	  
experiences	  are	  publicly	  stigmatized	  as	  socially	  undesirable	  behaviors	  (Schomerus,	  
Matschinger,	  &	  Angermeyer,	  2013;	  Yang	  et	  al.,	  2013),	  particularly	  among	  African-­‐
Americans	  (Anglin,	  Link,	  &	  Phelan,	  2006),	  and	  as	  such	  may	  be	  hidden	  by	  respondents	  and	  
underreported	  across	  the	  population.	  Although	  certain	  early	  psychosis	  proneness	  scales	  
were	  developed	  to	  minimize	  social	  desirability	  bias	  (Chapman	  et	  al.,	  1994),	  there	  are	  no	  
prior	  published	  studies	  directly	  examining	  the	  relationship	  between	  social	  desirability	  and	  
self-­‐reported	  psychotic	  experiences.	  	  
	   Prior	  to	  describing	  the	  three	  studies	  that	  are	  the	  focus	  of	  the	  dissertation,	  it	  is	  
necessary	  to	  establish	  basic	  descriptive	  data	  for	  psychotic	  experiences,	  as	  the	  primary	  
variables	  of	  interest	  in	  all	  three	  papers,	  including	  their	  prevalence,	  frequency,	  and	  average	  
age	  of	  onset.	  Lifetime	  prevalence	  of	  psychotic	  experiences	  was	  expected	  to	  approximate	  
that	  found	  in	  meta-­‐analyses	  (i.e.	  7.2%;	  Linscott	  &	  van	  Os,	  2013).	  In	  addition,	  this	  precursor	  
chapter	  will	  be	  used	  to	  discuss	  the	  cross-­‐cultural	  validity	  of	  the	  measurement	  of	  psychotic	  
experiences	  in	  these	  data,	  as	  well	  as	  the	  possible	  role	  of	  social	  desirability	  biases	  in	  
endorsing	  items	  assessing	  these	  experiences.	  Cross-­‐cultural	  validity	  would	  be	  supported	  by	  
similar	  associations	  between	  psychotic	  experiences	  and	  both	  treatment-­‐seeking	  and	  social	  







Data	  for	  this	  dissertation	  were	  drawn	  from	  the	  National	  Comorbidity	  Survey-­‐
Replication	  (NCS-­‐R;	  Alegría	  et	  al.,	  2007b;	  Kessler	  et	  al.,	  2004),	  National	  Latino	  and	  Asian	  
American	  Study	  (NSAAL;	  Alegría	  et	  al.,	  2004;	  Alegría	  &	  Takeuchi,	  2007)	  and	  the	  National	  
Survey	  of	  American	  Life	  (NSAL;	  Jackson	  et	  al.,	  2004;	  Jackson	  et	  al.,	  2007).	  These	  studies	  
collectively	  compose	  the	  Collaborative	  Psychiatric	  Epidemiology	  Surveys	  (CPES;	  Alegría	  et	  
al.,	  2007a),	  creating	  a	  total	  sample	  of	  20,013	  adults	  drawn	  from	  households	  in	  the	  
contiguous	  United	  States.	  Of	  these,	  the	  psychosis	  screen	  was	  administered	  to	  a	  random	  
sub-­‐sample	  of	  the	  respondents	  of	  part	  II1	  of	  the	  NCS-­‐R	  (n=2322),	  all	  respondents	  of	  the	  
NLAAS	  (n=4644),	  and	  all	  non-­‐white	  respondents	  of	  the	  NSAL	  (n=4995).	  An	  additional	  38	  
participants	  refused	  or	  responded	  with	  “don’t	  know”	  to	  at	  least	  one	  of	  the	  psychosis	  screen	  
items	  and	  were	  therefore	  excluded,	  although	  notably	  9	  (23.7%)	  of	  these	  participants	  
endorsed	  at	  least	  one	  psychotic	  experience,	  suggesting	  that	  people	  with	  psychotic	  
experiences	  may	  have	  been	  more	  likely	  to	  refuse	  response	  to	  these	  items.	  Planned	  
exclusion	  criterion	  for	  all	  studies	  was	  the	  presence	  of	  a	  threshold	  psychotic	  disorder,	  
including	  self-­‐reported	  schizophrenia	  or	  diagnoses	  of	  Bipolar	  I	  or	  Bipolar	  II	  disorder	  
(Entire	  data	  set:	  n=318;	  of	  participants	  with	  psychosis	  screen:	  n=180).	  Diagnosis	  of	  bipolar	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Part	  I	  of	  the	  NCS-­‐R	  was	  a	  nationally	  representative	  sample	  of	  households	  in	  the	  48	  
contiguous	  United	  States.	  Respondents	  were	  selected	  into	  part	  II	  in	  three	  strata:	  1)	  all	  
participants	  who	  met	  lifetime	  criteria	  for	  any	  mental	  disorder,	  met	  subthreshold	  criteria	  
and	  sought	  treatment,	  or	  reported	  a	  lifetime	  suicide	  plan	  or	  suicide	  attempt;	  2)	  59%	  of	  Part	  
I	  respondents	  who	  ever	  met	  subthreshold	  criteria	  for	  a	  mental	  disorder,	  ever	  sought	  
mental	  health	  treatment,	  ever	  experienced	  suicidal	  ideation,	  or	  recently	  used	  psychotropic	  
medications;	  and	  3)	  25%	  of	  the	  remaining	  Part	  I	  sample.	  Weights	  were	  adjusted	  so	  that	  
Part	  II	  likewise	  constituted	  a	  nationally	  representative	  sample	  when	  weighted	  
appropriately	  (Kessler	  et	  al.,	  2004).	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I	  and	  bipolar	  II	  are	  assessed	  using	  the	  World	  Health	  Organization	  Composite	  International	  
Diagnostic	  Interview	  (WHO-­‐CIDI).	  Diagnosis	  of	  schizophrenia	  is	  based	  on	  self-­‐report	  as	  
diagnoses	  of	  schizophrenia	  by	  lay	  interviewers	  were	  considered	  unreliable	  in	  these	  data	  
and	  were	  not	  released	  to	  the	  public	  (Kessler	  et	  al.,	  2005a).	  The	  final	  sample	  among	  the	  
entire	  CPES	  data	  set,	  excluding	  respondents	  with	  diagnosable	  psychotic	  disorders	  or	  
missing	  data	  for	  psychosis	  screen	  items,	  consisted	  of	  11744	  participants	  (NCS-­‐R:	  n=2233;	  
NLAAS:	  n=4622;	  NSAL:	  n=4889).	  	  
Analysis:	  rationale,	  procedure,	  and	  description	  of	  measures	  
The	  first	  step	  of	  this	  introductory	  chapter	  was	  to	  establish	  prevalence	  and	  
descriptive	  data	  for	  all	  measures	  assessed	  in	  the	  psychosis	  screen,	  among	  the	  entire	  sample	  
using	  the	  full	  CPES	  data	  set	  (n=11744)	  and	  for	  each	  constituent	  survey.	  	  Psychosis	  screen	  
items	  included	  presence	  or	  absence	  of	  any	  psychotic	  experience	  (lifetime	  and	  past	  12-­‐
months),	  of	  six	  specific	  psychotic	  experiences	  (lifetime	  only;	  see	  Table	  1),	  number	  of	  
lifetime	  incidents	  of	  each	  psychotic	  experience,	  number	  of	  days	  with	  psychotic	  experiences	  
in	  the	  past	  12	  months,	  and	  age	  of	  psychotic	  experience	  onset.	  I	  also	  tested	  for	  associations	  
between	  12-­‐month	  psychotic	  experiences	  and	  age,	  given	  that	  past	  research	  in	  adolescents	  
has	  shown	  that	  prevalence	  of	  current	  psychotic	  experiences	  declines	  with	  increasing	  age,	  
although	  their	  clinical	  significance	  increases	  (Kelleher	  et	  al.,	  2011).	  
The	  next	  step	  of	  this	  precursor	  analysis	  was	  to	  establish	  the	  prevalence	  of	  psychotic	  
experiences	  by	  ethnicity.	  In	  this	  dissertation,	  ethnicity	  is	  divided	  into	  the	  following	  groups:	  
African-­‐American,	  Afro-­‐Caribbean,	  Asian,	  Caucasian,	  Latino,	  and	  other.	  Of	  note,	  these	  
groups	  are	  heterogeneous	  with	  individuals	  from	  multiple	  nationalities	  and	  cultures,	  but	  
were	  collapsed	  into	  five	  broad	  categories	  to	  increase	  statistical	  power.	  Prevalence	  rates	  for	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Table 1. Psychotic experiences assessed with the WHO-CIDI psychosis screen, with associated interviewer 
prompts.  
Symptom Prompt 
Visual hallucination The first thing is seeing a vision -- that is, seeing something that other people who 
were there could not see. Did you ever see a vision that other people could not 
see? 
 
Auditory hallucination The second thing is hearing voices that other people could not hear. I don't mean 
having good hearing, but rather hearing things that other people said did not exist, 
like strange voices coming from inside your head talking to you or about you, or 
voices coming out of the air when there was no one around. Did you ever hear 
voices? 
 
Thought insertion The third thing is really two. One is believing that some mysterious force was 
inserting many different strange thoughts -- that were definitely not your own 
thoughts - directly into your head by means of x-rays or laser beams or other 
methods. The other is believing that your own thoughts were being stolen out of 
your mind by some strange force. Did you ever have either of these mind control 
experiences? 
 
Thought control The fourth unusual thing is feeling that your mind was being taken over by strange 
forces with laser beams or other methods that were making you do things you did 
not choose to do. Did you ever have a time when you felt that your mind was 
being taken over by strange forces? 
 
Telepathy The fifth thing is believing that some strange force was trying to communicate 
directly with you by sending special signs or signals that you could understand but 
that no one else could understand. Sometimes this happens by special signs 
coming through the radio or television. Did you ever experience these kinds of 
attempts at communication from strange forces? 
 
Delusions of persecution Sixth, did you ever believe that there was an unjust plot going on to harm you or 
to have people follow you that your family and friends did not believe was true? 
	  
psychotic	  experiences	  may	  vary	  across	  ethnicities,	  either	  due	  to	  true	  ethnic	  disparities	  in	  
risk	  for	  psychosis	  or	  due	  to	  a	  variety	  of	  cultural	  factors,	  including	  cultural	  and	  linguistic	  
variation	  in	  understanding	  and	  interpreting	  the	  meaning	  of	  the	  items,	  and	  how	  they	  deviate	  
from	  normative	  experiences.	  Although	  it	  is	  not	  possible	  to	  entirely	  disentangle	  these	  two	  
confounded	  explanations	  for	  any	  ethnic	  disparities	  based	  on	  these	  data,	  it	  can	  be	  predicted	  
that	  ethnic	  disparities	  in	  psychotic	  experiences	  would	  not	  vastly	  differ	  from	  those	  found	  in	  
threshold	  psychotic	  disorder,	  where	  prevalence	  tends	  to	  be	  2-­‐	  to	  3-­‐fold	  greater	  among	  
African-­‐Americans	  compared	  to	  Caucasians	  (Bresnahan	  et	  al.,	  2007).	  Ethnic	  disparities	  in	  
psychotic	  experiences	  have	  not	  been	  formally	  tested	  in	  the	  United	  States,	  but	  prior	  studies	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from	  the	  United	  Kingdom	  have	  confirmed	  that	  they	  resemble	  the	  disparities	  found	  in	  
schizophrenia,	  such	  that	  black	  Caribbean	  and	  African	  individuals	  are	  at	  greater	  risk	  relative	  
to	  Caucasians	  (Johns	  et	  al.,	  2002;	  2004;	  King	  et	  al.,	  2005;	  Morgan	  et	  al.,	  2009).	  Logistic	  
regression,	  using	  dummy	  coded	  variables	  for	  each	  ethnicity	  (Caucasian	  as	  reference	  group,	  
to	  be	  consistent	  with	  prior	  studies	  of	  ethnic	  disparities	  in	  psychosis),	  will	  be	  used	  to	  test	  for	  
differences	  in	  risk	  for	  lifetime	  and	  12-­‐month	  psychotic	  experiences	  between	  ethnic	  groups.	  
To	  further	  distinguish	  possible	  causes	  for	  any	  identified	  disparities,	  associations	  between	  
psychotic	  experiences	  and	  treatment-­‐seeking	  will	  be	  tested	  within	  each	  ethnic	  group	  using	  
logistic	  regression,	  with	  the	  prediction	  that	  the	  association	  will	  be	  of	  similar	  magnitude	  if	  
each	  group	  is	  endorsing,	  on	  average,	  symptoms	  that	  carry	  a	  similar	  degree	  of	  clinical	  
significance.	  	  
The	  final	  series	  of	  analyses	  tested	  for	  social	  desirability	  biases	  in	  the	  endorsement	  of	  
psychotic	  experiences.	  CPES	  includes	  a	  10-­‐item	  social	  desirability	  scale	  with	  items	  derived	  
from	  the	  Marlowe-­‐Crowne	  social	  desirability	  scale	  (Crowne	  &	  Marlowe,	  1960)	  and	  the	  
Zuckerman	  personality	  scales	  (Zuckerman	  &	  Link,	  1968),	  with	  adequate	  internal	  
consistency	  in	  this	  sample	  (Cronbach’s	  alpha=0.68).	  Each	  of	  the	  10	  items	  is	  coded	  as	  true	  or	  
false	  and	  summed	  into	  a	  total	  score.	  In	  the	  entire	  CPES	  data	  set,	  logistic	  regression	  was	  
used	  to	  test	  for	  associations	  between	  social	  desirability	  scale	  scores	  and	  both	  lifetime	  and	  
12-­‐month	  psychotic	  experiences,	  to	  examine	  potential	  social	  desirability	  biases.	  This	  was	  
likewise	  tested	  within	  specific	  ethnic	  groups,	  and	  separately	  within	  males	  and	  females,	  to	  
determine	  whether	  the	  influence	  of	  social	  desirability	  biases	  vary	  by	  ethnicity	  or	  gender	  for	  
the	  psychosis	  screen	  items.	  Associations	  between	  the	  social	  desirability	  scale	  and	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individual	  psychotic	  experience	  subtypes	  were	  also	  tested	  in	  the	  entire	  sample,	  to	  
determine	  whether	  particular	  symptoms	  are	  more	  susceptible	  to	  social	  desirability	  biases.	  	  
All	  analyses	  were	  two-­‐tailed,	  with	  results	  considered	  statistically	  significant	  at	  
alpha=0.05.	  	  
Table 2. Prevalence and other descriptive data for psychotic experiences across survey.   
Measure Value CPES NCS-R NLAAS NSAL 
Prevalence      
   Lifetime % (SE) 8.7 (0.4) 8.7 (0.9) 8.7 (0.6) 11.1 (0.7) 
   12-m % (SE) 2.7 (0.2) 2.9 (0.5) 2.9 (0.4) 3.8 (0.4) 
      
Symptom Subtype      
   Visual hallucinations      
     Prevalence % (SE) 6.1 (0.3) 6.0 (0.6) 5.7 (0.4) 8.3 (0.6) 
     # of instances M (SD) 8.0 (1.1) 7.5 (1.4) 8.5 (1.4) 8.3 (1.2) 
   Auditory hallucinations      
     Prevalence % (SE) 3.8 (0.3) 3.8 (0.6) 4.0 (0.4) 4.7 (0.5) 
     # of instances M (SD) 13.9 (1.9) 13.5 (2.8) 10.2 (1.0) 13.3 (2.3) 
   Thought insertion      
     Prevalence % (SE) 0.3 (0.1) 0.2 (0.1) 0.5 (0.2) 0.3 (0.1) 
     # of instances M (SD) 12.7 (0.1) 6.4 (0.0) 19.4 (0.2) 18.2 (0.2) 
   Thought control      
     Prevalence % (SE) 0.1 (0.0) 0.1 (0.0) 0.2 (0.1) 0.2 (0.1) 
     # of instances M (SD) 12.3 (0.8) 9.7 (0.0) 14.2 (0.0) 7.3 (3.1) 
   Telepathy      
     Prevalence % (SE) 0.6 (0.1) 0.7 (0.2) 0.8 (0.2) 0.5 (0.1) 
     # of instances M (SD) 11.0 (1.7) 10.7 (3.8) 15.6 (0.1) 12.3 (1.6) 
   Delusions of persecution      
     Prevalence % (SE) 0.7 (0.1) 0.5 (0.1) 0.8 (0.2) 1.1 (0.3) 
     # of instances M (SD) 9.2 (1.1) 16.1 (1.3) 6.2 (0.0) 9.4 (2.7) 
      
Onset & Frequency      
   Age of onset M (SD) 25.1 (1.0) 26.9 (1.6) 21.7 (1.2) 23.3 (0.8) 
   # of instances M (SD) 25.7 (8.1) 27.7 (10.5) 18.3 (3.9) 17.4 (4.6) 
   # days (12-m) * M (SD) 37.6 (6.5) 36.4 (7.6) 21.4 (6.3) 23.6 (10.6) 




Prevalence	  and	  characteristics	  of	  psychotic	  experiences	  
Descriptive	  data	  for	  psychotic	  experiences	  is	  presented	  in	  Table	  2.	  Lifetime	  and	  12-­‐
month	  psychotic	  experiences	  were	  highly	  prevalent	  in	  this	  sample,	  with	  similar	  prevalence	  
across	  the	  three	  constituent	  data	  sets.	  Visual	  and	  auditory	  hallucinations	  were	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substantially	  more	  common	  than	  the	  four	  classes	  of	  delusional	  experiences	  across	  all	  data	  
sets.	  The	  average	  age	  of	  onset	  was	  in	  the	  mid	  twenties,	  and	  most	  people	  that	  reported	  
psychotic	  experiences	  endorsed	  numerous	  instances	  over	  the	  lifetime	  and	  past	  year.	  	  	  
Table 3. Prevalence of psychotic experiences by ethnicity.   
  Lifetime 12-m 
African-American  11.6 (0.9) 4.1 (0.4) 
Afro-Caribbean  10.7 (1.5) 5.1 (0.9) 
Asian  6.3 (0.5) 1.7 (0.4) 
Caucasian  7.6 (0.7) 2.1 (0.3) 
Latino  9.5 (0.7) 3.2 (0.5) 
Other  15.5 (12.6) 0.3 (0.3) 
Note: Prevalence values are presented as weighted % (SE) 
	  
Validity	  of	  the	  WHO-­‐CIDI	  psychosis	  screen	  across	  cultural	  groups	  
Lifetime	  and	  12-­‐month	  psychotic	  experience	  prevalence	  rates	  are	  presented	  in	  
Table	  3.	  Relative	  to	  the	  Caucasian	  reference	  group,	  African-­‐Americans,	  OR[95%	  
CI]=1.60[1.23-­‐2.07],	  Afro-­‐Caribbeans,	  OR[95%	  CI]=1.46[1.01-­‐2.11],	  and	  Latinos,	  OR[95%	  
CI]=1.28[1.00-­‐1.63]	  were	  all	  more	  likely	  to	  report	  lifetime	  psychotic	  experiences.	  The	  
pattern	  was	  similar	  for	  12-­‐month	  psychotic	  experiences,	  which	  again	  were	  more	  prevalent	  
among	  African-­‐Americans,	  OR[95%	  CI]=1.95[1.32-­‐2.88]	  and	  Afro-­‐Caribbeans,	  OR[95%	  
CI]=2.48[1.54-­‐3.98],	  but	  not	  Latinos,	  OR[95%	  CI]=1.53[0.98-­‐2.38].	  Asians	  and	  ‘other’	  did	  
not	  significantly	  differ	  from	  Caucasians	  in	  terms	  of	  prevalence	  of	  lifetime	  or	  12-­‐month	  
psychotic	  experiences.	  With	  the	  exception	  of	  the	  ‘other’	  ethnicity	  category,	  psychotic	  
experiences	  were	  associated	  with	  approximately	  3-­‐fold	  greater	  odds	  of	  seeking	  treatment	  
odds	  (OR	  range:	  2.21-­‐3.68)	  compared	  to	  respondents	  who	  did	  not	  report	  psychotic	  
experiences	  (Table	  4),	  suggesting	  that	  the	  clinical	  significance	  of	  these	  symptoms	  was	  





Table 4. Association between psychotic experiences and treatment seeking within each ethnic group.  
 Treatment-seeking (lifetime) 
 OR [95% CI] Wald χ² 
Total sample 2.46 (2.00-3.02) 73.19, p<0.001 
African-American 2.61 (2.07-3.30) 65.98, p<0.001 
Afro-Caribbean 3.68 (2.11-6.40) 21.60, p<0.001 
Asian 2.31 (1.42-3.74) 11.64, p=0.001 
Caucasian 3.00 (1.87-4.79) 21.34, p<0.001 
Latino 2.21 (1.55-3.16) 19.45, p<0.001 
Other 20.06 (1.29-312.34) 4.65, p=0.031 
Note: Odds ratios are unadjusted. Degrees of freedom = 1 for all Wald X2 tests.  
	  
Social	  desirability	  biases	  
Social	  desirability	  was	  not	  associated	  with	  reported	  psychotic	  experiences	  in	  the	  
total	  sample	  (including	  individual	  symptoms;	  data	  not	  shown),	  although	  associations	  
varied	  across	  ethnicities	  (Table	  5).	  Psychotic	  experiences	  were	  associated	  with	  higher	  	  
Table 5. Associations between social desirability and reported lifetime psychotic experiences within the entire 
sample and subgroups based on survey, gender, and ethnicity.  
 PE +  PE - Statistics 
Lifetime PE    
   CPES total 2.15 (0.08) 2.15 (0.04) F(165)=0.00, p=0.965 
   NCS-R 1.98 (0.15) 2.08 (0.06) F(42)=0.36, p=0.550 
   NLAAS 2.18 (0.12) 2.53 (0.08) F(69)=6.62, p=0.012 
   NSAL 2.32 (0.09) 1.99 (0.05) F(54)=10.23, p=0.002 
    
Gender    
   Male 2.35 (0.12) 2.12 (0.05) F(165)=3.03, p=0.084 
   Female 2.01 (0.12) 2.18 (0.05) F(165)=1.51, p=0.22 
    
Ethnicity    
   African-American 2.28 (0.10) 2.01 (0.05) F(165)=5.87, p=0.017 
   Afro-Caribbean 1.66 (0.16) 1.93 (0.08) F(165)=3.17, p=0.077 
   Asian 2.41 (0.30) 2.23 (0.09) F(165)=0.30, p=0.582 
   Caucasian 2.14 (0.12) 2.01 (0.06) F(165)=1.08, p=0.301 
   Latino 2.20 (0.13) 2.62 (0.09) F(165)=7.70, p=0.006 
   Other 0.17 (0.18) 2.27 (0.52) F(165)=21.58, p<0.001 
Notes: Values indicate mean (sd) social desirability score. All statistics are Wald F tests, based on general linear 
model with adjustments for complex sampling design. Bold indicates significance, p<0.05.  
	  
social	  desirability	  scores	  in	  the	  NSAL	  data	  set,	  and	  with	  lower	  social	  desirability	  scores	  in	  
the	  NLAAS	  data	  set.	  This	  appears	  to	  be	  explained	  by	  ethnic	  differences,	  with	  African-­‐
Americans	  showing	  a	  positive	  association	  with	  social	  desirability	  and	  Latinos	  showing	  a	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negative	  association.	  Social	  desirability	  was	  not	  differentially	  related	  to	  reporting	  of	  




	   The	  estimated	  lifetime	  and	  12-­‐month	  prevalence	  of	  psychotic	  experiences	  in	  the	  
CPES	  data	  set,	  and	  in	  all	  three	  constituent	  surveys,	  was	  similar	  to	  that	  found	  in	  prior	  
studies,	  where	  the	  most	  recent	  meta-­‐analysis	  suggests	  a	  lifetime	  prevalence	  of	  7.2%	  
(Linscott	  &	  van	  Os,	  2013).	  However,	  the	  prevalence	  of	  hallucinatory	  experiences	  (visual	  
hallucinations	  and	  hearing	  voices)	  was	  far	  greater	  than	  that	  of	  delusional	  experiences	  in	  
these	  data,	  which	  is	  not	  typical	  across	  all	  prior	  studies,	  although	  a	  similar	  prevalence	  
pattern	  (favoring	  hallucinations)	  was	  recently	  found	  in	  a	  study	  using	  clinician	  interview	  
(Zammit	  et	  al.,	  2013),	  suggesting	  that	  hallucinations	  may	  in	  fact	  be	  the	  more	  prevalent	  form	  
of	  psychotic	  experience.	  Alternatively,	  delusional	  experiences	  may	  be	  underreported	  in	  
these	  data.	  One	  possible	  explanation	  is	  that	  the	  wording	  of	  the	  delusion	  items	  lends	  itself	  to	  
a	  greater	  threshold	  of	  psychopathology,	  whereas	  the	  hallucination	  experiences	  may	  appear	  
more	  normative.	  This	  cannot	  be	  tested	  directly	  in	  these	  data	  but	  does	  have	  face	  validity	  
based	  on	  review	  of	  the	  prompts	  associated	  with	  each	  psychosis	  screen	  item.	  Also,	  it	  has	  
previously	  been	  shown	  in	  the	  NCS-­‐R	  that	  the	  delusion	  items	  are	  of	  greater	  severity,	  and	  are	  
less	  likely	  to	  be	  deemed	  “culturally	  appropriate”	  or	  “odd	  but	  not	  psychotic”	  (Kessler	  et	  al.,	  
2005a).	  Alternatively,	  respondents	  may	  view	  these	  delusional	  experiences	  as	  more	  
pathological	  or	  stigmatized,	  although	  one	  would	  then	  expect	  them	  to	  be	  differentially	  
related	  to	  social	  desirability	  relative	  to	  the	  hallucination	  items,	  which	  was	  not	  the	  case.	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Previous	  research	  has	  suggested	  that	  hallucination	  items	  are	  more	  valid	  indicators	  of	  the	  
presence	  of	  psychotic	  experiences	  in	  population	  samples,	  but	  this	  has	  only	  been	  shown	  in	  
adolescents	  (Kelleher	  et	  al.,	  2011)	  and	  may	  not	  generalize	  to	  this	  adult	  sample.	  
	   The	  average	  age	  of	  onset	  of	  psychotic	  experiences	  in	  this	  sample	  is	  at	  the	  upper	  
range	  of	  typical	  age	  of	  onset	  for	  psychotic	  disorders	  (Thompson,	  Pogue-­‐Geile,	  &	  Grace,	  
2004),	  likely	  reflecting	  the	  exclusion	  of	  adolescents	  and	  children.	  Prior	  studies	  have	  
suggested	  that	  sub-­‐threshold	  psychotic	  experiences	  are	  much	  more	  prevalent	  in	  childhood,	  
when	  they	  are	  generally	  not	  pathological,	  compared	  to	  adolescence,	  when	  they	  are	  less	  
common	  but	  associated	  with	  extensive	  comorbidity	  (Kelleher	  et	  al.,	  2012a).	  That	  is,	  these	  
experiences	  tend	  to	  become	  less	  common	  but	  more	  clinically	  significant	  over	  the	  early	  life	  
course.	  If	  this	  trajectory	  of	  declining	  prevalence	  does	  extend	  into	  adulthood,	  then	  that	  
would	  suggest	  that	  the	  age	  of	  onset	  should	  be	  during	  childhood	  or	  adolescence	  for	  most	  
respondents	  with	  lifetime	  psychotic	  experiences.	  It	  is	  likely	  that	  the	  estimated	  age	  of	  onset	  
is	  subject	  to	  some	  recall	  bias	  in	  these	  surveys,	  although	  it	  is	  within	  a	  reasonable	  range	  that	  
would	  be	  predicted	  for	  a	  valid	  measure	  of	  psychotic	  experiences	  based	  on	  the	  continuum	  
model	  (van	  Os	  et	  al.,	  2009).	  	  	  
	   Psychotic	  experiences	  were	  assessed	  in	  these	  data	  using	  lay-­‐administered	  
interviews.	  	  Meta-­‐analysis	  has	  produced	  a	  median	  lifetime	  prevalence	  estimate	  of	  11.9%	  
among	  studies	  using	  self-­‐report	  measures	  versus	  3.8%	  with	  interviews	  (Linscott	  &	  van	  Os,	  
2013).	  The	  prevalence	  presented	  in	  these	  data	  is	  more	  in	  line	  with	  that	  found	  in	  self-­‐report	  
studies.	  Lay-­‐administered	  interviews	  may	  be	  conceived	  as	  an	  approximation	  of	  self-­‐report	  
in	  that	  they	  do	  not	  involve	  clinician	  judgment;	  this	  may	  explain	  the	  higher	  prevalence	  
(relative	  to	  the	  meta-­‐analytic	  median)	  of	  psychotic	  experiences	  in	  these	  data	  relative	  to	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other	  interview	  studies.	  One	  possible	  explanation	  is	  that	  lay-­‐administered	  interviews	  may	  
have	  high	  false	  positive	  rates.	  In	  a	  clinical	  re-­‐appraisal	  study,	  Kessler	  and	  colleagues	  
(2005b)	  found	  in	  a	  subset	  of	  this	  data	  set	  that	  many	  psychotic	  experiences	  were	  better	  
classified	  as	  “culturally	  appropriate”	  or	  “odd	  but	  not	  psychotic.”	  However,	  this	  does	  not	  
negate	  their	  significance,	  as	  even	  false	  positive	  screens	  of	  psychotic	  experiences	  are	  known	  
to	  share	  risk	  factors	  with	  threshold	  psychosis	  (van	  Nierop	  et	  al.,	  2011)	  and	  to	  be	  predictive	  
of	  schizophrenia	  onset	  (Kaymaz	  et	  al.,	  2012).	  	  
	   Kessler	  and	  colleagues	  (2005b)	  previously	  reported	  on	  the	  prevalence	  of	  psychotic	  
experiences	  in	  the	  NCS-­‐R	  data	  set.	  Of	  note,	  prevalence	  estimates	  for	  the	  NCS-­‐R	  in	  this	  
analysis	  are	  slightly	  lower	  than	  those	  previously	  presented.	  Kessler	  and	  colleagues	  did	  not	  
exclude	  participants	  who	  were	  missing	  single	  items	  on	  the	  screen,	  whereas	  those	  
respondents	  were	  excluded	  in	  the	  present	  study,	  which	  would	  explain	  our	  lower	  
prevalence	  given	  that	  the	  excluded	  participants	  had	  a	  higher	  prevalence	  of	  psychotic	  
experience	  (i.e.	  those	  that	  refused	  to	  answer	  some	  questions	  were	  more	  likely	  to	  positively	  
endorse	  other	  symptoms).	  	  
Cultural	  validity	  
	   Lifetime	  and	  12-­‐month	  prevalence	  of	  psychotic	  experiences	  were	  both	  found	  to	  vary	  
by	  ethnicity,	  with	  African-­‐Americans	  and	  Afro-­‐Caribbeans	  both	  having	  higher	  prevalence	  
using	  each	  time	  frame	  and	  Latinos	  additionally	  having	  a	  higher	  prevalence	  when	  
considering	  lifetime	  only.	  Prevalence	  of	  psychotic	  experiences	  is	  known	  to	  vary	  by	  ethnicity	  
(Linscott	  &	  van	  Os,	  2010;	  van	  Os	  et	  al.,	  2009),	  although	  most	  support	  for	  this	  association	  
has	  come	  from	  one	  racial	  group	  in	  one	  country	  (Black	  Caribbean	  and	  African	  individuals	  
residing	  in	  the	  United	  Kingdom;	  Johns	  et	  al.,	  2002;	  2004;	  King	  et	  al.,	  2005;	  Morgan	  et	  al.,	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2009),	  with	  the	  same	  measure	  of	  psychotic	  experiences	  (Psychosis	  Screening	  
Questionnaire;	  PSQ,	  Bebbington	  &	  Nayani,	  1995),	  limiting	  generalizability.	  However,	  
studies	  of	  schizophrenia	  have	  shown	  that	  this	  ethnic	  disparity	  extends	  to	  the	  United	  States,	  
where	  black	  individuals	  are	  likewise	  at	  greater	  risk	  for	  psychosis	  (Bresnahan	  et	  al.,	  2007),	  
to	  a	  similar	  magnitude	  as	  found	  in	  the	  present	  analysis.	  This	  suggests	  that	  ethnic	  disparities	  
extend	  across	  the	  continuum	  of	  psychosis	  in	  the	  United	  States.	  	  
	   Alternatively,	  the	  experiences	  being	  endorsed	  in	  response	  to	  psychosis	  screen	  items	  
may	  be	  more	  normative	  in	  particular	  cultures,	  rather	  than	  pathological.	  Previous	  analysis	  
of	  the	  NCS-­‐R	  suggest	  that	  this	  may	  explain	  as	  many	  as	  one	  third	  of	  the	  hallucinatinatory	  
experiences	  but	  fewer	  of	  the	  delusional	  experiences	  (Kessler	  et	  al.,	  2005a).	  Associations	  
between	  psychotic	  experiences	  and	  treatment-­‐seeking	  were	  tested	  within	  each	  ethnic	  
group	  to	  control	  for	  varying	  clinical	  significance	  across	  ethnic	  groups;	  if	  respondents	  were	  
endorsing	  normative	  experiences	  as	  ‘psychotic’	  due	  to	  poor	  cultural	  validity	  of	  the	  items	  
than	  we	  would	  not	  expect	  these	  experiences	  to	  be	  associated	  with	  treatment-­‐seeking.	  This	  
was	  not	  found	  to	  be	  the	  case;	  rather,	  psychotic	  experiences	  were	  associated	  with	  a	  greater	  
than	  2-­‐fold	  increase	  in	  odds	  of	  seeking	  treatment	  across	  every	  ethnicity.	  Similar	  effect	  sizes	  
have	  been	  found	  in	  prior	  studies	  that	  did	  not	  test	  separately	  within	  ethnic	  groups	  
(DeVylder	  et	  al.,	  in	  press;	  Murphy	  et	  al.,	  2012).	  	  
	   In	  contrast	  to	  the	  generally	  consistent	  results	  between	  African-­‐Americans,	  Afro-­‐
Caribbeans,	  Asians,	  Caucasians,	  and	  Latinos,	  the	  ‘other’	  ethnic	  group	  showed	  some	  very	  
unusual	  patterns.	  The	  lifetime	  prevalence	  of	  psychotic	  experiences	  was	  particularly	  high	  in	  
this	  group	  (15.5%)	  whereas	  the	  12-­‐month	  prevalence	  was	  extremely	  low	  (0.3%).	  In	  
addition,	  the	  magnitude	  of	  association	  between	  psychotic	  experiences	  and	  treatment-­‐
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seeking	  was	  approximately	  8-­‐fold	  greater	  for	  the	  ‘other’	  group	  compared	  to	  the	  entire	  
sample	  or	  any	  individual	  ethnicity,	  although	  this	  estimate	  may	  be	  unreliable	  given	  the	  
exceedingly	  large	  confidence	  interval	  of	  the	  odds	  ratio	  (1.29-­‐312.34).	  This	  finding	  may	  be	  
considered	  tentative	  due	  to	  the	  limited	  sample	  size	  of	  the	  ‘other’	  group	  (and	  consequent	  
low	  statistical	  power	  and	  questionable	  reliability	  of	  the	  outcome),	  this	  may	  also	  reflect	  true	  
differences	  in	  the	  threshold	  of	  endorsing	  psychotic	  experiences,	  with	  the	  ‘other’	  group	  only	  
positively	  endorsing	  psychosis	  items	  in	  reference	  to	  significant	  and	  notable	  experiences.	  	  
Social	  desirability	  biases	  
	   No	  social	  desirability	  biases	  were	  found	  when	  considering	  the	  whole	  sample,	  
neither	  for	  psychotic	  experiences	  as	  a	  whole	  or	  for	  individual	  symptoms.	  However,	  there	  
were	  associations	  within	  specific	  surveys,	  which	  subsequent	  analysis	  showed	  were	  due	  to	  
ethnic	  differences	  in	  the	  association	  between	  psychotic	  experiences	  and	  social	  desirability.	  
Interestingly,	  the	  direction	  of	  the	  association	  varied,	  with	  a	  positive	  association	  among	  
African-­‐Americans	  and	  a	  negative	  association	  among	  Latinos.	  A	  speculative	  interpretation	  
is	  that	  greater	  social	  desirability	  biases	  among	  African	  Americans	  may	  be	  related	  to	  more	  
forthcoming	  answers,	  whereas	  the	  same	  biases	  in	  Latinos	  may	  be	  lead	  to	  the	  denial	  of	  
stigmatized	  conditions.	  Regardless	  of	  the	  explanation,	  this	  variability	  in	  the	  effects	  of	  social	  
desirability	  biases	  should	  be	  considered	  when	  interpreting	  any	  ethnic	  differences	  found	  in	  
the	  subsequent	  papers.	  	  
Conclusions	  &	  considerations:	  is	  the	  WHO-­‐CIDI	  a	  valid	  measure	  of	  psychotic	  experiences?	  	  	  
The	  measure	  of	  psychotic	  experiences	  used	  in	  these	  surveys	  appears	  to	  be	  valid	  
given	  that	  prevalence	  and	  age	  of	  onset	  fall	  in	  the	  expected	  range	  based	  on	  past	  studies	  
(reviewed	  in	  Linscott	  &	  van	  Os,	  2010;	  2013;	  van	  Os	  et	  al.,	  2009).	  Prevalence	  patterns	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between	  ethnicities	  parallel	  those	  found	  in	  the	  United	  Kingdom	  for	  psychotic	  experiences	  
(Johns	  et	  al.,	  2002;	  2004;	  King	  et	  al.,	  2005;	  Morgan	  et	  al.,	  2009)	  and	  those	  found	  in	  the	  
United	  States	  for	  schizophrenia	  (Bresnahan	  et	  al.,	  2007).	  Also,	  psychotic	  experiences	  were	  
similarly	  associated	  with	  treatment	  within	  each	  ethnic	  group,	  suggesting	  that	  the	  measure	  
consistently	  evaluates	  clinically	  significant	  symptoms	  across	  cultures.	  Finally,	  social	  
desirability	  biases	  appear	  to	  have	  minimal	  influence	  on	  results	  except	  when	  considering	  
individual	  ethnic	  groups.	  Clinical	  reappraisal	  of	  positive	  psychosis	  screens,	  as	  was	  
previously	  done	  with	  the	  NCS-­‐R	  (Kessler	  et	  al.,	  2005a)	  would	  have	  been	  the	  ideal	  way	  to	  
test	  cultural	  validity,	  but	  unfortunately	  was	  not	  carried	  out	  with	  the	  NLAAS	  and	  NSAL	  and	  
was	  not	  possible	  in	  this	  secondary	  analysis.	  	  
	   Although	  these	  preliminary	  results	  generally	  support	  the	  psychosis	  screen	  as	  a	  valid	  
measure	  of	  psychotic	  experiences,	  they	  also	  highlight	  some	  limitations	  in	  the	  data	  that	  need	  
to	  be	  considered	  when	  interpreting	  subsequent	  results.	  First,	  the	  prevalence	  of	  delusional	  
experiences	  is	  low	  compared	  to	  hallucinatory	  experiences	  in	  this	  sample	  and	  compared	  to	  
the	  prevalence	  of	  delusional	  experiences	  in	  past	  studies	  (Linscott	  &	  van	  Os,	  2013).	  It	  is	  
possible	  that	  the	  threshold	  for	  endorsing	  these	  items	  is	  at	  a	  more	  severe	  point	  along	  the	  
psychosis	  continuum,	  and	  may	  produce	  differential	  results	  when	  considering	  
hallucinations	  and	  delusions	  separately.	  The	  lower	  prevalence	  of	  delusional	  experiences	  
also	  means	  that	  the	  variable	  representing	  the	  presence	  or	  absence	  of	  any	  psychotic	  
experience	  will	  be	  disproportionately	  indicative	  of	  hallucinations,	  which	  are	  relatively	  
common,	  rather	  than	  delusions,	  which	  are	  comparatively	  rare.	  A	  second	  point	  pertaining	  to	  
the	  psychosis	  screen	  is	  that	  the	  age	  of	  onset	  is	  higher	  than	  expected,	  given	  that	  psychotic	  
experiences	  are	  generally	  believed	  to	  onset	  in	  children	  or	  adolescents	  (who	  were	  not	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included	  in	  these	  surveys);	  however,	  this	  is	  not	  a	  key	  variable	  of	  interest	  in	  the	  remainder	  
of	  the	  dissertation.	  Two	  final	  points	  pertain	  to	  ethnicity	  in	  this	  data	  set.	  First,	  the	  measure	  
of	  psychotic	  experiences	  among	  the	  ‘other’	  group	  follows	  a	  distinct	  pattern	  from	  the	  
remaining	  ethnic	  groups,	  possibly	  due	  to	  heterogeneity	  or	  small	  sample	  size	  of	  this	  group.	  
Regardless,	  any	  findings	  that	  specifically	  pertain	  to	  the	  ‘other’	  ethnic	  group	  should	  be	  
considered	  tentative.	  Finally,	  although	  social	  desirability	  is	  not	  related	  to	  psychotic	  
experiences	  in	  the	  entire	  sample,	  it	  is	  related	  within	  African-­‐Americans	  and	  Asians,	  and	  
therefore	  will	  be	  considered	  for	  analyses	  specifically	  assessing	  associations	  within	  ethnic	  
groups.	  	  




Suicidal	  Ideation	  and	  Attempts	  
	   Suicide	  is	  a	  leading	  cause	  of	  preventable	  death	  in	  the	  United	  States	  and	  worldwide,	  
accounting	  globally	  for	  nearly	  one	  million	  deaths	  annually	  (Beaglehole,	  Irwin,	  &	  Prentice,	  
2003),	  with	  approximately	  0.4-­‐0.6%	  of	  the	  United	  States	  population	  attempting	  suicide	  
each	  year	  	  (Kessler,	  Berglund,	  Borges,	  Nock,	  &	  Wang,	  2005a).	  Psychiatric	  disorders	  are	  
present	  in	  nearly	  all	  individuals	  who	  report	  suicidal	  thoughts	  or	  behavior	  (Bertolote	  &	  
Fleischmann,	  2002;	  Kessler	  et	  al.,	  2005b),	  with	  schizophrenia	  accounting	  for	  approximately	  
14%	  of	  completed	  suicides	  worldwide	  (Bertolote,	  Fleischmann,	  De	  Leo,	  &	  Wasserman,	  
2004).	  It	  is	  conceivable	  that	  vulnerability	  towards	  suicide	  may	  extend	  beyond	  categorical	  
diagnostic	  boundaries	  to	  broader	  pathological	  phenotypes.	  This	  paper	  aims	  to	  examine	  the	  
association	  between	  sub-­‐threshold	  psychosis	  and	  suicidal	  thoughts	  and	  behavior.	  
Suicidality	  in	  psychotic	  disorders	  
	   Suicide	  is	  a	  common	  cause	  of	  death	  associated	  with	  psychotic	  disorders,	  with	  a	  5%	  
estimated	  lifetime	  prevalence	  of	  completed	  suicide	  among	  people	  with	  schizophrenia	  
(Palmer,	  Pankratz,	  &	  Bostwick,	  2005).	  Compared	  to	  people	  without	  psychotic	  disorders,	  
those	  with	  schizophrenia	  are	  more	  likely	  to	  make	  attempts	  using	  higher-­‐risk	  methods	  
(Koeda	  et	  al.,	  2012)	  and	  with	  greater	  intent	  to	  die	  (Harkavy-­‐Friedman	  et	  al.,	  1999).	  
Threshold	  psychotic	  disorder	  is	  also	  prospectively	  associated	  with	  increased	  risk	  for	  later	  
suicide	  among	  individuals	  previously	  hospitalized	  for	  suicide	  attempts	  or	  ideation	  (Wenzel	  
et	  al.,	  2011).	  Risk	  for	  completed	  suicide	  is	  greater	  among	  individuals	  with	  delusions	  
(Fenton,	  McGlashan,	  Victor,	  &	  Blyler,	  1997)	  and	  generally	  lower	  among	  those	  with	  
hallucinations	  (Hawton,	  Sutton,	  Haw,	  Sinclair,	  &	  Deeks,	  2005),	  although	  attempts	  are	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sometimes	  made	  directly	  in	  response	  to	  command	  hallucinations	  (Harkavy-­‐Friedman	  et	  al.,	  
2003;	  Wong	  et	  al.,	  2013).	  Risk	  for	  suicidal	  behavior	  among	  those	  with	  schizophrenia	  may	  
also	  be	  elevated	  in	  the	  context	  of	  substance	  use	  (Hawton	  et	  al.,	  2005)	  and	  depression,	  
although	  significant	  risk	  remains	  in	  the	  absence	  of	  depression	  as	  well	  (Harkavy-­‐Friedman,	  
Nelson,	  Venarde,	  &	  Mann,	  2004).	  Additional	  risk	  factors	  for	  suicide	  among	  people	  with	  
schizophrenia	  are	  younger	  age,	  male	  gender,	  and	  higher	  level	  of	  education	  (Hor	  &	  Taylor,	  
2010).	  	  
Of	  note,	  symptoms	  do	  not	  have	  to	  be	  long-­‐standing	  to	  lead	  to	  suicidal	  thoughts	  or	  
behavior:	  risk	  for	  completed	  suicides	  as	  well	  as	  thoughts,	  plans,	  and	  attempts	  is	  greatest	  in	  
schizophrenia	  following	  the	  first	  psychotic	  episode	  (Bertelsen	  et	  al.,	  2007;	  Dutta	  et	  al.,	  
2010),	  and	  risk	  for	  suicide	  is	  comparable	  between	  chronic	  conditions,	  including	  
schizophrenia	  and	  bipolar	  disorder,	  and	  brief	  psychotic	  states,	  including	  ICD-­‐10	  acute	  and	  
transient	  psychotic	  disorders	  (duration	  1-­‐3	  months,	  similar	  to	  DSM-­‐IV	  ‘brief	  psychotic	  
disorder’).	  The	  increased	  suicide	  risk	  following	  the	  first	  psychotic	  episode,	  however,	  is	  also	  
suggestive	  that	  suicidality	  may	  be	  a	  reaction	  to	  the	  diagnosis,	  onset	  of	  the	  clinical	  condition,	  
or	  the	  disruption	  in	  social,	  familial,	  and	  role	  function	  that	  frequently	  accompanies	  onset.	  
There	  has	  been	  mixed	  evidence	  that	  suicide	  risk	  may	  be	  greater	  among	  individuals	  with	  
more	  insight	  into	  the	  illness	  (Lincoln,	  Lullmann,	  &	  Rieff,	  2007;	  Lopez-­‐Morinigo,	  Ramos-­‐
Ríos,	  David,	  &	  Dutta,	  2012)	  and	  superior	  neurocognitive	  function	  (Kim,	  Jayathilake,	  &	  
Meltzer,	  2003),	  further	  suggesting	  that	  suicidality	  may	  reflect	  initial	  awareness	  of	  
psychosis	  onset.	  If	  such	  is	  the	  case,	  the	  association	  between	  psychosis	  and	  suicide	  may	  not	  




	   There	  is	  now	  strong	  evidence	  that	  psychosis	  occurs	  on	  a	  population-­‐level	  
continuum,	  with	  a	  substantially	  greater	  prevalence	  of	  psychotic	  experiences	  relative	  to	  full	  
psychotic	  disorders	  (Linscott	  &	  van	  Os,	  2010;	  2013;	  van	  Os	  et	  al.,	  2009).	  These	  symptoms	  
alone	  have	  rather	  poor	  predictive	  value	  for	  identifying	  individuals	  who	  will	  later	  develop	  
schizophrenia	  (Schultze-­‐Lutter	  et	  al.,	  in	  press;	  Werbeloff	  et	  al.,	  2012),	  but	  may	  be	  clinically	  
relevant	  in	  themselves.	  Studies	  have	  shown	  that	  psychotic	  experiences	  are	  associated	  with	  
psychological	  distress	  (Armando	  et	  al.,	  2010;	  Cohen	  &	  Marino,	  2013;	  Yung	  et	  al.,	  2006;	  
2009),	  as	  well	  as	  greater	  need	  for	  care	  and	  utilization	  of	  mental	  health	  services	  (Bak	  et	  al.,	  
2005;	  DeVylder	  et	  al.,	  in	  press;	  Murphy	  et	  al.,	  2012).	  They	  also	  are	  associated	  with	  greater	  
severity	  of	  affective	  and	  anxiety	  disorders,	  although	  this	  has	  only	  been	  shown	  in	  
adolescents	  and	  young	  adults	  and	  may	  not	  generalize	  across	  the	  life	  course	  (Kelleher	  et	  al.,	  
2012a;	  2013a;	  Wigman	  et	  al.,	  2012).	  Given	  the	  drastically	  elevated	  rates	  of	  suicide	  and	  
suicide-­‐related	  behavior	  among	  individuals	  with	  psychotic	  disorders,	  it	  can	  be	  predicted	  
that	  suicidality	  may	  also	  be	  associated	  with	  the	  sub-­‐threshold	  range	  of	  the	  psychosis	  
continuum.	  
Suicidality	  with	  psychotic	  experiences	  
	   There	  has	  been	  limited	  research	  on	  suicidality	  among	  individuals	  with	  psychotic	  
experiences.	  One	  population-­‐based	  study	  of	  adolescents	  in	  Ireland	  found	  that	  psychotic	  
experiences	  were	  associated	  with	  approximately	  10-­‐fold	  odds	  of	  any	  suicidal	  behavior,	  
including	  ideation,	  plans,	  or	  attempts,	  particularly	  among	  youth	  with	  co-­‐occurring	  
depressive	  disorders,	  and	  were	  further	  associated	  with	  greatly	  increased	  odds	  (OR=19.6)	  
of	  suicide	  plans	  or	  attempts	  among	  those	  with	  ideation	  (Kelleher	  et	  al.,	  2012b).	  Similar	  but	  
weaker	  associations	  were	  identified	  between	  psychotic	  experiences	  and	  suicidal	  ideation	  
	  
	  25	  
(OR=3.1)	  and	  self-­‐harm	  behaviors	  (OR=3.1)	  among	  adolescents	  in	  Japan	  (Nishida	  et	  al.,	  
2010)	  and	  between	  specifically	  delusional	  experiences	  and	  suicidal	  thoughts	  and	  behavior	  
among	  adults	  in	  Australia	  (Saha	  et	  al.,	  2011a).	  In	  a	  prospective	  cohort	  study	  in	  New	  
Zealand,	  11-­‐year	  olds	  who	  were	  assessed	  as	  having	  psychotic	  experiences	  were	  more	  likely	  
to	  attempt	  suicide	  by	  age	  38,	  controlling	  for	  demographic	  and	  clinical	  factors	  (Fisher	  et	  al.,	  
2013).	  A	  prospective	  relationship	  between	  psychotic	  experiences	  and	  suicidality	  has	  
likewise	  been	  recently	  shown	  in	  adolescents,	  where	  20%	  of	  those	  reporting	  psychotic	  
experiences	  subsequently	  attempt	  suicide	  over	  the	  following	  year	  (OR=11.3;	  Kelleher	  et	  al.,	  
2013b).	  	  
The	  population-­‐based	  research	  on	  associations	  between	  psychotic	  experiences	  and	  
suicidality	  is	  in	  concurrence	  with	  findings	  from	  clinical	  high	  risk	  cohort	  studies	  (i.e.	  
samples	  of	  help-­‐seeking	  youth	  with	  psychotic	  experiences,	  with	  enriched	  recruitment	  
criteria	  to	  maximize	  risk	  for	  schizophrenia;	  Miller	  et	  al.,	  2003),	  where	  as	  many	  as	  1/3	  of	  
respondents	  endorse	  suicidal	  ideation	  over	  a	  one-­‐week	  period	  (DeVylder	  et	  al.,	  2012),	  and	  
in	  clinical	  samples	  of	  adolescents	  at	  a	  public	  mental	  health	  outpatient	  service	  (Kelleher	  et	  
al.,	  2013a)	  and	  among	  adults	  presenting	  with	  attenuated	  hallucinations	  in	  a	  psychiatric	  
emergency	  setting	  (Penagaluri,	  Walker,	  &	  El-­‐Mallakh,	  2010).	  	  
Specific	  aims	  
	   The	  purpose	  of	  this	  study	  is	  to	  examine	  the	  association	  between	  12-­‐month	  psychotic	  
experiences	  and	  concurrent	  suicidal	  ideation	  and	  suicide	  attempts	  among	  a	  large	  general	  
population	  sample	  of	  adults	  living	  in	  the	  United	  States.	  Several	  specific	  aims	  will	  be	  
addressed.	  First,	  prevalence	  of	  suicide	  ideation	  and	  attempts	  will	  be	  compared	  between	  
those	  with	  and	  without	  psychotic	  experiences,	  with	  the	  hypothesis	  that	  there	  would	  be	  a	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positive	  association	  between	  psychotic	  experiences	  and	  suicidality	  in	  this	  sample,	  as	  
suggested	  by	  prior	  studies	  (Fisher	  et	  al.,	  2013;	  Kelleher	  et	  al.,	  2012b;	  2013b;	  Nishida	  et	  al.,	  
2010;	  Saha	  et	  al.,	  2011a).	  Second,	  associations	  with	  suicidality	  were	  tested	  separately	  for	  
delusional	  experiences	  and	  hallucinations	  to	  determine	  whether	  these	  associations	  varied	  
by	  symptom	  subtype.	  Third,	  psychotic	  experiences	  were	  recoded	  according	  to	  number	  of	  
days	  impaired	  over	  the	  past	  year,	  in	  order	  to	  test	  for	  a	  dose-­‐response	  relationship	  between	  
psychotic	  experiences	  and	  suicidality,	  which	  would	  support	  a	  causal	  link	  between	  the	  two	  
clinical	  phenomena.	  Forth,	  exploratory	  moderation	  analyses	  tested	  whether	  any	  
relationship	  between	  suicidality	  and	  psychotic	  experiences	  varies	  by	  the	  presence	  of	  co-­‐
occurring	  mental	  disorders	  or	  by	  selected	  demographic	  factors.	  Psychotic	  experiences	  may	  
be	  particularly	  associated	  with	  suicidality	  when	  occurring	  in	  the	  context	  of	  depressive	  and	  
anxiety	  disorders,	  given	  that	  they	  are	  known	  to	  modify	  the	  severity	  of	  these	  disorders	  in	  
young	  adults	  (Wigman	  et	  al.,	  2012).	  The	  association	  may	  also	  be	  more	  pronounced	  among	  
males	  and	  individuals	  with	  higher	  education,	  as	  has	  been	  found	  in	  threshold	  psychotic	  
disorders	  (Hor	  &	  Taylor,	  2010).	  Finally,	  I	  tested	  for	  an	  association	  between	  psychotic	  
experiences	  and	  greater	  severity	  of	  suicidality,	  both	  by	  testing	  for	  risk	  of	  suicide	  attempts	  
among	  the	  subgroup	  endorsing	  ideation,	  and	  for	  intent	  to	  die	  among	  the	  subgroup	  
endorsing	  attempts.	  Given	  that	  threshold	  psychosis	  is	  associated	  with	  severe	  attempts	  
(Harkavy-­‐Friedman	  et	  al.,	  1999;	  Koeda	  et	  al.,	  2012),	  it	  was	  predicted	  that	  this	  would	  also	  
hold	  true	  for	  psychotic	  experiences.	  Alternatively,	  if	  suicidality	  in	  threshold	  psychosis	  is	  a	  
reaction	  to	  illness	  onset	  then	  this	  association	  should	  not	  generalize	  to	  individuals	  with	  sub-­‐






	   The	  Collaborative	  Psychiatric	  Epidemiology	  Surveys	  (CPES;	  Alegría	  et	  al.,	  2007a)	  is	  a	  
national	  household	  survey	  of	  20,013	  adults,	  age	  18	  and	  over.	  CPES	  data	  is	  assembled	  from	  
three	  constituent	  surveys	  conducted	  in	  the	  United	  States:	  1)	  the	  National	  Comorbidity	  
Survey-­‐Replication	  (NCS-­‐R),	  a	  nationally	  representative	  sample	  (Alegría	  et	  al.,	  2007b;	  
Kessler	  et	  al.,	  2004),	  2)	  the	  National	  Latino	  and	  Asian	  American	  Study	  (NLAAS),	  a	  national	  
area	  probability	  sample	  with	  supplements	  for	  adults	  of	  Latino	  and	  Asian	  national	  origin	  
(Alegría	  et	  al.,	  2004;	  Alegría	  &	  Takeuchi,	  2007),	  and	  3)	  the	  National	  Survey	  of	  American	  Life	  
(NSAL),	  a	  nationally	  representative	  sample	  of	  African-­‐Americans,	  with	  Afro-­‐Caribbean	  and	  
non-­‐Hispanic	  white	  adults	  drawn	  from	  the	  same	  source	  population	  and	  of	  similar	  
socioeconomic	  status	  (Jackson	  2004;	  2007).	  All	  surveys	  utilized	  multi-­‐stage	  clustered	  
sampling	  designs	  (Heeringa	  et	  al.,	  2004).	  Respondents	  were	  included	  if	  they	  were	  assessed	  
with	  the	  non-­‐affective	  psychosis	  screen,	  which	  was	  administered	  to	  a	  random	  sub-­‐sample	  
of	  the	  respondents	  of	  the	  NCS-­‐R	  (n=2322),	  all	  respondents	  of	  the	  NLAAS	  (n=4644),	  and	  all	  
non-­‐white	  respondents	  of	  the	  NSAL	  (n=4995).	  Because	  the	  focus	  of	  this	  study	  is	  on	  sub-­‐
threshold	  psychosis,	  participants	  were	  excluded	  if	  they	  had	  a	  lifetime	  psychotic	  disorder,	  
defined	  as	  a	  self-­‐reported	  a	  lifetime	  diagnosis	  of	  schizophrenia	  or	  meeting	  WHO-­‐CIDI	  
criteria	  for	  lifetime	  bipolar	  disorder.	  Participants	  were	  also	  excluded	  if	  they	  were	  missing	  
data	  for	  any	  of	  the	  variables	  of	  interest.	  The	  final	  sample	  for	  this	  study	  consisted	  of	  11,716	  
respondents.	  	  
Measures	  	  
	   Demographics	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Demographic	  information	  (age,	  sex,	  race,	  years	  of	  education,	  employment	  status,	  
marital	  status)	  was	  reported	  by	  respondents.	  Age	  was	  recoded	  into	  three	  groups	  (18-­‐29	  
years,	  30-­‐44	  years,	  45	  years	  or	  greater).	  The	  age	  range	  of	  the	  oldest	  group	  was	  very	  wide	  to	  
accommodate	  the	  low	  frequency	  of	  12-­‐month	  psychotic	  experiences	  among	  older	  adults	  in	  
this	  sample	  (Borges	  et	  al.,	  2006).	  Race	  was	  coded	  into	  five	  categories	  (non-­‐Latino	  black,	  
non-­‐Latino	  white,	  Latino,	  Asian,	  and	  other);	  low	  prevalence	  of	  psychosis	  and	  suicidality	  
precluded	  analysis	  using	  more	  specific	  groupings	  by	  nationality.	  Years	  of	  education	  was	  
broadly	  coded	  into	  two	  categories	  representing	  participants	  who	  did	  not	  attend	  college	  and	  
those	  who	  attended	  at	  least	  some	  college.	  Marital	  status	  was	  coded	  as	  married,	  single	  (i.e.	  
never	  married),	  or	  previously	  married,	  which	  included	  people	  who	  were	  divorced,	  
separated,	  or	  widowed.	  Employment	  status	  was	  coded	  as	  currently	  employed,	  currently	  
unemployed,	  or	  not	  in	  the	  labor	  force.	  	  
Social	  desirability	  
Social	  desirability	  was	  measured	  through	  the	  sum	  score	  of	  a	  10-­‐item	  (true/false)	  
scale,	  with	  items	  derived	  from	  the	  Marlowe-­‐Crowne	  social	  desirability	  scale	  (Crowne	  &	  
Marlowe,	  1960)	  and	  the	  Zuckerman	  personality	  scale	  (Zuckerman	  &	  Link,	  1968).	  	  
	   Psychotic	  experiences	  
Psychotic	  experiences	  were	  assessed	  in	  the	  CPES	  data	  set	  out	  using	  the	  WHO-­‐CIDI	  
3.0	  psychosis	  screen,	  which	  improved	  on	  previous	  epidemiological	  psychosis	  assessments	  
by	  reducing	  the	  frequency	  of	  false	  positives	  (Kessler	  et	  al.,	  2005a).	  	  Respondents	  were	  
asked	  to	  report	  the	  lifetime	  presence	  of	  six	  specific	  psychotic	  experiences	  from	  the	  WHO-­‐
CIDI	  3.0	  psychosis	  screen	  including	  two	  types	  of	  hallucinations	  (visual	  and	  auditory	  
hallucinations)	  and	  four	  types	  of	  delusional	  experiences	  (thought	  insertion,	  thought	  
	  
	  29	  
control,	  telepathy,	  and	  delusions	  of	  persecution).	  Responses	  were	  excluded	  if	  the	  
experience	  took	  place	  in	  the	  context	  of	  falling	  asleep,	  dreaming,	  or	  substance	  use.	  Those	  
with	  any	  lifetime	  experiences	  were	  asked	  whether	  the	  psychotic	  experiences	  had	  taken	  
place	  in	  the	  past	  12	  months,	  and	  how	  many	  days	  they	  occurred	  during	  that	  12-­‐month	  
period.	  	  
	   CIDI	  diagnoses	  
CIDI	  diagnoses	  are	  widely	  utilized	  in	  psychiatric	  epidemiology	  studies,	  having	  been	  
used	  to	  establish	  national	  and	  international	  prevalence	  estimates	  of	  many	  psychiatric	  
disorders	  (e.g.	  Kessler	  et	  al.,	  1994;	  2005c;	  2005d;	  2007),	  and	  are	  generally	  in	  concordance	  
with	  diagnoses	  determined	  through	  clinical	  interview	  using	  the	  Structured	  Clinical	  
Interview	  for	  DSM-­‐IV	  diagnoses	  (Haro	  et	  al.,	  2006).	  Clinical	  variables	  of	  interest	  were	  12-­‐
month	  diagnoses	  of	  axis	  I	  disorders,	  as	  defined	  by	  the	  Diagnostic	  and	  Statistical	  Manual	  of	  
Mental	  Disorders,	  fourth	  edition	  (DSM-­‐IV).	  	  Affective	  disorders	  included	  include	  major	  
depressive	  disorder	  and	  dysthymia.	  Anxiety	  disorders	  included	  generalized	  anxiety	  
disorder,	  agoraphobia	  with	  and	  without	  panic	  disorder,	  panic	  disorder,	  social	  phobia,	  and	  
post-­‐traumatic	  stress	  disorder.	  Drug	  use	  disorders	  included	  drug	  abuse	  and	  dependence,	  
and	  alcohol	  use	  disorders	  included	  both	  alcohol	  abuse	  and	  dependence.	  	  
Suicidality	  
	   The	  suicidality	  section	  of	  the	  interview	  was	  provided	  as	  a	  written	  self-­‐report	  
module	  for	  respondents	  literate	  in	  English,	  81.4%	  (se=1.4),	  which	  has	  been	  shown	  to	  
facilitate	  accurate	  reporting	  of	  socially	  undesirable	  behaviors	  (Turner	  et	  al.,	  1998).	  The	  
remaining	  respondents,	  17.4%	  (se=1.4)	  were	  asked	  the	  suicidality	  items	  orally.	  Suicidality	  
variables	  were	  collapsed	  across	  response	  type	  as	  prevalence	  of	  suicidal	  ideation	  and	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suicide	  attempts	  did	  not	  vary	  by	  mode	  of	  response.	  Respondents	  reported	  whether	  they	  
had	  ever	  seriously	  thought	  about	  committing	  suicide	  and	  whether	  they	  had	  ever	  attempted	  
suicide.	  They	  were	  then	  asked	  whether	  each	  of	  these	  events	  had	  ever	  occurred	  during	  the	  
12-­‐month	  period	  prior	  to	  the	  interview.	  Positive	  responses	  were	  confirmed	  through	  
follow-­‐up	  questions	  assessing	  the	  time	  of	  first	  and	  last	  thoughts	  or	  attempts,	  number	  of	  
lifetime	  instances,	  and	  subjective	  seriousness	  of	  attempts.	  Past	  year	  suicidal	  ideation	  and	  
suicide	  attempt	  measures	  were	  recorded	  as	  dichotomous	  (present/absent)	  variables.	  
Intent	  to	  die	  was	  assessed	  among	  those	  who	  attempted	  suicide	  by	  asking	  respondents	  
whether	  their	  most	  recent	  attempt	  was	  best	  described	  as	  “a	  serious	  attempt	  to	  kill	  myself	  
and	  it	  was	  only	  luck	  that	  I	  did	  not	  succeed,”	  with	  positive	  responses	  classified	  as	  severe	  
attempt	  with	  intent	  to	  die,	  in	  contrast	  to	  positive	  responses	  to	  “I	  tried	  to	  kill	  myself,	  but	  I	  
knew	  the	  method	  was	  not	  fool-­‐proof,”	  or	  “my	  attempt	  was	  a	  cry	  for	  help,	  I	  did	  not	  want	  to	  
die.”	  Because	  intent	  was	  only	  assessed	  for	  the	  most	  recent	  attempt	  and	  respondents	  may	  
have	  made	  multiple	  attempts	  in	  the	  past	  year	  (with	  degree	  of	  intent	  known	  to	  vary	  across	  
attempts;	  Nock	  &	  Kessler,	  2006),	  suicide	  attempts	  were	  coded	  in	  the	  primary	  analysis	  to	  
include	  all	  self-­‐reported	  attempts,	  regardless	  of	  level	  of	  intent.	  A	  secondary	  analysis	  of	  
severity	  of	  suicidality,	  described	  below,	  then	  tested	  between	  those	  with	  and	  without	  intent	  
to	  die	  during	  their	  most	  recent	  attempt.	  	  
Statistical	  analyses	  
	   All	  analyses	  were	  conducted	  using	  the	  complex	  sample	  features	  of	  SPSS	  version	  21.	  
Design-­‐based	  analyses	  were	  used	  to	  estimate	  standard	  errors	  that	  accounted	  for	  the	  
complex	  multistage	  clustered	  design	  of	  the	  CPES	  sample.	  All	  statistical	  estimates	  were	  
weighted	  using	  CPES	  sampling	  weights	  to	  account	  for	  individual-­‐level	  sampling	  factors	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including	  non-­‐response	  and	  unequal	  probabilities	  of	  selection.	  	  Modified	  weights	  were	  
created	  for	  the	  purpose	  of	  this	  study,	  in	  which	  NCS-­‐R	  respondents	  were	  additionally	  
weighted	  proportionately	  to	  the	  inverse	  of	  their	  odds	  of	  being	  randomly	  selected	  from	  the	  
NCS-­‐R	  pool	  to	  receive	  the	  psychosis	  screen	  (i.e.	  5692/2322=2.4513).	  Subsequent	  analyses	  
revealed	  negligible	  differences	  in	  results	  regardless	  of	  which	  weight	  variable	  was	  used.	  
Therefore,	  all	  results	  will	  be	  presented	  using	  the	  original	  CPES	  weight	  included	  in	  the	  data	  
set,	  which	  was	  calculated	  with	  close	  attention	  to	  sampling	  parameters	  and	  which	  
consistently	  yielded	  more	  conservative	  results	  in	  the	  following	  analyses.	  	  
	   Primary	  analyses	  
The	  prevalence	  of	  each	  12-­‐month	  suicidality	  outcome	  was	  assessed	  among	  those	  
with	  and	  without	  12-­‐month	  psychotic	  experiences.	  Odds	  ratios	  were	  calculated	  using	  
blocked	  hierarchical	  logistic	  regression.	  First,	  bivariate	  logistic	  regression	  analyses	  were	  
used	  to	  determine	  whether	  those	  with	  psychotic	  experiences	  were	  at	  increased	  risk	  for	  
both	  measures	  of	  suicidality,	  with	  significance	  tested	  using	  Wald	  chi-­‐square	  tests,	  two-­‐
tailed	  alpha	  =	  0.05.	  In	  the	  second	  block,	  the	  logistic	  regression	  analyses	  were	  repeated	  with	  
adjustments	  for	  potential	  demographic	  confounders,	  given	  that	  prevalence	  of	  both	  
psychotic	  experiences	  and	  suicidality	  are	  known	  to	  vary	  across	  demographic	  groups	  in	  the	  
population	  (Kessler	  et	  al.,	  2005a;	  2005b;	  Linscott	  &	  van	  Os,	  2010;	  2013).	  Demographic	  and	  
social	  desirability	  factors	  were	  included	  as	  potential	  confounders	  if	  they	  were	  significantly	  
associated	  with	  both	  12-­‐month	  psychotic	  experiences	  and	  either	  suicidality	  variable	  at	  
least	  at	  a	  broad	  trend	  level	  (alpha=0.15).	  In	  the	  third	  and	  final	  block,	  clinical	  variables	  were	  
added	  (diagnosis	  of	  a	  depressive,	  anxiety,	  or	  substance	  use	  disorder)	  as	  predictors	  to	  
determine	  whether	  associations	  with	  psychotic	  experiences	  were	  independent	  of	  other	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mental	  health	  conditions,	  which	  have	  been	  shown	  to	  frequently	  co-­‐occur	  with	  psychotic	  
experiences	  in	  previous	  epidemiological	  studies	  (Kelleher	  et	  al.,	  2012a;	  Varghese	  et	  al.,	  
2011;	  Wigman	  et	  al.	  2012).	  Using	  the	  fully	  adjusted	  model,	  adjusted	  odds	  ratios	  were	  
calculated	  for	  the	  association	  between	  subtypes	  of	  psychotic	  experiences	  (visual	  or	  
auditory	  hallucinations,	  delusional	  experiences)	  and	  indicators	  of	  12-­‐month	  suicidal	  
ideation	  and	  attempts,	  to	  determine	  whether	  associations	  between	  psychotic	  experiences	  
and	  suicidality	  were	  primarily	  driven	  by	  a	  particular	  symptom	  class.	  	  
Dose-­‐response	  relationship	  
Next,	  psychotic	  experience	  exposure	  was	  recoded	  based	  on	  the	  number	  of	  days	  of	  
reported	  psychotic	  experiences	  in	  the	  past	  year,	  rather	  than	  the	  simple	  dichotomous	  
presence	  or	  absence	  of	  any	  psychotic	  experience,	  in	  order	  to	  test	  for	  a	  dose-­‐response	  
relationship	  between	  psychotic	  experiences	  and	  suicidality.	  This	  was	  tested	  using	  logistic	  
regression	  analyses	  with	  predictor	  variables	  indicating	  never	  (0	  days;	  reference	  group),	  
rarely	  (1-­‐2	  days/year),	  occasionally	  (3-­‐11	  days/year),	  or	  at	  greater	  than	  monthly	  (12	  or	  
more	  days/years)	  instances	  experiencing	  psychotic	  symptoms	  in	  the	  past	  year,	  using	  the	  
fully	  adjusted	  model.	  A	  dose-­‐response	  relationship	  would	  be	  indicated	  if	  the	  odds	  ratios	  
associated	  with	  suicidal	  ideation	  and	  suicide	  attempts	  progressively	  increase	  as	  the	  
number	  of	  days	  of	  psychotic	  experiences	  increases,	  with	  a	  significant	  linear	  trend.	  Dose-­‐
response	  relationships	  were	  examined	  for	  frequency	  of	  any	  psychotic	  experience	  
(hallucinations	  and	  delusions)	  and	  then	  separately	  for	  frequency	  of	  hallucinations	  only.	  	  
Moderation	  analyses	  
The	  relationship	  between	  psychotic	  experiences	  and	  suicidal	  ideation	  and	  suicide	  
attempts	  was	  further	  explored	  through	  several	  moderation	  analyses.	  Data	  were	  stratified	  
	  
	  33	  
to	  test	  for	  moderation	  by	  sex	  and	  level	  of	  education	  using	  the	  fully	  adjusted	  model	  
(demographics	  and	  clinical	  variables),	  given	  known	  sex	  and	  educational	  attainment	  
differences	  in	  suicidality	  among	  people	  with	  psychotic	  disorders	  (Hawton	  et	  al.,	  2000;	  Hor	  
&	  Taylor,	  2010).	  Determining	  moderating	  sociodemographic	  factors	  would	  buttress	  clinical	  
and	  public	  health	  efforts	  to	  allocate	  resources	  to	  those	  at	  greatest	  risk.	  Data	  were	  stratified	  
by	  the	  presence	  or	  absence	  of	  affective,	  anxiety,	  drug	  use,	  or	  alcohol	  use	  disorders,	  with	  the	  
prediction	  that	  psychotic	  experiences	  may	  have	  a	  greater	  effect	  on	  suicide	  attempts	  in	  
individuals	  who	  have	  comorbid	  conditions	  that	  are	  themselves	  known	  to	  be	  associated	  
with	  suicidality	  (Borges	  et	  al.,	  2000;	  Rihmer,	  2007).	  This	  also	  allowed	  examination	  of	  
whether	  psychotic	  experiences	  have	  an	  independent	  effect	  on	  suicide	  attempts	  in	  
individuals	  with	  no	  comorbid	  psychiatric	  condition.	  Analyses	  stratified	  by	  clinical	  variables	  
were	  adjusted	  for	  demographic	  but	  not	  diagnostic	  variables.	  Stratified	  associations	  were	  
reported	  as	  odds	  ratios,	  with	  significance	  tested	  using	  Wald	  χ²	  tests,	  two-­‐tailed	  alpha=0.05.	  	  
Progression	  along	  the	  continuum	  of	  suicidal	  behavior	  
A	  final	  set	  of	  regression	  analyses	  examined	  the	  role	  of	  psychotic	  experiences	  in	  the	  
progression	  towards	  more	  severe	  suicidal	  behavior.	  First,	  data	  were	  restricted	  only	  to	  
those	  reporting	  12-­‐month	  suicidal	  ideation.	  Within	  this	  subsample,	  logistic	  regression	  was	  
used	  to	  determine	  whether	  individuals	  with	  suicidal	  ideation	  who	  also	  report	  psychotic	  
experiences	  are	  at	  increased	  odds	  making	  a	  suicide	  attempt	  compared	  to	  those	  with	  
suicidal	  ideation	  alone.	  Second,	  data	  were	  restricted	  only	  to	  those	  reported	  12-­‐month	  
suicide	  attempts.	  Within	  this	  second	  subsample,	  logistic	  regression	  was	  used	  to	  determine	  
whether	  individuals	  with	  severe	  attempts	  with	  intent	  to	  die	  were	  more	  likely	  endorse12-­‐
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month	  psychotic	  experiences.	  Associations	  were	  reported	  as	  odds	  ratios,	  with	  significance	  
tested	  using	  Wald	  chi-­‐square	  tests,	  two-­‐tailed	  alpha=0.05.	  	  
Population	  attributable	  risk	  
Given	  the	  potential	  impact	  of	  suicide	  attempts	  on	  the	  health	  of	  the	  population,	  the	  
population	  attributable	  risk	  was	  calculated	  from	  the	  OR,	  (OR-­‐1)/OR	  x	  prevalence	  of	  
psychotic	  experience	  exposure	  (Hennekens,	  Buring,	  &	  Mayrent,	  1987),	  among	  those	  with	  
any	  attempts	  and	  specifically	  for	  severe	  attempts.	  This	  provided	  an	  estimate	  of	  the	  
percentage	  of	  attempts	  that	  could	  be	  prevented	  if	  psychotic	  experiences	  were	  removed	  
from	  the	  population,	  assuming	  a	  causal	  relationship.	  In	  addition,	  positive	  predictive	  value	  
(PPV)	  of	  12-­‐month	  psychotic	  experiences	  for	  predicting	  suicide	  attempts	  was	  calculated	  
(separately	  for	  any	  attempts	  and	  for	  severe	  attempts	  only),	  first	  in	  the	  entire	  sample	  and	  
then	  in	  a	  subsample	  limited	  to	  respondents	  who	  had	  endorsed	  12-­‐month	  suicidal	  ideation,	  
given	  that	  it	  would	  be	  clinically	  useful	  to	  have	  indicators	  of	  future	  attempts	  among	  
respondents	  expressing	  ideation.	  
	  
Results	  
Descriptives	  and	  demographics	  
	   The	  sample	  was	  weighted	  to	  be	  nationally	  representative	  of	  U.S.	  households	  based	  
on	  year	  2000	  census	  data,	  with	  some	  divergence	  from	  census	  due	  to	  the	  exclusion	  of	  
subjects	  with	  psychotic	  disorders	  or	  who	  otherwise	  did	  not	  respond	  to	  items,	  as	  described	  
above.	  Most	  notably,	  many	  respondents	  from	  the	  predominantly	  Caucasian	  NCS-­‐R	  sample	  
were	  not	  assessed	  for	  psychosis,	  leaving	  ethnic	  minorities	  overrepresented	  in	  the	  present	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sample	  relative	  to	  the	  U.S.	  population.	  Descriptive	  data	  for	  the	  sample	  is	  provided	  in	  Table	  
6.	  Modified	  CPES	  weights	  produced	  a	  sample	  for	  which	  more	  closely	  resembled	  the	  	  
Table 6. Sample characteristics 
  N = 11716 Weighted % (SE) 
Age 
   18-29 
   30-44 










   Male 








   White, non-Latino 
   Black, non-Latino 
   Latino 
   Asian 














   Married 
   Never married 










   HS grad or less 








   Employed 
   Unemployed 










   Depressive disorder 
   Anxiety 
   Drug abuse/dependence 
   Alcohol abuse/dependence 













Psychotic experiences (12) 
   Hallucination (only) 
   Delusion (only) 
   Both 












   Ideation 
   Attempt (any) 









Note: values represent weighted percentage (standard error).  
Diagnoses, psychotic experiences, and suicide are not composed of mutually exclusive categories 
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sociodemographic	  profile	  of	  the	  U.S.	  based	  on	  the	  2000	  Census;	  however,	  data	  will	  only	  be	  
presented	  using	  the	  original	  CPES	  weights	  given	  negligible	  differences	  in	  results	  when	  
applying	  the	  modified	  weights.	  	  
The	  twelve-­‐month	  prevalence	  of	  psychotic	  experiences	  was	  2.6%	  (SE=0.2),	  which	  
primarily	  consisted	  of	  hallucinations.	  Suicide	  ideation	  was	  more	  prevalent	  among	  those	  
unemployed	  or	  not	  in	  the	  labor	  force,	  χ²(df=2)=11.56,	  p=0.003.	  Married	  respondents	  were	  
less	  likely	  to	  report	  psychotic	  experiences,	  χ²(df=2)=22.84,	  p<0.001,	  suicide	  attempts,	  
χ²(df=2)=8.22,	  p=0.016,	  and	  suicidal	  ideation,	  χ²(df=2)=34.68,	  p<0.001.	  Younger	  adults	  
were	  more	  likely	  to	  endorse	  suicidal	  ideation,	  χ²(df=2)=25.71,	  p<0.001,	  attempts,	  
χ²(df=2)=10.73,	  p=0.005,	  and	  psychotic	  experiences,	  χ²(df=2)=6.91,	  p=0.032.	  Psychotic	  
Figure 1. Prevalence of common mental disorders among respondents with or without psychotic experiences, 
suicidal ideation, and suicide attempts. Prevalence of each disorder is significantly greater among respondents 




	  experiences	  were	  more	  common	  among	  black	  and	  Latino	  respondents,	  χ²(df=4)=30.00,	  
p<0.001,	  and	  suicide	  attempts,	  χ²(df=4)=7.06,	  p=0.133,	  (but	  not	  ideation,	  χ²(df=4)=1.48,	  
p=0.830)	  also	  varied	  on	  race	  at	  the	  trend	  level.	  Suicidality	  and	  psychosis	  variables	  did	  not	  
vary	  between	  males	  and	  females	  or	  by	  employment	  status	  (data	  not	  shown).	  Social	  
desirability	  scores	  did	  not	  vary	  between	  participants	  endorsing	  or	  not	  endorsing	  psychotic	  
experiences,	  M(SD)=2.15(0.08)	  versus	  2.15(0.04),	  F(165)=0.00,	  p=0.965,	  or	  suicide	  
attempts,	  M(SD)=1.77(0.27)	  versus	  2.15(0.04),	  F(165)=2.01,	  p=0.158,	  but	  were	  lower	  for	  
those	  endorsing	  suicidal	  ideation,	  M(SD)=1.68(0.08)	  versus	  2.16(0.04),	  F(165)=32.27,	  
p<0.001.	  All	  diagnoses	  were	  significantly	  more	  prevalent	  among	  respondents	  with	  
psychotic	  experiences,	  suicidal	  ideation,	  or	  suicide	  attempts	  (Figure	  1).	  According	  to	  
criteria	  described	  above,	  race,	  marital	  status,	  and	  age	  were	  therefore	  included	  in	  
subsequent	  models	  as	  potential	  confounders,	  as	  were	  variables	  indicating	  the	  presence	  or	  
absence	  of	  depressive,	  anxiety,	  drug	  use,	  and	  alcohol	  use	  disorders.	  	  
Table 7. Associations between psychotic experiences and concurrent suicidal ideation and suicide attempts 




Respondents with psychotic experiences    
   n  35 9 
   % (SE)  8.8 (2.4) 2.7 (1.0) 
Unadjusted 
   OR [95% CI] 








   OR [95% CI] 








   OR [95% CI] 








1 Adjusted for age, race, and marital status 
2 Adjusted for demographic variables as well as 12-month depressive disorders, anxiety disorders, alcohol use 




Psychotic	  experiences	  and	  suicidality	  
	   In	  the	  unadjusted	  analyses,	  individuals	  reporting	  psychotic	  experiences	  were	  
approximately	  five-­‐fold	  more	  likely	  to	  report	  suicidal	  ideation	  and	  nearly	  10-­‐fold	  more	  
likely	  to	  report	  a	  suicide	  attempt	  over	  the	  corresponding	  12-­‐month	  period.	  This	  pattern	  
was	  consistent	  across	  the	  entire	  age	  range	  (Figure	  2).	  These	  associations	  remained	  
significant	  when	  adjusting	  for	  demographic	  factors	  and	  for	  co-­‐occurring	  clinical	  conditions	  
(Table	  7).	  Psychotic	  experiences	  were	  then	  split	  into	  subtypes	  to	  determine	  whether	  these	  
associations	  were	  primarily	  driven	  by	  sub-­‐threshold	  delusions,	  hallucinations,	  or	  both.	  
Both	  measures	  of	  suicidality	  were	  associated	  with	  hallucinations	  but	  not	  delusions,	  which	  
appeared	  to	  be	  specific	  to	  the	  co-­‐occurrence	  of	  visual	  and	  auditory	  hallucinations	  rather	  	  
Figure 2. Prevalence of suicidal ideation and suicide attempts by presence or absence of psychotic experiences 





than	  either	  type	  in	  isolation	  (Table	  8).	  Psychotic	  experiences	  were	  then	  subdivided	  based	  
on	  the	  number	  of	  days	  in	  the	  past	  years	  on	  which	  psychotic	  experiences	  had	  occurred,	  in	  	  
	  
Table 8. Association between specific psychotic experience subtypes and suicidal behaviors 
 n Suicidal ideation Suicide attempt 
Psychotic experiences     
   None 11290 - - 
   Hallucinations only 340 2.38 (1.22-4.65) 5.82 (2.16-15.63) 
   Delusions only 30 0.21 (0.03-1.59) na 
   Hall & Del 56 7.61 (0.55-104.64) 1.42 (0.27-7.62) 
    
Post-hoc analysis    
   No hallucinations 11320 - - 
   Visual hallucination 166 1.13 (0.42-3.04) 0.94 (0.12-7.61) 
   Hearing voices 101 1.12 (0.20-6.31) 3.60 (0.33-39.64) 
   Voices & visual 129 11.97 (2.75-52.14) 13.60 (4.74-38.99) 
Note: All analyses are fully adjusted for demographic and clinical variables. Bold font indicates significant 
associations.  
	  
order	  to	  test	  for	  dose-­‐response	  relationships.	  When	  sub-­‐divided	  by	  number	  of	  days,	  	  
psychotic	  experiences	  were	  not	  significantly	  associated	  with	  suicidal	  ideation	  or	  suicide	  
attempts,	  and	  the	  pattern	  of	  effect	  sizes	  was	  not	  consistent	  with	  a	  dose-­‐response	  
relationship	  between	  psychotic	  experiences	  and	  either	  suicidality	  outcome.	  However,	  when	  
excluding	  respondents	  with	  delusional	  experiences	  (which	  were	  not	  associated	  with	  
psychotic	  experiences	  in	  the	  primary	  analysis),	  frequency	  of	  hallucinations	  was	  associated	  
with	  risk	  for	  suicide	  attempts	  (but	  not	  ideation)	  in	  a	  dose-­‐response	  fashion,	  confirmed	  with	  




	   When	  divided	  by	  sex,	  psychotic	  experiences	  were	  significantly	  associated	  with	  
suicidal	  ideation,	  χ²(df=1)=6.78,	  p=0.009,	  OR[95%	  CI]=3.96[1.40-­‐11.25],	  and	  suicide	  
attempts,	  χ²(df=1)=16.92,	  p<0.001,	  OR[95%	  CI]=7.43[2.84-­‐19.44]	  among	  females,	  but	  	  
Table 9. Tests of dose-response relationships between frequency of psychotic experiences (total and hallucinations-
only) and measures of suicidal behavior.  
 n Suicidal ideation Suicide attempt 
Any psychotic experience    
   Never 11290 - - 
   Rarely 192 1.61 (0.54-4.82) 1.85 (0.22-15.45) 
   Occasionally 108 5.47 (0.75-40.12) 4.53 (0.74-27.74) 
   > Monthly 77 0.87 (0.24-3.17) 3.99 (0.66-24.27) 
   Linear trend  X2(df=1)=0.12, p=0.73 X2(df=1)=2.71, p=0.10 
    
Hallucinations only    
   Never 11416 - - 
   Rarely 169 2.08 (0.74-5.86) 4.03 (0.79-20.41) 
   Occasionally 83 2.36 (0.35-15.99) 7.89 (1.05-59.24) 
   > Monthly 48 1.72 (0.54-5.54) 9.75 (1.89-50.27) 
   Linear trend  X2(df=1)=0.69, p=0.41 X2(df=1)=8.18, p=0.004 
Note: All analyses are fully adjusted for demographic and clinical variables. Bold font indicates significant 
associations.  
	  
were	  not	  significantly	  associated	  with	  ideation,	  χ²(df=1)=0.16,	  p=0.90,	  OR[95%	  
CI]=0.92[0.27-­‐3.14],	  or	  attempts,	  χ²(df=1)=0.09,	  p=0.77,	  OR[95%	  CI]=1.41[0.14-­‐13.86],	  
among	  males.	  Psychotic	  experiences	  were	  only	  significantly	  associated	  with	  suicidal	  
ideation,	  χ²(df=1)=4.83,	  p=0.028,	  OR[95%	  CI]=5.32[1.19-­‐23.88],	  and	  suicide	  attempts	  
χ²(df=1)=12.86,	  p<0.001,	  OR[95%	  CI]=8.01[2.55-­‐25.20],	  among	  those	  with	  at	  least	  some	  
college	  education,	  compared	  to	  no	  college	  (ideation:	  χ²(df=1)=0.44,	  p=0.51,	  OR[95%	  
CI]=1.34[0.56-­‐3.22];	  attempts:	  χ²(df=1)=0.00,	  p=0.96,	  OR[95%	  CI]=0.95[0.16-­‐5.55]).	  
Psychotic	  experiences	  were	  associated	  with	  greater	  risk	  for	  suicidal	  ideation	  both	  among	  
respondents	  with	  co-­‐occurring	  diagnosable	  disorders,	  χ²(df=1)=5.20,	  p=0.023,	  OR[95%	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CI]=1.92[1.09-­‐3.38],	  and	  without	  co-­‐occurring	  disorders,	  χ²(df=1)=6.49,	  p=0.011,	  OR[95%	  
CI]=7.25[1.56-­‐33.64].	  Moderation	  analysis	  of	  suicide	  attempts	  by	  the	  presence	  or	  absence	  
of	  co-­‐occurring	  disorders	  could	  not	  be	  conducted	  as	  there	  were	  no	  suicide	  attempts	  among	  
respondents	  who	  did	  not	  also	  meet	  criteria	  for	  DSM-­‐IV	  depressive,	  anxiety,	  or	  substance	  
use	  disorders.	  	  
Severity	  of	  suicidality	  
	   Two	  additional	  analyses	  were	  conducted	  to	  determine	  whether	  psychotic	  
experiences	  were	  associated	  with	  more	  severe	  suicidal	  behavior.	  First,	  the	  sample	  was	  
limited	  to	  those	  reporting	  12-­‐month	  suicidal	  ideation	  to	  test	  whether	  psychotic	  
experiences	  were	  associated	  with	  attempts	  among	  those	  who	  already	  had	  suicidal	  
thoughts.	  Among	  this	  group,	  psychotic	  experiences	  were	  not	  significantly	  associated	  with	  
increased	  odds	  for	  a	  suicide	  attempt	  in	  bivariate	  analyses,	  but	  were	  associated	  with	  more	  
than	  3-­‐fold	  greater	  odds	  of	  making	  an	  attempt	  when	  adjusting	  for	  demographic	  and	  clinical	  	  
Table 10. Associations between psychotic experiences and suicide attempt among the subsample of respondents 
who reported suicidal ideation over the past 12-months. 
Analysis Statistics 
Unadjusted 
   OR [95% CI] 





   OR [95% CI] 





   OR [95% CI] 





1 Adjusted for age, race, and marital status 
2 Adjusted for demographic variables as well as 12-month depressive disorders, anxiety disorders, alcohol use 




covariates	  (Table	  10).	  By	  comparison,	  depressive	  disorders,	  OR[95%	  CI]=1.67[0.62-­‐4.52],	  
anxiety	  disorders,	  OR[95%	  CI]=1.57[0.40-­‐6.09],	  alcohol	  use	  disorders,	  OR[95%	  
CI]=2.10[0.58-­‐7.59],	  and	  drug	  use	  disorders,	  OR[95%	  CI]=1.64[0.24-­‐11.17],	  were	  not	  
predictive	  of	  suicide	  attempts	  among	  those	  with	  ideation.	  Subsequent	  analyses	  in	  which	  
confounders	  were	  individually	  added	  to	  the	  bivariate	  model	  identified	  depressive	  disorder	  
(which	  is	  inversely	  correlated	  with	  psychotic	  experiences	  among	  people	  with	  suicidal	  
ideation)	  as	  the	  suppression	  variable	  responsible	  for	  the	  attenuated	  relationship	  between	  
psychotic	  experiences	  and	  suicide	  attempts	  in	  the	  unadjusted	  analysis.	  	  




1 Severe attempt is defined as attempts made with intention and expectation of death 
2 Unadjusted due to low frequency of severe attempts 
	  
The	  sample	  was	  then	  further	  limited	  to	  those	  with	  a	  12-­‐month	  suicide	  attempt.	  Most	  
respondents	  with	  psychotic	  experiences	  who	  made	  attempts	  specifically	  made	  attempts	  
with	  intent	  to	  die	  (7/8;	  weighted	  %	  (SE)=76.8	  (21.0)),	  and	  psychotic	  experiences	  were	  
present	  in	  more	  than	  1/3	  of	  all	  severe	  suicide	  attempts	  and	  were	  associated	  with	  
substantially	  greater	  odds	  of	  reporting	  an	  intent	  to	  die	  during	  the	  most	  recent	  suicide	  
 Severe attempt1 
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Psychotic experiences 
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   OR [95% CI] 






attempt,	  although	  this	  association	  was	  not	  significant,	  likely	  due	  to	  the	  low	  frequency	  of	  
severe	  attempts	  in	  this	  sample	  (Table	  11).	  	  
Population	  attributable	  risk	  
Measured	  as	  population	  attributable	  risk,	  17.53%	  of	  total	  suicide	  attempts	  and	  
29.01%	  of	  severe	  suicide	  attempts	  annually	  could	  be	  attributed	  to	  the	  presence	  of	  
psychotic	  experiences	  during	  the	  concurrent	  period,	  assuming	  a	  causal	  relationship.	  The	  
positive	  predictive	  value	  of	  psychotic	  experiences	  for	  suicide	  attempts	  (with	  any	  level	  of	  
intent)	  was	  2.11%	  in	  the	  entire	  sample	  and	  25.7%	  in	  the	  subsample	  endorsing	  past-­‐year	  
suicidal	  ideation.	  Specifically	  for	  severe	  suicide	  attempts,	  the	  PPV	  was	  1.64%	  in	  the	  entire	  
sample	  and	  20.0%	  among	  respondents	  endorsing	  past-­‐year	  suicidal	  ideation.	  	  
	  
Discussion	  
	   In	  support	  of	  the	  primary	  hypotheses,	  12-­‐month	  psychotic	  experiences	  were	  
associated	  with	  more	  than	  three-­‐fold	  greater	  odds	  of	  suicide	  attempts	  during	  the	  
concurrent	  period	  in	  a	  general	  population	  sample	  of	  adults,	  and	  more	  than	  two-­‐fold	  greater	  
odds	  of	  suicidal	  ideation,	  even	  when	  controlling	  for	  potential	  demographic	  and	  clinical	  
confounders.	  This	  is	  consistent	  with	  prior	  studies	  of	  suicidality	  among	  individuals	  with	  
psychotic	  experiences,	  which	  have	  demonstrated	  cross-­‐sectional	  associations	  between	  
psychotic	  experiences	  and	  suicidal	  ideation,	  plans,	  attempts,	  and	  deliberate	  self-­‐harm	  in	  
adolescents	  (Kelleher	  et	  al.,	  2012b;	  Nishida	  et	  al.,	  2010)	  and	  in	  adults	  (Saha	  et	  al.,	  2011a),	  
and	  longitudinally	  in	  adolescence	  (Kelleher	  et	  al.,	  2013b)	  and	  from	  childhood	  into	  
adulthood	  (Fisher	  et	  al.,	  2013).	  The	  association	  between	  psychotic	  experiences	  and	  suicidal	  
acts	  was	  very	  similar	  in	  magnitude	  to	  that	  identified	  in	  two	  cross-­‐sectional	  cohorts	  by	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Kelleher	  and	  colleagues	  (unadjusted	  OR=9.48	  in	  this	  study,	  OR=9.0	  and	  8.5	  in	  their	  two	  
samples;	  2012b),	  despite	  the	  older	  age	  group	  of	  this	  sample	  (adults	  rather	  than	  
adolescents)	  and	  lower	  prevalence	  of	  psychotic	  experiences,	  which	  consisted	  
predominantly	  of	  auditory	  hallucinations	  in	  both	  studies.	  These	  findings	  are	  therefore	  in	  
concurrence	  with	  their	  conclusion	  that:	  “while	  psychotic	  symptoms	  in	  general	  decline	  with	  
age,	  their	  relationship	  with	  suicidal	  behavior	  does	  not	  show	  the	  same	  decline”	  (page	  1281,	  
Kelleher	  et	  al.,	  2012b).	  	  
	   Individual	  subtype	  analysis	  revealed	  that	  the	  association	  with	  suicide	  attempts	  was	  
specific	  to	  sub-­‐threshold	  hallucinations,	  particularly	  the	  co-­‐occurrence	  of	  visual	  and	  
auditory	  hallucinations,	  with	  risk	  for	  attempts	  increasing	  in	  a	  dose-­‐response	  fashion	  with	  
increasing	  frequency	  of	  hallucinations.	  Exposure	  to	  hallucinations-­‐only	  was	  likewise	  
associated	  with	  suicidal	  ideation,	  when	  delusional	  experiences	  were	  excluded.	  The	  
symptom	  make-­‐up	  of	  this	  sample	  appears	  similar	  to	  that	  of	  Kelleher	  and	  colleagues’	  
(2012b)	  study	  of	  suicidality	  and	  psychosis,	  in	  that	  it	  was	  predominantly	  hallucinations	  with	  
delusions	  being	  less	  common	  and	  generally	  only	  occurring	  in	  the	  context	  of	  hallucinations.	  
Hallucinations	  were	  likewise	  the	  most	  common	  psychotic	  experience	  subtype	  in	  the	  study	  
by	  Nishida	  and	  colleagues	  (2010),	  and	  auditory	  hallucinations	  were	  the	  only	  symptom	  
assessed	  in	  the	  recent	  prospective	  cohort	  study	  by	  Kelleher	  and	  colleagues	  (2013b),	  both	  of	  
which	  showed	  associations	  between	  psychotic	  experiences	  and	  suicidality.	  However,	  Saha	  
and	  colleagues	  (2011a)	  found	  a	  close	  association	  between	  delusional	  experiences	  and	  
suicidal	  behaviors,	  in	  contrast	  to	  this	  sample	  in	  which	  the	  ‘delusions	  only’	  group	  had	  no	  
suicide	  attempts	  and	  was	  actually	  at	  reduced	  odds	  for	  suicidal	  ideation	  relative	  to	  the	  
general	  population.	  The	  prevalence	  of	  delusional	  experiences	  was	  far	  greater	  in	  the	  study	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by	  Saha	  and	  colleagues,	  and	  it	  is	  likely	  that	  the	  discrepancy	  in	  findings	  reflects	  variation	  in	  
the	  definition	  and	  measurement	  of	  delusions.	  Of	  note,	  assessment	  of	  psychotic	  experiences	  
using	  semi-­‐structured	  clinician	  interview	  has	  produced	  similar	  distribution	  of	  symptom	  
types	  as	  that	  found	  in	  our	  study	  (i.e.	  predominantly	  hallucinations,	  low	  prevalence	  of	  
delusional	  experiences),	  supporting	  the	  validity	  of	  our	  subtype	  measures	  (Zammit	  et	  al.,	  
2013).	  	  	  
	   Respondents	  with	  psychotic	  experiences	  also	  reported	  greater	  severity	  of	  suicidal	  
behavior	  in	  two	  separate	  tests.	  Specifically,	  people	  with	  psychotic	  experiences	  were	  at	  3.5	  
times	  the	  odds	  of	  a	  suicide	  attempt	  among	  those	  who	  reported	  ideation,	  and	  nearly	  five	  
times	  the	  odds	  of	  a	  severe	  attempt	  with	  intent	  to	  die	  among	  those	  who	  made	  an	  attempt,	  
although	  this	  second	  test	  was	  not	  statistically	  significant,	  likely	  due	  to	  lack	  of	  power	  related	  
to	  the	  small	  size	  of	  the	  subsamples	  of	  interest.	  In	  contrast,	  other	  clinical	  diagnoses	  typically	  
associated	  with	  suicide,	  including	  depressive	  disorders	  and	  substance	  use	  disorders,	  were	  
not	  associated	  with	  increased	  severity	  of	  suicidal	  behavior,	  suggesting	  that	  psychotic	  
experiences	  may	  uniquely	  serve	  as	  indicators	  of	  risk	  for	  attempts	  among	  respondents	  with	  
ideation.	  	  
No	  prior	  studies	  have	  specifically	  examined	  intent	  to	  die	  among	  people	  with	  
psychotic	  experiences.	  Intent	  to	  die	  is	  of	  notable	  clinical	  significance	  as	  it	  is	  associated	  with	  
more	  lethal	  behaviors	  and	  the	  greater	  likelihood	  of	  a	  subsequent	  completed	  suicide	  (Nock	  
&	  Kessler,	  2006).	  Kelleher	  et	  al.	  (2012b)	  likewise	  found	  a	  significant	  association	  between	  
psychotic	  experiences	  and	  more	  severe	  suicidal	  behaviors	  (plans	  or	  attempts)	  among	  
individuals	  who	  reported	  ideation,	  although	  to	  an	  even	  greater	  magnitude	  (OR=19.6).	  This	  
was	  also	  consistent	  with	  findings	  from	  the	  National	  Comorbidity	  Survey	  that	  non-­‐affective	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psychosis	  was	  associated	  with	  intent	  to	  die	  among	  respondents	  reporting	  suicide	  attempts	  
(Nock	  &	  Kessler,	  2006).	  In	  a	  sample	  of	  adolescents,	  Nishida	  and	  colleagues	  (2010)	  
described	  associations	  between	  psychotic	  experiences	  and	  deliberate	  self-­‐harm	  behaviors	  
(without	  intent	  to	  die).	  Deliberate	  self-­‐harm	  was	  rare	  among	  respondents	  endorsing	  
psychotic	  experiences	  in	  this	  sample,	  most	  of	  who	  made	  attempts	  with	  serious	  intent	  to	  die.	  
Moderation	  by	  comorbidities	  	  
	   The	  association	  between	  psychotic	  experiences	  and	  suicide	  attempts	  was	  limited	  to	  
respondents	  with	  co-­‐morbid	  DSM-­‐IV	  diagnoses	  of	  depressive,	  anxiety,	  or	  substance	  use	  
disorders.	  This	  is	  in	  concurrence	  with	  Kelleher	  and	  colleagues’	  (2012b)	  finding	  of	  
increased	  risk	  for	  broadly	  defined	  suicidal	  behavior	  (ideation,	  plans,	  or	  attempts)	  
associated	  with	  psychotic	  experiences	  specifically	  among	  adolescents	  with	  depressive,	  
anxiety,	  or	  childhood-­‐onset	  disorders.	  Notably,	  there	  were	  no	  suicide	  attempts	  in	  the	  
absence	  of	  a	  co-­‐occurring	  diagnosable	  disorder	  regardless	  of	  the	  presence	  of	  psychotic	  
experiences,	  although	  psychotic	  experiences	  were	  associated	  with	  suicidal	  ideation	  in	  this	  
subgroup.	  	  
Direction	  of	  causality	  
	   The	  relationship	  between	  psychotic	  experiences	  and	  suicidality	  may	  reflect	  either	  a	  
causal	  relationship,	  such	  that	  the	  experience	  of	  psychotic	  symptoms	  directly	  leads	  to	  
suicidal	  thoughts	  and	  behavior,	  or	  it	  may	  reflect	  the	  presence	  of	  shared	  underlying	  risk	  
factors.	  A	  causal	  relationship	  would	  imply	  that	  intervening	  directly	  with	  psychotic	  
experiences	  could	  reduce	  the	  prevalence	  of	  suicidal	  behaviors.	  In	  the	  absence	  of	  a	  causal	  
relationship,	  psychotic	  experiences	  may	  nonetheless	  serve	  as	  useful	  risk	  indicators	  of	  
suicidality	  that	  can	  be	  quickly	  screened	  in	  the	  clinical	  setting.	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   This	  study	  tested	  for	  a	  dose-­‐response	  relationship	  between	  days	  of	  total	  psychotic	  
experiences	  or	  hallucinations	  and	  risk	  for	  suicidal	  ideation	  and	  attempts,	  proposing	  that	  a	  
dose-­‐response	  relationship	  would	  be	  evidence	  for	  a	  causal	  association.	  When	  limiting	  the	  
exposure	  category	  to	  hallucinations,	  a	  dose-­‐response	  relationship	  (significant	  linear	  trend)	  
was	  found	  for	  suicide	  attempts	  but	  not	  suicidal	  ideation.	  This	  is	  in	  agreement	  with	  stronger	  
evidence	  for	  causality	  from	  the	  prospective	  cohort	  study	  by	  Fisher	  and	  colleagues	  (2013),	  
who	  recently	  demonstrated	  that	  childhood	  psychotic	  experiences	  are	  associated	  with	  a	  
four-­‐fold	  greater	  risk	  for	  suicide	  attempts	  or	  completed	  suicides	  by	  age	  38,	  and	  the	  
prospective	  cohort	  study	  of	  adolescents	  by	  Kelleher	  and	  colleagues	  (2013b),	  showing	  that	  
psychotic	  experiences	  are	  associated	  with	  an	  11-­‐fold	  greater	  odds	  of	  suicide	  attempts	  over	  
the	  subsequent	  year.	  	  
	   Alternatively,	  both	  psychotic	  experiences	  and	  suicidality	  may	  both	  serve	  as	  non-­‐
diagnosis-­‐specific	  indicators	  of	  severe	  psychopathology,	  and	  may	  relate	  to	  shared	  risk	  
factors	  such	  as	  childhood	  trauma	  or	  victimization.	  These	  factors	  were	  not	  assessed	  in	  the	  
present	  study	  and	  therefore	  could	  not	  be	  included	  as	  potential	  confounds	  in	  the	  regression	  
models.	  However,	  two	  prior	  studies	  have	  tested	  associations	  between	  psychotic	  
experiences	  and	  suicidality	  controlling	  for	  trauma	  and	  victimization,	  which	  did	  not	  explain	  
the	  association	  in	  either	  case	  (Nishida	  et	  al.,	  2010;	  Saha	  et	  al.,	  2011a).	  It	  is	  therefore	  
unlikely	  that	  associations	  between	  psychosis	  and	  suicidality	  will	  be	  explained	  entirely	  by	  
shared	  risk	  factors.	  Other	  possible	  common	  causes	  that	  have	  not	  been	  sufficiently	  explored	  
include	  general	  psychological	  distress	  (Chamberlain,	  Goldney,	  Delfabbro,	  Gill,	  &	  Dal	  
Grande,	  2009;	  Saha,	  Scott,	  Varghese,	  &	  McGrath,	  2011b)	  and	  emotional	  reactivity	  to	  routine	  
stress	  (Palmier-­‐Claus,	  Taylor,	  Gooding,	  Dunn,	  &	  Lewis,	  2012).	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Suicide	  in	  schizophrenia	  and	  other	  psychotic	  disorders	  
	   Certain	  aspects	  of	  suicidality	  among	  individuals	  with	  psychotic	  disorders,	  
particularly	  elevated	  risk	  following	  the	  first	  episode	  (Bertelsen	  et	  al.,	  2007;	  Dutta	  et	  al.,	  
2010),	  associations	  with	  insight	  (Lincoln,	  Lullmann,	  &	  Rieff,	  2007;	  Lopez-­‐Morinigo	  et	  al.,	  
2012),	  and	  associations	  with	  cognitive	  function	  (Kim	  et	  al.,	  2003),	  may	  suggest	  that	  suicidal	  
thoughts	  and	  behavior	  are	  a	  reaction	  to	  onset	  or	  related	  functional	  disruptions.	  Examining	  
suicidality	  among	  individuals	  with	  sub-­‐threshold	  psychosis	  provides	  a	  critical	  test	  for	  this	  
explanation.	  The	  presented	  findings	  that	  the	  association	  between	  psychosis	  and	  suicide	  
extends	  to	  the	  sub-­‐threshold	  range	  of	  the	  psychosis	  continuum	  are	  not	  consistent	  with	  the	  
hypothesis	  that	  suicidality	  in	  psychotic	  disorders	  is	  entirely	  a	  reaction	  to	  the	  illness	  itself	  
(although	  this	  can	  still	  be	  a	  contributing	  factor	  in	  those	  with	  threshold	  psychotic	  disorder).	  
Instead,	  these	  findings	  are	  more	  consistent	  with	  a	  direct	  link	  between	  suicidality	  and	  
psychosis,	  either	  through	  shared	  genetic	  or	  environmental	  risk	  factors	  or	  possibly	  through	  
a	  causal	  relationship,	  as	  discussed	  above.	  	  
Public	  health	  impact	  
	   The	  presented	  results	  implicate	  psychotic	  experiences	  as	  indicators	  of	  suicide	  
attempts	  during	  the	  concurrent	  period,	  particularly	  severe	  attempts.	  Psychotic	  experiences	  
were	  found	  to	  be	  present	  in	  an	  estimated	  36.1%	  of	  all	  severe	  suicide	  attempts	  with	  intent	  
and	  expectation	  to	  die,	  with	  a	  population	  attributable	  risk	  of	  29.01%.	  These	  estimates	  
assume	  a	  causal	  relationship	  between	  psychotic	  experiences	  and	  suicidal	  behavior,	  which	  
has	  recently	  been	  supported	  through	  two	  prospective	  studies	  (Fisher	  et	  al.,	  2013;	  Kelleher	  
et	  al.,	  2013b).	  Regardless	  of	  whether	  the	  causality	  assumption	  is	  valid,	  which	  could	  not	  be	  
tested	  in	  these	  cross-­‐sectional	  data,	  psychotic	  experiences	  may	  nonetheless	  serve	  as	  useful	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indicators	  of	  future	  attempts.	  Further,	  the	  number	  of	  suicide	  attempts	  associated	  with	  
psychotic	  experiences	  is	  likely	  an	  underestimate	  of	  the	  true	  population	  given	  that	  only	  
living	  participants	  could	  be	  interviewed	  in	  these	  household	  surveys,	  excluding	  detection	  of	  
completed	  suicide	  attempts.	  Given	  that	  attempts	  associated	  with	  psychotic	  experiences	  
were	  of	  the	  most	  severe	  quality	  and	  greatest	  degree	  of	  intent,	  and	  that	  non-­‐affective	  
psychosis	  is	  associated	  with	  completed	  versus	  attempted	  suicide	  (Beautrais,	  2001),	  it	  is	  
likely	  that	  there	  would	  have	  been	  a	  substantially	  greater	  prevalence	  of	  undetected	  
completed	  suicides	  in	  the	  psychotic	  experience	  group	  compared	  to	  the	  general	  population.	  
Despite	  the	  high	  prevalence	  of	  severe	  suicide	  attempts	  among	  people	  with	  psychotic	  
experiences,	  the	  PPV	  was	  still	  low	  within	  the	  entire	  sample,	  limiting	  the	  usefulness	  of	  these	  
symptoms	  alone	  as	  predictors	  of	  suicide	  attempts.	  However,	  PPV	  increased	  greatly	  
(20.00%	  versus	  1.64%)	  when	  limiting	  the	  sample	  to	  those	  with	  12-­‐month	  suicidal	  ideation,	  
suggesting	  that	  they	  may	  be	  highly	  useful	  in	  predicting	  attempts	  among	  those	  who	  are	  
already	  expressing	  ideation.	  Clinical	  contact	  is	  common	  immediately	  preceding	  completed	  
suicides	  (Luoma,	  Martin,	  &	  Pearson,	  2002),	  making	  it	  feasible	  to	  prevent	  more	  severe	  
suicidal	  behavior	  if	  those	  at	  greatest	  risk	  can	  be	  identified.	  	  
Practice	  implications	  
	   The	  estimates	  described	  above	  would	  suggest	  that	  identifying	  people	  with	  psychotic	  
experiences	  and	  intervening	  appropriately	  and	  effectively	  could	  potentially	  reduce	  the	  
annual	  prevalence	  of	  severe	  suicide	  attempts	  in	  the	  United	  States	  by	  approximately	  one	  
third.	  Psychotic	  experiences	  are	  primarily	  predictive	  of	  attempts	  when	  they	  occur	  among	  
people	  with	  suicidal	  ideation.	  The	  vast	  majority	  of	  individuals	  reporting	  concurrent	  
psychotic	  experiences	  and	  suicide	  attempts	  met	  diagnostic	  criteria	  for	  affective,	  anxiety,	  or	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substance	  use	  disorders.	  An	  efficient	  approach	  therefore	  may	  be	  for	  social	  workers	  to	  
screen	  for	  psychotic	  experiences	  among	  individuals	  in	  treatment	  for	  these	  disorders,	  
identifying	  an	  elevated	  risk	  group	  for	  psychotic	  experience-­‐related	  suicidality.	  The	  
moderation	  analyses	  presented	  here	  can	  further	  guide	  the	  definition	  of	  the	  high-­‐risk	  group,	  
as	  psychotic	  experiences	  appear	  to	  be	  predominantly	  related	  to	  suicide	  attempts	  among	  
women	  and	  among	  individuals	  with	  at	  least	  some	  college	  education.	  Even	  with	  appropriate	  
screening	  and	  detection	  protocols	  in	  place,	  prevention	  of	  suicide	  attempts	  will	  depend	  on	  
the	  development	  of	  effective	  interventions	  tailored	  towards	  this	  high-­‐risk	  group.	  Future	  
development	  of	  such	  approaches	  can	  draw	  from	  known	  efficacious	  interventions	  for	  
suicidality	  among	  people	  with	  depression,	  anxiety,	  or	  psychosis,	  including	  cognitive	  
behavior	  therapy	  for	  suicide	  prevention	  (Stanley	  et	  al.,	  2009).	  Given	  the	  limited	  public	  
awareness	  of	  sub-­‐threshold	  psychosis,	  psychoeducation	  approaches	  may	  likewise	  be	  
valuable	  in	  maintaining	  and	  reinforcing	  social	  support	  for	  individuals	  with	  psychotic	  
experiences	  (Chen	  &	  Lukens,	  2011),	  and	  may	  reduce	  the	  risk	  of	  associated	  suicide	  attempts	  
(Bergmans	  &	  Links,	  2002).	  	  
Strengths,	  limitations,	  and	  conclusions	  
	   Strengths	  of	  this	  study	  include	  the	  large	  population-­‐level	  sample,	  multiple	  measures	  
of	  suicidality	  including	  intent	  to	  die	  (which	  had	  not	  been	  assessed	  in	  prior	  studies	  of	  
psychotic	  experiences	  &	  suicidality),	  and	  data	  on	  clinical	  diagnoses	  and	  a	  broad	  range	  of	  
potentially	  confounding	  demographic	  variables.	  Further,	  this	  is	  only	  the	  second	  study	  to	  
directly	  assess	  the	  population	  attributable	  risk	  for	  suicide	  attempts	  among	  respondents	  
with	  psychotic	  experiences	  (Kelleher	  et	  al.,	  2013b),	  and	  the	  first	  to	  do	  so	  in	  adults,	  which	  is	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highly	  valuable	  in	  assessing	  the	  utility	  of	  screening	  for	  psychotic	  experiences	  as	  a	  means	  to	  
identify	  individuals	  at	  clinical	  risk	  for	  suicide.	  	  
There	  are	  several	  potential	  limitations	  as	  well.	  First,	  this	  is	  a	  household	  survey	  that	  
did	  not	  sample	  individuals	  who	  were	  institutionalized	  or	  homeless,	  where	  the	  prevalence	  
of	  both	  psychotic	  experiences	  and	  suicidality	  may	  be	  greater.	  The	  use	  of	  in-­‐person	  
interviews	  rather	  than	  a	  national	  registry	  or	  interviews	  with	  family	  informants,	  for	  
example,	  also	  precluded	  the	  detection	  of	  completed	  suicides.	  Second,	  psychotic	  
experiences,	  suicidality,	  and	  clinical	  diagnoses	  were	  assessed	  through	  trained	  lay	  interview	  
rather	  than	  by	  experienced	  clinicians.	  The	  use	  of	  12-­‐month	  rather	  than	  lifetime	  measures	  
biases	  the	  measures	  towards	  more	  severe	  cases	  of	  psychotic	  experiences,	  suicidality,	  and	  
diagnoses,	  yet	  allowed	  analysis	  of	  concurrent	  relationships	  between	  clinical	  phenomena.	  
Suicide	  attempts	  and	  psychotic	  experiences	  may	  be	  two	  particularly	  stigmatized	  
experiences,	  and	  therefore	  may	  have	  been	  a	  reporting	  bias	  such	  that	  those	  who	  were	  more	  
likely	  to	  report	  one	  were	  also	  more	  likely	  to	  report	  the	  other,	  although	  this	  is	  unlikely	  to	  
explain	  these	  data	  given	  that	  neither	  measure	  was	  significantly	  associated	  with	  social	  
desirability	  scores.	  It	  is	  also	  a	  potential	  limitation	  that	  neither	  the	  presence	  of	  commands	  
nor	  other	  qualitative	  aspects	  of	  hallucinations	  (or	  other	  psychotic	  experiences)	  could	  be	  
assessed	  in	  these	  data.	  Hallucinations	  vary	  in	  their	  relation	  to	  suicidality	  depending	  on	  
whether	  they	  are	  persecutory	  commands	  or	  otherwise	  (Harkavy-­‐Friedman	  et	  a.,	  2003),	  and	  
case	  reports	  have	  likewise	  suggested	  that	  qualitative	  content	  may	  be	  more	  important	  than	  
quantitative	  (Siris	  &	  Acosta,	  2012).	  However,	  one	  prior	  study	  suggested	  that	  command	  
hallucinations	  only	  explain	  a	  small	  minority	  of	  suicidal	  cases	  among	  those	  with	  psychotic	  
experiences	  (Kelleher	  et	  al.,	  2012b).	  Finally,	  several	  potential	  shared	  causal	  factors	  were	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not	  available	  for	  all	  respondents	  and	  therefore	  were	  not	  included	  in	  the	  analysis,	  including	  
childhood	  trauma	  exposure	  and	  general	  psychological	  distress.	  However,	  prior	  studies	  
have	  shown	  that	  trauma	  exposure	  and	  victimization	  cannot	  fully	  explain	  the	  relationship	  
between	  psychotic	  experiences	  and	  suicidality	  (Nishida	  et	  al.,	  2010;	  Saha	  et	  al.,	  2011a).	  	  
	   This	  study,	  taken	  in	  context	  of	  prior	  research	  that	  has	  generally	  yielded	  consistent	  
results	  using	  varying	  demographic	  samples,	  definitions	  of	  psychotic	  experiences,	  and	  
definitions	  of	  suicidal	  behavior	  (Fisher	  et	  al.,	  2013;	  Kelleher	  et	  al.,	  2012b;	  Nishida	  et	  al.,	  
2010;	  Saha	  et	  al.,	  2011a),	  strongly	  supports	  an	  association	  between	  psychotic	  experiences	  
and	  suicidal	  thoughts	  and	  behavior.	  Most	  importantly,	  it	  implicates	  psychotic	  experiences	  
as	  either	  an	  indicator	  or	  causal	  agent	  in	  progression	  towards	  greater	  severity	  of	  suicidality,	  
particularly	  in	  that	  they	  predict	  attempts	  among	  those	  with	  ideation	  and	  that	  they	  are	  
present	  in	  more	  than	  one	  third	  of	  respondents	  reporting	  severe	  suicide	  attempts	  with	  
intent	  to	  die.	  No	  other	  clinical	  variable,	  including	  depressive	  and	  substance	  use	  disorders,	  
reliably	  distinguished	  those	  who	  made	  attempts	  from	  those	  who	  did	  not	  among	  the	  
subsample	  of	  respondents	  with	  12-­‐month	  ideation.	  It	  would	  be	  very	  useful	  in	  future	  studies	  
to	  identify	  factors	  that	  distinguish	  people	  with	  psychotic	  experiences	  who	  do	  attempt	  
suicide	  from	  those	  who	  do	  not,	  as	  has	  been	  done	  in	  schizophrenia	  (Harkavy-­‐Friedman	  et	  
al.,	  1999),	  which	  could	  then	  be	  used	  to	  improve	  their	  positive	  predictive	  validity	  and,	  
consequently,	  their	  utility	  in	  screening	  for	  risk	  of	  severe	  suicidal	  behavior.	  Future	  studies	  
also	  should	  continue	  to	  build	  on	  existing	  evidence	  that	  there	  is	  a	  causal	  relationship	  
between	  psychotic	  experiences	  and	  suicidality	  (Fisher	  et	  al.,	  2013;	  Kelleher	  et	  al.,	  2013b).	  If	  
the	  relationship	  is	  causal	  than	  interventions	  can	  address	  psychotic	  experiences	  directly,	  
thereby	  reducing	  distress	  associated	  with	  these	  symptoms	  as	  well	  as	  risk	  for	  suicidal	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behavior.	  If	  the	  relationship	  is	  not	  causal	  then	  psychotic	  experiences	  are	  nonetheless	  useful	  
clinical	  indicators	  of	  severe	  suicidal	  behavior.	  Clinical	  screens	  can	  be	  implemented	  
accordingly,	  and	  interventions	  can	  be	  developed	  to	  prevent	  suicidal	  behavior	  among	  
individuals	  with	  psychotic	  experiences	  in	  the	  general	  population.	  Either	  approach,	  properly	  
implemented,	  has	  great	  potential	  public	  health	  benefits	  in	  reducing	  risk	  of	  death	  or	  
disability	  associated	  with	  severe	  suicide	  attempts	  and	  other	  suicidal	  behavior.	  
	  




Comorbidities	  with	  Common	  Mental	  Health	  Conditions	  
Comorbidities	  with	  common	  mental	  health	  conditions	  are	  common	  in	  schizophrenia	  
(Buckley,	  Miller,	  Lehrer,	  &	  Castle,	  2009;	  Tsai	  &	  Rosenheck,	  2013)	  and	  its	  risk	  states	  
(Addington	  et	  al.,	  2011a;	  DeVylder	  et	  al.,	  2012;	  Fusar-­‐Poli,	  Nelson,	  Valmaggia,	  Yung,	  &	  
McGuire,	  2012a),	  complicating	  presentation	  of	  the	  disorder	  and	  its	  treatment.	  Psychosis	  is	  
now	  widely	  believed	  to	  occur	  on	  a	  continuum	  in	  the	  population,	  with	  an	  estimated	  7.2%	  of	  
the	  general	  population	  experiencing	  sub-­‐threshold	  psychotic	  experiences	  at	  some	  point	  in	  
their	  lifetimes	  (Linscott	  &	  van	  Os,	  2013).	  Co-­‐morbidity	  of	  common	  mental	  health	  conditions	  
(i.e.	  non-­‐psychotic	  disorders	  that	  tend	  to	  be	  highly	  prevalent	  in	  the	  population,	  including	  
major	  depressive	  disorder,	  anxiety	  disorders,	  post-­‐traumatic	  stress	  disorder,	  substance	  use	  
disorders)	  among	  people	  with	  psychotic	  experiences	  may	  indicate	  clinical	  significance	  in	  
two	  ways.	  First,	  it	  can	  directly	  indicate	  that	  those	  with	  psychotic	  experiences	  have	  more	  
extensive	  mental	  health	  difficulties	  and	  therefore	  also	  greater	  potential	  need	  for	  treatment.	  
Secondly,	  it	  has	  been	  suggested	  that	  the	  presence	  of	  psychotic	  experiences	  in	  common	  
mental	  disorders	  may	  be	  associated	  with	  greater	  clinical	  need	  than	  that	  associated	  with	  the	  
primary	  diagnosis	  alone.	  
Psychotic	  experiences	  among	  individuals	  with	  specific	  diagnoses	  
Population-­‐based	  studies	  of	  co-­‐morbidity	  have	  generally	  focused	  on	  the	  prevalence	  
of	  psychotic	  experiences	  among	  people	  with	  particular	  primary	  diagnoses,	  finding	  
widespread	  associations.	  For	  example,	  prevalence	  of	  psychotic	  experiences	  is	  greater	  in	  
adults	  with	  major	  depressive	  disorder	  or	  any	  anxiety	  disorder	  in	  Europe	  (van	  Nierop	  et	  al.,	  
2012;	  Wigman	  et	  al.,	  2012)	  and	  Australia,	  with	  or	  without	  inclusion	  of	  post-­‐traumatic	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stress	  disorder	  (PTSD)	  (Saha	  et	  al.,	  2012;	  Varghese	  et	  al.,	  2011),	  which	  is	  no	  longer	  
classified	  as	  an	  anxiety	  disorder	  (American	  Psychiatric	  Association,	  2013).	  PTSD	  itself	  is	  
associated	  in	  cross	  section	  specifically	  with	  delusional	  experiences	  (Scott,	  Chant,	  Andrews,	  
Martin,	  &	  McGrath,	  2007),	  consistent	  with	  other	  studies	  showing	  elevated	  prevalence	  of	  
trauma	  exposure	  history	  among	  individuals	  reporting	  psychotic	  experiences	  (Johns	  et	  al.,	  
2004;	  Kelleher	  et	  al.,	  2008;	  Lataster	  et	  al.,	  2006).	  In	  addition,	  psychotic	  experiences	  are	  
likewise	  associated	  with	  substance	  use	  disorders,	  including	  both	  alcohol	  and	  drug	  
dependence	  in	  England	  (Johns	  et	  al.,	  2004).	  Others	  studies	  have	  shown	  associations	  with	  
drug	  use	  across	  a	  broad	  range	  of	  substances	  (opiate,	  cannabis,	  alcohol,	  tobacco;	  
Degenhardt	  &	  Hall,	  2001)	  and	  particularly	  cannabis	  use	  (Rössler	  et	  al.,	  2007).	  Only	  two	  
studies	  have	  suggested	  that	  there	  may	  be	  a	  limit	  to	  this	  extensive	  co-­‐morbidity	  between	  
psychotic	  experiences	  and	  common	  mental	  disorders.	  In	  one	  prospective	  study,	  Fisher	  and	  
colleagues	  (2013)	  showed	  that	  childhood	  psychotic	  experiences	  only	  significantly	  
predicted	  the	  future	  onset	  of	  PTSD	  among	  common	  disorders	  (and	  schizophrenia),	  not	  of	  
persistent	  depressive,	  anxiety,	  or	  substance	  use	  disorders.	  Among	  adolescents,	  Kelleher	  and	  
colleagues	  (2012a)	  likewise	  found	  no	  association	  between	  psychotic	  experiences	  and	  
anxiety	  disorders,	  but	  did	  present	  significant	  associations	  with	  affective	  and	  behavioral	  
disorders.	  Of	  note,	  the	  samples	  for	  all	  of	  the	  above	  studies	  were	  racially	  homogenous,	  
either	  primarily	  or	  entirely	  white	  respondents	  from	  Europe,	  Australia,	  or	  New	  Zealand.	  	  	  	  
Psychotic	  experiences	  in	  the	  context	  of	  general	  psychopathology	  
One	  possible	  explanation	  for	  widespread	  associations	  between	  psychotic	  
experiences	  and	  nearly	  all	  classes	  of	  psychopathology	  is	  that	  risk	  for	  psychosis	  may	  
increase	  with	  greater	  severity	  of	  mental	  health	  difficulties,	  regardless	  of	  the	  particular	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quality	  of	  such	  impairment.	  Overall	  severity	  of	  psychopathology	  may	  be	  indicated	  by	  
quantifying	  the	  number	  of	  co-­‐occurring	  disorders,	  or	  by	  measuring	  symptom	  severity	  
within	  disorders	  or	  phenotypic	  dimensions.	  Several	  studies	  have	  found	  dose-­‐response	  
relationships	  between	  severity	  of	  co-­‐morbidities	  and	  risk	  for	  psychotic	  experiences.	  Among	  
children	  and	  adolescents	  in	  Ireland,	  risk	  for	  psychotic	  experiences	  appears	  to	  increase	  
linearly	  as	  the	  child	  meets	  criteria	  for	  an	  increasing	  number	  of	  diagnosable	  conditions,	  
replicated	  across	  four	  population	  data	  sets	  using	  different	  categories	  of	  disorder	  and	  
means	  of	  assessment	  (Kelleher	  et	  al.,	  2012a)	  and	  among	  a	  help-­‐seeking	  clinical	  sample	  
(Kelleher	  et	  al.,	  2013a).	  Similarly,	  within	  a	  single	  disorder,	  risk	  for	  delusional	  experiences	  
increases	  with	  increasing	  severity	  of	  major	  depression	  (Saha	  et	  al.,	  2012).	  These	  findings,	  
coupled	  with	  the	  widespread	  associations	  with	  specific	  mental	  health	  conditions,	  suggest	  
that	  the	  quantitative	  extent	  of	  psychopathology	  (i.e.	  number	  of	  comorbid	  diagnoses)	  may	  
be	  as	  important	  or	  more	  important	  than	  the	  qualitative	  nature	  of	  psychopathology	  (i.e.	  
presence	  of	  particular	  comorbid	  diagnoses)	  in	  determining	  risk	  for	  psychotic	  experiences.	  	  
Outcomes	  in	  the	  context	  of	  primary	  diagnoses	  
Psychotic	  experiences	  not	  only	  occur	  frequently	  within	  common	  disorders,	  but	  also	  
may	  impact	  their	  clinical	  significance.	  This	  has	  been	  demonstrated	  among	  young	  adults	  
with	  major	  depression	  and	  anxiety	  disorders,	  where	  psychotic	  experiences	  are	  associated	  
with	  a	  more	  persistent	  illness	  course,	  publicly	  apparent	  illness	  behavior,	  and	  greater	  
utilization	  of	  services	  (Wigman	  et	  al.,	  2012).	  Kelleher	  and	  colleagues	  (2013a)	  found	  that	  
psychotic	  experiences	  were	  related	  to	  suicidal	  behaviors	  among	  adolescents	  with	  affective,	  
anxiety,	  or	  behavioral	  disorders,	  although	  this	  study	  did	  not	  find	  an	  association	  with	  
suicidal	  thoughts.	  Other	  studies	  have	  shown	  that	  psychotic	  experiences	  are	  associated	  with	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increased	  utilization	  of	  services	  even	  when	  adjusting	  for	  co-­‐morbid	  conditions	  (DeVylder	  et	  
al.,	  in	  press;	  Murphy	  et	  al.,	  2012),	  although	  one	  analysis	  found	  no	  added	  effect	  of	  psychotic	  
experiences	  on	  treatment-­‐seeking	  when	  statistically	  adjusting	  for	  the	  severity	  of	  
depressive	  symptoms	  over	  the	  concurrent	  period	  (Kobayashi,	  Nemoto,	  Murakami,	  
Kashima,	  &	  Mizuno,	  2011).	  In	  addition,	  psychosis	  is	  associated	  with	  impairment	  in	  
cognition	  (Heinrichs	  &	  Zakzanis,	  1998;	  Krabbendam,	  Arts,	  van	  Os,	  &	  Aleman,	  2005;	  Rund,	  
1998),	  even	  in	  prodromal	  (Fusar-­‐Poli	  et	  al.,	  2012b)	  and	  first	  episode	  psychosis	  (Mesholam-­‐
Gately,	  Giuliano,	  Goff,	  Faraone,	  &	  Seidman,	  2009),	  as	  well	  as	  role	  function	  (Cornblatt	  et	  al.,	  
2007;	  Rinaldi	  et	  al.,	  2010),	  suggesting	  that	  psychotic	  experiences	  may	  be	  associated	  with	  
poor	  cognitive	  function	  and	  role	  impairment	  within	  the	  context	  of	  common	  disorders,	  
although	  this	  has	  not	  previously	  been	  tested.	  	  
Ethnic	  differences	  in	  co-­‐morbidities	  with	  psychosis	  
	   All	  studies	  of	  comorbidities	  between	  psychotic	  experiences	  and	  general	  mental	  
health	  conditions,	  reviewed	  above,	  have	  been	  conducted	  with	  samples	  consisting	  entirely	  
or	  nearly	  entirely	  of	  white	  respondents,	  with	  the	  exception	  of	  two	  studies	  of	  treatment-­‐
seeking,	  both	  of	  which	  including	  comorbid	  conditions	  as	  potential	  confounds	  rather	  than	  
primary	  variables	  of	  interest	  (in	  Japan,	  Kobayashi	  et	  al.,	  2011;	  in	  the	  United	  States	  with	  
oversampling	  of	  Asians,	  Latinos,	  African-­‐Americans,	  and	  Afro-­‐Caribbeans,	  DeVylder	  et	  al.,	  
in	  press).	  Generalizability	  of	  findings	  of	  comorbidity	  across	  racial	  and	  ethnic	  groups	  is	  
therefore	  unknown.	  However,	  threshold	  schizophrenia	  is	  known	  to	  occur	  worldwide	  
(Tandon,	  Keshavan,	  &	  Nasrallah,	  2008),	  and	  sub-­‐threshold	  psychotic	  experiences	  were	  
identified	  in	  all	  52	  countries	  of	  the	  World	  Health	  Organization’s	  World	  Health	  Survey	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(Nuevo	  et	  al.,	  2012).	  	  As	  such,	  the	  psychosis	  continuum	  is	  likely	  a	  universal	  phenomenon,	  
conceivably	  with	  a	  similar	  clinical	  profile	  across	  disparate	  cultural	  and	  ethnic	  groups.	  	  
Aims	  and	  hypotheses	  
This	  dissertation	  paper	  examines	  mental	  health	  comorbidities,	  specifically	  
depressive,	  anxiety,	  trauma,	  and	  substance	  use	  disorders	  among	  adults	  reporting	  psychotic	  
experiences	  in	  the	  general	  population,	  using	  four	  population-­‐level	  datasets	  including	  one	  
nationally	  representative	  survey	  and	  three	  surveys	  of	  distinct	  ethnic	  groups	  in	  the	  United	  
States.	  Replicating	  results	  across	  different	  ethnicities	  supports	  the	  cross-­‐cultural	  
generalizability	  of	  findings,	  whereas	  significant	  variation	  in	  the	  magnitude	  or	  type	  of	  
comorbidity	  would	  support	  ethnic	  differences.	  The	  primary	  hypothesis	  was	  that	  psychotic	  
experiences	  would	  be	  highly	  prevalent	  across	  disorders	  and	  across	  surveys,	  and	  would	  be	  
increasingly	  prevalent	  with	  greater	  co-­‐morbidity	  in	  a	  dose-­‐response	  fashion.	  A	  strong	  dose-­‐
response	  relationship	  with	  multi-­‐morbidity	  (i.e.	  number	  of	  subtypes	  of	  disorder)	  in	  the	  
context	  of	  weak	  relationships	  with	  individual	  disorders	  would	  be	  consistent	  with	  the	  
proposition	  that	  psychosis	  may	  derive	  from	  more	  extensive	  and	  severe	  psychopathology	  
rather	  than	  from	  specific	  types	  of	  disorder	  (i.e.	  quantity	  rather	  than	  quality).	  Alternatively,	  
if	  Fisher	  and	  colleague’s	  (2013)	  suggestion	  is	  correct	  that	  psychotic	  experiences	  are	  
specifically	  related	  to	  post-­‐traumatic	  stress	  disorder	  (and	  schizophrenia),	  then	  prevalence	  
of	  psychotic	  experiences	  would	  be	  hypothesized	  to	  only	  be	  independently	  associated	  with	  
this	  disorder	  and	  should	  not	  increase	  in	  a	  dose-­‐response	  fashion	  with	  an	  increasing	  
number	  of	  co-­‐morbid	  conditions.	  The	  secondary	  aim	  was	  to	  examine	  the	  added	  clinical	  
significance	  of	  psychotic	  experiences	  among	  people	  with	  co-­‐occurring	  disorders	  in	  terms	  of	  
suicide	  risk,	  cognitive	  impairment,	  role	  impairment,	  and	  service	  utilization,	  with	  the	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prediction	  that	  psychotic	  experiences	  would	  be	  associated	  with	  increased	  impairment	  and	  
service	  utilization,	  as	  found	  in	  young	  adults	  (Wigman	  et	  al.,	  2012).	  Alternatively,	  the	  true	  
clinical	  need	  may	  be	  carried	  by	  the	  primary	  diagnosis,	  with	  psychotic	  experiences	  
representing	  qualitative	  distinctions	  that	  do	  not	  necessarily	  indicate	  greater	  severity	  or	  
need	  for	  care	  beyond	  that	  of	  the	  co-­‐morbid	  disorder	  (Kobayashi	  et	  al.,	  2011).	  Finally,	  it	  was	  
hypothesized	  that	  findings	  would	  be	  consistent	  across	  all	  surveys	  since	  there	  is	  no	  clear	  a	  
priori	  evidence	  or	  reason	  to	  expect	  that	  psychotic	  experiences	  vary	  in	  terms	  of	  clinical	  need	  
and	  co-­‐morbidities	  across	  ethnic	  groups,	  although	  this	  prediction	  was	  tentative	  given	  that	  




	   The	  analyses	  presented	  in	  this	  paper	  were	  conducted	  separately	  with	  four	  samples	  
drawn	  from	  three	  general	  population	  surveys	  from	  the	  United	  States.	  The	  surveys	  used	  
similar	  methodology	  and	  sampling	  design,	  and	  collectively	  compose	  the	  Collaborative	  
Psychiatric	  Epidemiology	  Surveys	  (CPES;	  Alegría	  et	  al.,	  2007a).	  The	  four	  samples	  are	  drawn	  
from1)	  the	  National	  Comorbidity	  Survey-­‐Replication	  (NCS-­‐R;	  Alegría	  et	  al.,	  2007b;	  Kessler	  
et	  al.,	  2004),	  2)	  the	  National	  Latino	  and	  Asian	  American	  Study	  (NLAAS;	  Alegría	  et	  al.,	  2004;	  
Alegría	  &	  Takeuchi,	  2007),	  and	  3)	  the	  National	  Survey	  of	  American	  Life	  (NSAL;	  Jackson	  et	  
al.,	  2004;	  2007).	  All	  surveys	  utilized	  multi-­‐stage	  sampling	  designs,	  drawing	  participants	  
from	  households	  in	  the	  48	  contiguous	  states.	  The	  NCS-­‐R	  is	  a	  nationally	  representative	  
survey	  of	  9282	  individuals	  (predominantly	  Caucasian,	  reflecting	  the	  general	  population	  of	  
the	  United	  States),	  of	  which	  a	  random	  subsample	  (n=2322)	  completed	  the	  psychosis	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screen.	  The	  NLAAS	  is	  a	  survey	  of	  Latino	  (n=2554)	  and	  Asian	  Americans	  (n=2095),	  which	  
was	  analyzed	  as	  two	  separate	  samples	  (divided	  by	  ethnicity)	  for	  the	  purposes	  of	  this	  paper.	  
Finally,	  the	  NSAL	  is	  a	  nationally	  representative	  sample	  of	  African-­‐American	  households	  
(n=3570),	  with	  Afro-­‐Caribbean	  (n=1621)	  and	  Caucasian	  (n=891)	  respondents	  drawn	  from	  
the	  same	  source	  neighborhoods,	  although	  Caucasians	  were	  not	  assessed	  with	  the	  psychosis	  
screen.	  Because	  the	  focus	  of	  this	  study	  is	  on	  sub-­‐threshold	  psychosis,	  participants	  were	  
excluded	  if	  they	  had	  a	  lifetime	  psychotic	  disorder,	  conservatively	  defined	  as	  a	  self-­‐reported	  
a	  lifetime	  diagnosis	  of	  schizophrenia	  or	  meeting	  WHO-­‐CIDI	  criteria	  for	  lifetime	  bipolar	  
disorder	  (regardless	  of	  presence	  of	  psychosis).	  Participants	  were	  also	  excluded	  if	  they	  were	  
missing	  data	  for	  any	  of	  the	  variables	  of	  interest,	  including	  sociodemographic	  confounders.	  
Following	  exclusion,	  the	  sample	  sizes	  and	  percent	  included	  for	  each	  survey	  were:	  NCS-­‐R:	  
n=2216	  (95.4%);	  NLAAS	  Latino:	  n=2539	  (99.4%);	  NLAAS	  Asian:	  n=2077	  (99.1%);	  NSAL:	  
n=4884	  (94.1%).	  
Measures	  
Demographic	  variables	  (age,	  sex,	  race,	  foreign	  birth,	  education,	  employment	  status,	  
and	  marital	  status)	  were	  self-­‐reported	  by	  respondents.	  Psychotic	  experiences	  were	  
assessed	  using	  the	  WHO-­‐CIDI	  3.0	  psychosis	  screen,	  which	  included	  items	  assessing:	  1)	  
visual	  hallucinations,	  2)	  auditory	  hallucinations,	  3)	  thought	  insertion,	  4)	  thought	  control,	  5)	  
telepathy,	  and	  6)	  delusions	  of	  persecution.	  Psychotic	  experiences	  were	  excluded	  if	  the	  
experience	  took	  place	  solely	  in	  the	  context	  of	  falling	  asleep,	  dreaming,	  or	  substance	  use.	  	  
Respondents	  were	  assessed	  for	  lifetime	  DSM-­‐IV	  axis	  I	  disorders	  using	  the	  World	  
Mental	  Health	  Composite	  International	  Diagnostic	  Interview	  (WHO-­‐CIDI),	  a	  widely	  used	  
and	  reliable	  structured	  interview	  assessment	  for	  diagnosis	  (Haro	  et	  al.,	  2006;	  Wittchen,	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1994).	  Participants	  were	  coded	  positive	  for	  affective	  disorders	  if	  they	  met	  criteria	  for	  major	  
depressive	  disorder	  or	  dysthymia;	  for	  anxiety	  disorders	  if	  they	  met	  criteria	  for	  generalized	  
anxiety	  disorder,	  agoraphobia	  with	  and	  without	  panic	  disorder,	  panic	  disorder,	  or	  social	  
phobia;	  for	  substance	  use	  disorders	  if	  meeting	  criteria	  for	  abuse	  or	  dependence	  of	  alcohol	  
or	  other	  substances;	  and	  individually	  for	  post-­‐traumatic	  stress	  disorder,	  which	  is	  no	  longer	  
classified	  as	  an	  anxiety	  disorder	  in	  the	  most	  recent	  edition	  of	  the	  Diagnostic	  and	  Statistic	  
Manual	  for	  Mental	  Disorders	  (DSM-­‐5;	  American	  Psychiatric	  Association,	  2013).	  	  
Respondents	  were	  also	  assessed	  on	  four	  outcome	  variables,	  indicating	  lifetime	  
treatment	  seeking,	  lifetime	  suicide	  attempts,	  cognitive	  function,	  and	  role	  function.	  
Treatment-­‐seeking	  was	  defined	  as	  having	  ever	  seen	  a	  mental	  health	  professional	  (lifetime),	  
which	  included	  a	  psychiatrist,	  psychologist,	  clinical	  social	  worker,	  or	  other	  medical	  (e.g.	  
general	  practitioner,	  nurse	  practitioner)	  or	  counseling	  professional	  (e.g.	  counselor,	  
psychotherapist,	  spiritual	  advisor)	  seen	  for	  mental	  health	  reasons.	  Respondents	  were	  
asked	  whether	  they	  had	  ever	  attempted	  suicide,	  either	  as	  part	  of	  a	  written	  self-­‐report	  
module	  (for	  respondents	  literate	  in	  English),	  which	  has	  been	  shown	  to	  facilitate	  accurate	  
reporting	  of	  suicidal	  behavior	  (Turner	  et	  al.,	  1998),	  or	  orally	  for	  those	  not	  literate	  in	  
English.	  Cognitive	  function	  and	  role	  function	  (i.e.	  time	  out	  of	  role)	  were	  assessed	  using	  
World	  Health	  Organization	  Disability	  Assessment	  Schedule	  (WHO-­‐DAS)	  scales.	  WHO-­‐DAS	  
items	  were	  highly	  skewed	  and	  were	  therefore	  recoded	  into	  dichotomous	  variables	  
indicating	  high	  impairment	  (as	  close	  as	  possible	  to	  the	  top	  20%	  of	  impairment	  on	  that	  
measure	  among	  the	  sample),	  in	  accordance	  with	  past	  studies	  of	  psychosis	  in	  these	  data	  




	   All	  analyses	  were	  conducted	  using	  the	  complex	  sample	  features	  of	  SPSS	  version	  21.	  
All	  statistical	  estimates	  were	  weighted	  using	  sampling	  weights	  for	  the	  corresponding	  
survey,	  in	  order	  to	  account	  for	  individual-­‐level	  sampling	  factors	  including	  non-­‐response	  
and	  unequal	  probabilities	  of	  selection.	  	  Design-­‐based	  analyses	  were	  used	  to	  estimate	  
standard	  errors	  that	  accounted	  for	  the	  complex	  multistage	  clustered	  design	  of	  each	  survey.	  
The	  analytic	  plan	  was	  conducted	  independently	  but	  following	  identical	  procedures	  for	  each	  
of	  the	  four	  surveys	  (NCS-­‐R,	  NLAAS	  Latino	  sample,	  NLAAS	  Asian	  sample,	  NSAL).	  Post-­‐hoc	  
analyses	  tested	  for	  differences	  between	  the	  Afro-­‐Caribbean	  and	  African	  American	  
subsamples	  of	  the	  NSAL	  in	  terms	  of	  comorbidities	  with	  psychotic	  experiences;	  all	  main	  
results	  were	  in	  the	  same	  direction	  and	  of	  similar	  effect	  size	  magnitude.	  NSAL	  results	  are	  
therefore	  presented	  as	  a	  single	  set	  of	  analyses.	  	  
	   Descriptive	  data	  for	  demographic	  variables	  and	  prevalence	  of	  psychotic	  
experiences,	  by	  diagnosis,	  were	  reported	  across	  all	  four	  samples.	  Demographic	  variables	  
(age,	  sex,	  foreign	  birth,	  marital	  status,	  employment	  status,	  education)	  were	  first	  
independently	  compared	  between	  participants	  with	  and	  without	  psychotic	  experiences	  
using	  bivariate	  logistic	  regression,	  in	  order	  to	  identify	  potential	  confounder	  variables.	  
Associations	  between	  each	  diagnostic	  group	  (depressive,	  anxiety,	  substance	  use,	  and	  PTSD)	  
were	  tested	  using	  logistic	  regression,	  first	  without	  adjustment	  as	  separate	  bivariate	  
analyses,	  and	  then	  together	  in	  a	  single	  model	  (with	  adjustment	  for	  demographic	  
confounds)	  in	  order	  to	  assess	  independent	  associations	  between	  each	  diagnostic	  category	  
and	  psychotic	  experiences.	  Diagnostic	  categories	  were	  then	  summed	  to	  create	  a	  measure	  of	  
multi-­‐morbidity,	  in	  order	  to	  test	  for	  a	  dose-­‐response	  relationship	  between	  the	  number	  of	  
disorder	  subtypes	  and	  risk	  for	  psychotic	  experiences.	  This	  was	  likewise	  tested	  using	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Table 12. Descriptive data for all variables, divided by data set.  








Continuous      
Age  46.45 39.03 38.03 42.46 
Categorical      
Sex 
   Male 














   White, non-Latino 
   Black, non-Latino 
   Latino 
   Asian 


























   Yes 














   Married 
   Never married 


















   HS grad or less 














   Employed 
   Unemployed 


















   Depressive disorder 
   Anxiety disorder 
   PTSD 
   Substance use disorder 

























Suicide attempt (lifetime) 
   Yes 














   Yes 














   Yes 














   Yes 













Psychotic experiences  
   Yes 













Notes: values indicate weighted % (standard error) 
1 Diagnoses are not mutually exclusive	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logistic	  regression	  (excluding	  variables	  indicating	  specific	  diagnoses),	  with	  adjustment	  for	  
potential	  demographic	  confounds.	  	  
	   A	  final	  set	  of	  analyses	  compared	  participants	  with	  and	  without	  psychotic	  
experiences	  among	  a	  limited	  sample	  consisting	  solely	  of	  those	  who	  met	  lifetime	  diagnostic	  
criteria	  for	  any	  depressive,	  anxiety,	  or	  substance	  use	  disorder,	  or	  PTSD,	  in	  order	  to	  examine	  
whether	  psychotic	  experiences	  modified	  the	  severity	  of	  common	  disorders	  in	  terms	  of	  
cognitive	  impairment,	  role	  impairment,	  suicide	  risk,	  and	  whether	  they	  were	  associated	  
with	  utilization	  of	  services.	  Respondents	  with	  and	  without	  psychotic	  experiences	  were	  
compared	  separately	  on	  each	  outcome	  measure	  using	  logistic	  regression,	  with	  adjustment	  
for	  potential	  demographic	  confounders.	  A	  second	  set	  of	  outcome	  analyses	  additionally	  
controlled	  for	  the	  number	  of	  co-­‐morbid	  mental	  health	  conditions.	  	  
Table 13. Prevalence of psychotic experience by diagnosis and diagnostic category, across each data set.   





No diagnosis 6.4 (1.2) 5.2 (0.7) 6.7 (0.5) 8.0 (0.5) 
     
Depressive 15.7 (2.1) 10.0 (2.4) 16.6 (2.5) 21.4 (2.9) 
   Major depression 15.4 (1.9) 9.3 (2.4) 16.2 (2.5) 21.6 (3.0) 
   Dysthymia 30.1 (7.7) 19.0 (7.5) 23.1 (6.7) 20.3 (6.3) 
     
Anxiety 14.8 (1.9) 12.6 (2.2) 15.9 (2.6) 21.5 (2.1) 
   Generalized anxiety disorder 15.1 (2.8) 17.5 (8.1) 13.9 (3.9) 28.2 (5.2) 
   Agoraphobia with panic 17.0 (5.6) 6.0 (5.6) 19.3 (6.1) 15.0 (3.3) 
   Agoraphobia without panic 18.6 (5.7) 4.4 (4.2) 17.5 (4.9) 17.7 (3.6) 
   Panic disorder 16.5 (3.8) 12.7 (4.6) 21.5 (5.6) 33.9 (4.4) 
   Social phobia 15.0 (2.2) 11.1 (3.4) 15.2 (3.1) 18.5 (2.8) 
     
PTSD 18.1 (3.9) 19.2 (9.1) 22.0 (5.2) 25.1 (2.9) 
     
Substance 14.2 (2.2) 16.4 (4.1) 22.0 (5.2) 18.7 (2.7) 
   Alcohol abuse 13.6 (2.3) 17.8 (4.5) 18.6 (4.1) 16.9 (2.4) 
   Alcohol dependence 15.7 (3.3) - 22.3 (4.9) 18.0 (3.5) 
   Drug abuse 15.8 (3.1) 5.6 (3.3) 23.0 (6.0) 22.7 (4.1) 
   Drug dependence 19.4 (6.3) 6.6 (0.6) 39.3 (10.4) 37.8 (6.8) 
Note: Values indicate weighted percentage (standard error). No respondents endorsed both drug abuse and psychotic 




Statistical	  significance	  was	  assessed	  for	  all	  tests	  using	  Wald	  χ²,	  with	  two-­‐tailed	  
alpha=0.05.	  Effect	  sizes	  were	  reported	  as	  unadjusted	  (bivariate	  analyses)	  or	  adjusted	  
(multiple	  logistic	  regression	  analyses)	  odds	  ratios	  (OR)	  with	  95%	  confidence	  intervals	  (CI).	  	  
Table 14. Odds ratios indicating difference in risk for psychotic experiences within a particular diagnostic category.  
Diagnosis   Psychotic Experiences: 
OR [95% CI] 
Statistics, p 
NCS-R     
None   0.45 [0.29-0.70] χ²(df=1)=13.17, p<0.001 
Depressive   2.32 [1.54-3.47] χ²(df=1)=17.51, p<0.001 
Anxiety   2.17 [1.51-3.12] χ²(df=1)=18.57, p<0.001 
PTSD   2.51 [1.48-4.27] χ²(df=1)=12.27, p<0.001 
Substance   1.95 [1.27-2.99] χ²(df=1)=9.89, p=0.002 
     
Asian     
None   0.44 [0.26-0.75] χ²(df=1)=9.75, p=0.002 
Depressive   1.77 [0.98-3.22] χ²(df=1)=3.73, p=0.053 
Anxiety   2.40 [1.49-3.86] χ²(df=1)=13.82, p<0.001 
PTSD   3.73 [1.07-13.05] χ²(df=1)=4.48, p=0.034 
Substance   3.16 [1.65-6.03] χ²(df=1)=12.81, p<0.001 
     
Latino     
None   0.36 [0.23-0.55] χ²(df=1)=21.79, p<0.001 
Depressive   2.15 [1.53-3.02] χ²(df=1)=20.66, p<0.001 
Anxiety   1.98 [1.39-2.83] χ²(df=1)=15.09, p<0.001 
PTSD   2.84 [1.55-5.20] χ²(df=1)=11.85, p=0.001 
Substance   2.64 [1.43-4.87] χ²(df=1)=10.01, p=0.002 
     
NSAL     
None   0.38 [0.30-0.49] χ²(df=1)=65.05, p<0.001 
Depressive   2.47 [1.74-3.52] χ²(df=1)=26.24, p<0.001 
Anxiety   2.54 [1.96-3.29]  χ²(df=1)=52.16, p<0.001 
PTSD   3.09 [2.28-4.19] χ²(df=1)=54.96, p<0.001 
Substance   2.02 [1.47-2.79] χ²(df=1)=54.96, p<0.001 
Note: Odds ratios are unadjusted 




	   Descriptive	  data	  for	  all	  demographic	  and	  clinical	  variables	  in	  each	  data	  set,	  which	  
differed	  primarily	  in	  terms	  of	  ethnic	  make-­‐up,	  are	  presented	  in	  Table	  12.	  Psychotic	  
experiences,	  comorbid	  diagnoses,	  treatment,	  and	  suicide	  are	  all	  notably	  uncommon	  among	  
the	  Asian-­‐American	  sample	  compared	  to	  others,	  possibly	  limiting	  statistical	  power	  for	  
further	  analysis	  with	  this	  group.	  Prevalence	  of	  psychotic	  experiences	  was	  numerically	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greater	  in	  the	  context	  of	  every	  individual	  disorder	  and	  diagnostic	  subtype,	  across	  all	  data	  
sets,	  with	  the	  exception	  of	  agoraphobia	  (without	  panic	  disorder)	  among	  the	  Asian	  sample	  
(Table	  13).	  All	  remaining	  analyses	  utilized	  diagnostic	  subtypes	  (depressive,	  anxiety,	  PTSD,	  
substance)	  rather	  than	  individual	  disorders.	  In	  unadjusted	  bivariate	  analyses,	  lifetime	  	  
prevalence	  of	  psychotic	  experiences	  was	  significantly	  greater	  among	  respondents	  with	  
each	  subtype	  of	  mental	  health	  condition	  (depressive,	  anxiety,	  and	  substance	  use	  disorders,	  
and	  PTSD	  diagnosis)	  compared	  to	  the	  remainder	  of	  the	  sample,	  across	  all	  four	  data	  sets	  
(Table	  14).	  	  
	   Relationships	  were	  then	  tested	  between	  each	  diagnostic	  category	  and	  psychotic	  
experiences	  using	  a	  fully	  adjusted	  model,	  which	  controlled	  for	  demographic	  variables	  as	  
well	  as	  each	  remaining	  subtype	  of	  mental	  disorder.	  In	  the	  fully	  adjusted	  model,	  odds	  for	  
psychotic	  experiences	  were	  still	  greater	  within	  each	  data	  set	  and	  each	  mental	  health	  
condition,	  except	  for	  depressive	  disorders	  in	  the	  NLAAS	  Asian	  data	  set	  (Table	  15).	  	  
Table 15. Final adjusted model of the association between each diagnostic category and psychotic experiences, 
within each data set.  
 NCS-R NLAAS (Asian) NLAAS (Latino) NSAL 
Clinical variables     
None (reference) - - - - 
Depressive 1.70 [1.15-2.53] 0.98 [0.45-2.17] 1.62 [1.16-2.27] 1.71 [1.14-2.56] 
Anxiety 1.56 [1.08-2.26] 1.53 [0.77-3.02] 1.35 [0.89-2.05] 1.76 [1.31-2.36] 
PTSD 1.46 [0.82-2.60] 2.41 [0.55-10.55] 1.77 [0.93-3.38] 2.15 [1.58-2.93] 
Substance 1.85 [1.15-2.96] 1.95 [0.90-4.21] 2.14 [1.19-3.87] 1.44 [1.05-1.98] 
     
Confounder variables     
Age 0.99 [0.98-1.01] 1.00 [0.98-1.02] 1.01 [1.00-1.02] 1.00 [0.99-1.01] 
Sex (ref: male) 1.84 [1.22-2.78] 0.82 [0.54-1.26] 1.06 [0.82-1.37] 0.99 [0.78-1.26] 
Foreign-born (ref: no) 1.18 [0.66-2.12] 0.73 [0.46-1.16] 0.82 [0.53-1.26] 0.81 [0.54-1.21] 
Marital (ref: married) - - - - 
   Never married 1.36 [0.78-2.35] 1.50 [0.83-2.70] 1.84 [1.33-2.55] 1.21 [0.90-1.64] 
   Previously married 1.35 [0.77-2.37] 1.57 [0.72-3.44] 1.14 [0.82-1.57] 1.53 [1.05-2.23] 
Education (ref: no college) 0.80 [0.55-1.16] 1.46 [0.98-2.18] 1.48 [0.91-2.39] 1.03 [0.77-1.39] 
Employm. (ref: employed) - - - - 
   Unemployed 1.15 [0.51-2.59] 2.61 [1.15-5.88] 1.09 [0.53-2.23] 1.47 [1.04-2.06] 
   Not in labor force 1.22 [0.79-1.88] 0.54 [0.33-0.90] 1.02 [0.70-1.49] 1.64 [1.18-2.27] 
Note: Values presented as OR [95% CI], with each OR adjusted for the remaining clinical conditions as well as 
sociodemographic factors. Significant associations are presented in bold.  




However,	  the	  effect	  sizes	  were	  reduced	  relative	  to	  those	  from	  the	  unadjusted	  analyses	  and	  
many	  were	  no	  longer	  statistically	  significant.	  Specifically,	  adjusted	  associations	  were	  only	  
significant	  with	  depressive	  disorders	  in	  the	  NCS-­‐R,	  NLAAS	  Latino,	  and	  NSAL	  samples,	  with	  
anxiety	  disorders	  in	  the	  NCS-­‐R	  and	  NSAL	  samples,	  with	  PTSD	  in	  the	  NSAL	  sample,	  and	  with	  
substance	  use	  disorders	  in	  the	  NCS-­‐R,	  NLAAS,	  and	  NSAL	  samples.	  Sociodemographic	  
associations	  with	  psychotic	  experiences	  likewise	  varied	  across	  the	  data	  sets,	  with	  
respondents	  reporting	  psychotic	  experiences	  more	  likely	  to	  be	  female	  in	  the	  NCS-­‐R	  only,	  
less	  likely	  to	  be	  foreign-­‐born	  in	  the	  NLAAS	  Asian,	  NLAAS	  Latino,	  and	  NSAL,	  more	  likely	  to	  
be	  never	  married	  in	  the	  NLAAS	  Latino	  only,	  previously	  married	  in	  the	  NSAL,	  and	  
unemployed	  in	  the	  NLAAS	  Asian	  and	  NSAL,	  and	  more	  likely	  to	  be	  out	  of	  the	  labor	  force	  in	  
the	  NSAL	  but	  less	  likely	  in	  the	  NLAAS	  Asian.	  Consistent	  with	  the	  elevated	  risk	  for	  psychotic	  
experiences	  among	  respondents	  with	  mental	  disorders,	  prevalence	  of	  mental	  disorders	  
was	  likewise	  high	  among	  respondents	  with	  psychotic	  experiences,	  although	  psychotic	  
experiences	  without	  comorbidities	  were	  notably	  more	  common	  among	  Asian-­‐Americans	  
(Table	  16).	  	  
Table 16. Prevalence of disorders among respondents with PE 
 NCS-R NLAAS (Asians) NLAAS (Latinos) NSAL 
None 48.8 (5.3) 69.7 (5.9) 49.0 (5.6) 50.7 (2.6) 
Depressive 26.4 (3.9) 14.6 (3.7) 24.7 (2.6) 20.7 (2.7) 
Anxiety 28.4 (3.0) 17.3 (3.7) 21.3 (3.0) 23.2 (1.9) 
PTSD 11.5 (2.3) 5.9 (3.1) 10.2 (2.1) 19.4 (2.0) 
Substance 21.1 (3.5) 10.0 (2.9) 22.5 (6.0) 18.1 (2.1) 
Note: Values indicate % (standard error) 
	  
	   The	  next	  set	  of	  analyses	  tested	  for	  a	  dose-­‐response	  relationship	  between	  the	  
number	  of	  subtypes	  of	  common	  mental	  disorders	  and	  odds	  for	  psychotic	  experiences.	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There	  was	  a	  significant	  linear	  relationship	  between	  the	  number	  of	  co-­‐morbid	  conditions	  
and	  psychosis	  risk	  across	  all	  four	  data	  sets	  (Table	  17).	  	  
	   Finally,	  each	  data	  set	  was	  examined	  for	  associations	  between	  psychotic	  experiences	  
and	  clinically	  significant	  outcome	  variables	  among	  respondents	  with	  co-­‐occurring	  
diagnosable	  disorders.	  There	  was	  a	  general	  pattern	  of	  more	  severe	  clinical	  and	  functional	  
outcomes	  among	  respondents	  with	  psychotic	  experiences	  (Figure	  3),	  although	  this	  was	  not	  
statistically	  significant	  across	  all	  analyses.	  Specifically,	  respondents	  with	  psychotic	  
experiences	  were	  significantly	  more	  likely	  to	  be	  classified	  as	  having	  high	  cognitive	  	  
Table 17. Logistic regression tests for dose-response relationships between increasing numbers of comorbid 






OR [95% CI] 
Statistics, p 
NCS-R   χ²(df=3)=39.01, p<0.001 
0 6.4 (1.2) - - 
1 10.4 (1.6) 1.70 [1.01-2.87] - 
2 15.5 (2.1) 2.62 [1.58-4.33] - 
3+ 25.0 (4.6) 5.04 [2.91-8.73] - 
Lin trend   χ²(df=1)=38.85, p<0.001 
    
Asian   χ²(df=3)=8.27, p=0.041 
0 5.2 (0.7) - - 
1 8.7 (2.2) 1.53 [0.76-3.08] - 
2 17.2 (5.1) 2.62 [1.10-6.23] - 
3+ 16.9 (5.8) 2.46 [0.89-6.86] - 
Lin trend   χ²(df=1)=4.28, p=0.039 
    
Latino   χ² (df=3)=32.14, p<0.001 
0 6.7 (0.5) - - 
1 14.9 (2.9) 2.30 [1.36-3.90] - 
2 20.5 (3.8) 3.59 [2.23-5.77] - 
3+ 18.7 (5.2) 3.09 [1.47-6.47] - 
Lin trend   χ² (df=1)=10.05, p=0.002 
    
NSAL   χ² (df=3)=97.58, p<0.001 
0 8.0 (0.5) - - 
1 15.0 (2.0) 1.93 [1.39-2.66] - 
2 21.6 (2.8) 3.05 [2.10-4.44] - 
3+ 37.0 (5.7) 6.13 [3.87-9.69] - 
Lin trend  - χ²(df=1)=64.25, p<0.001 
Note: All analyses are fully adjusted for all potential sociodemographic confounders 
impairment (NCS-R, NLAAS Latino, NSAL, but not NLAAS Asian) and high role impairment  
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(NLAAS	  Asian,	  NLAAS	  Latino,	  but	  not	  NCS-­‐R	  or	  NSAL)	  in	  some	  but	  not	  all	  surveys.	  Those	  
with	  psychotic	  experiences	  were	  also	  more	  likely	  to	  have	  made	  a	  lifetime	  suicide	  attempt	  in	  
the	  NCS-­‐R,	  NLAAS	  Latino,	  and	  NSAL,	  but	  not	  in	  the	  NLAAS	  Asian.	  Finally,	  psychotic	  
experiences	  were	  significantly	  associated	  with	  greater	  utilization	  of	  services	  in	  the	  NCS-­‐R	  
and	  NSAL,	  but	  not	  in	  either	  NLAAS	  sample.	  Associations	  were	  slightly	  attenuated	  but	  
largely	  unchanged	  when	  controlling	  for	  multi-­‐morbidity	  (Figure	  4).	  	  
	  
Figure 3. Odds ratios for outcomes associated with psychotic experiences among respondents with a common 
mental disorder. Odds ratio values are displayed on a logarithmic scale.  
	  
  












Figure 4. Odds ratios for outcomes associated with psychotic experiences among respondents with a common 




	   There	  is	  increasing	  evidence	  that	  sub-­‐threshold	  psychotic	  experiences	  occur	  
frequently	  in	  the	  general	  population,	  particularly	  among	  individuals	  with	  one	  or	  more	  
other	  diagnosable	  disorders	  (Johns	  et	  al.,	  2004;	  Kelleher	  et	  al.,	  2012a;	  Saha	  et	  al.,	  2012;	  
Scott	  et	  al.,	  2007;	  van	  Nierop	  et	  al.,	  2012;	  Varghese	  et	  al.,	  2011;	  Wigman	  et	  al.,	  2012).	  In	  this	  
analysis,	  there	  were	  widespread	  moderate	  associations	  with	  psychotic	  experiences	  across	  
all	  types	  of	  psychopathology,	  replicated	  in	  four	  data	  sets	  including	  a	  nationally	  
representative	  sample	  and	  three	  samples	  within	  specific	  ethnic	  groups.	  These	  associations	  
were	  consistently	  weakened	  and	  only	  variably	  significant,	  although	  still	  in	  the	  predicted	  
direction,	  when	  controlling	  for	  sociodemographic	  confounders	  and,	  perhaps	  more	  
importantly,	  the	  remaining	  subtypes	  of	  disorder.	  However,	  the	  relationship	  between	  the	  











extent	  of	  co-­‐morbidity	  (i.e.	  number	  of	  subtypes	  of	  diagnosable	  disorders)	  was	  robust	  to	  
controls	  for	  sociodemographic	  factors,	  exhibiting	  a	  strong	  linear	  relationship	  across	  all	  four	  
data	  sets,	  suggesting	  that	  psychotic	  experiences	  may	  specifically	  be	  related	  to	  the	  quantity	  
(number	  of	  co-­‐occurring	  disorders)	  rather	  than	  the	  quality	  (specific	  diagnoses)	  of	  co-­‐
occurring	  mental	  health	  conditions.	  Finally,	  psychotic	  experiences	  modify	  the	  clinical	  
severity	  of	  common	  mental	  disorders	  in	  terms	  of	  increased	  risk	  for	  suicide	  attempts	  and	  
cognitive	  impairment	  in	  these	  data	  across	  all	  groups	  except	  Asian-­‐Americans,	  with	  more	  
variable	  findings	  for	  treatment-­‐seeking	  behavior	  and	  role	  impairment.	  	  
Is	  psychosis	  risk	  related	  to	  the	  quality	  of	  or	  the	  degree	  of	  psychopathology?	  	  
	   The	  prevalence	  of	  psychotic	  experiences	  was	  elevated	  in	  the	  context	  of	  every	  
individual	  diagnosis	  and	  diagnostic	  category	  examined,	  across	  all	  samples,	  with	  a	  single	  
exception	  (Agoraphobia	  without	  panic	  disorder	  among	  Asian-­‐Americans).	  Several	  studies	  
have	  now	  tested	  for	  associations	  between	  psychotic	  experiences	  and	  specific	  psychiatric	  
diagnoses,	  generally	  finding	  significantly	  greater	  prevalence	  of	  psychotic	  experiences	  
among	  those	  with	  the	  disorder	  in	  question	  compared	  to	  those	  without	  the	  disorder,	  
regardless	  of	  what	  that	  particular	  disorder	  may	  be	  (i.e.	  depressive,	  anxiety,	  and	  substance	  
use	  disorders,	  and	  PTSD;	  Johns	  et	  al.,	  2004;	  Saha	  et	  al.,	  2012;	  Scott	  et	  al.,	  2007;	  van	  Nierop	  
et	  al.,	  2012;	  Varghese	  et	  al.,	  2011;	  Wigman	  et	  al.,	  2012)	  The	  notable	  exception	  is	  the	  recent	  
study	  by	  Fisher	  and	  colleagues	  (2013),	  in	  which	  childhood	  psychotic	  experiences	  were	  
prospectively	  associated	  with	  schizophrenia	  and	  PTSD	  in	  adulthood,	  but	  not	  with	  
persistent	  anxiety	  or	  depressive	  disorders	  or	  substance	  dependence.	  However,	  even	  in	  
their	  analyses,	  prevalence	  of	  each	  class	  of	  disorder	  was	  higher	  among	  respondents	  with	  
childhood	  psychotic	  experiences	  (anxiety:	  RR=1.47;	  depression:	  RR=1.50;	  substance	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dependence:	  RR=1.91),	  and	  may	  not	  have	  been	  statistically	  significant	  due	  to	  low	  power	  
(i.e.	  psychotic	  experiences	  with	  anxiety:	  n=5;	  with	  depression:	  n=4;	  with	  substance	  
dependence:	  n=6).	  Overall	  therefore,	  the	  literature	  points	  to	  widespread	  associations	  
between	  psychotic	  experiences	  and	  psychopathology	  in	  general,	  with	  few	  convincing	  
examples	  of	  null	  associations.	  Given	  that	  the	  data	  presented	  here	  likewise	  demonstrate	  
consistent	  associations	  with	  every	  disorder	  subtype	  (in	  bivariate	  analysis)	  it	  would	  be	  
parsimonious	  to	  conclude	  that	  the	  odds	  of	  psychotic	  experiences	  are	  increased	  in	  the	  
context	  of	  psychopathology	  in	  general,	  not	  any	  particular	  subtype	  of	  mental	  health	  
condition.	  	  Such	  non-­‐specific	  comorbidity	  has	  likewise	  been	  found	  among	  people	  with	  
schizophrenia,	  a	  population	  with	  an	  elevated	  prevalence	  of	  comorbidity	  across	  the	  entire	  
spectrum	  of	  mental	  health	  conditions	  (Buckley	  et	  al.,	  2009),	  and	  among	  individuals	  with	  a	  
family	  history	  of	  schizophrenia,	  who	  are	  likewise	  at	  elevated	  risk	  for	  a	  broad	  range	  of	  
psychiatric	  disorders	  (Dean	  et	  al.,	  2010;	  DeVylder	  &	  Lukens,	  2013)	  
	   Although	  psychosis	  may	  not	  be	  related	  to	  the	  type	  of	  co-­‐occurring	  psychopathology,	  
it	  may	  be	  related	  to	  the	  severity	  of	  co-­‐occurring	  psychopathology,	  as	  indicated	  by	  the	  
number	  of	  co-­‐occurring	  disorders.	  Such	  an	  explanation	  is	  consistent	  with	  the	  linear	  dose-­‐
response	  relationship	  identified	  here	  across	  all	  four	  data	  sets,	  which	  is	  likewise	  in	  
concurrence	  with	  past	  studies	  showing	  that	  odds	  for	  psychotic	  experiences	  increase	  with	  
more	  extensive	  multi-­‐morbidity	  (Kelleher	  et	  al.,	  2012a;	  2013a)	  and	  with	  greater	  severity	  
within	  a	  single	  diagnosis	  (Saha	  et	  al.,	  2012).	  There	  is	  substantially	  more	  evidence	  (below)	  
that	  psychosis	  and	  common	  mental	  disorders	  share	  risk	  factors	  than	  there	  is	  that	  psychosis	  
causes	  the	  emergence	  of	  co-­‐occurring	  conditions	  (or	  vice	  versa),	  suggesting	  this	  
relationship	  may	  highlight	  the	  utility	  of	  psychotic	  experiences	  as	  indicators	  of	  extensive	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comorbidity	  and	  clinical	  significance,	  but	  not	  necessarily	  as	  causes.	  	  This	  appears	  to	  point	  
to	  a	  construct	  of	  sub-­‐threshold	  psychosis	  as	  an	  independent	  syndrome	  or	  dimension	  of	  
psychopathology,	  the	  risk	  for	  which	  is	  increased	  with	  greater	  extent	  of	  comorbidity	  but	  
which	  is	  not	  bound	  to	  a	  single	  class	  of	  disorder.	  	  
Mechanisms	  of	  multi-­‐morbidity	  
	   There	  are	  numerous	  potential	  explanations	  for	  the	  co-­‐occurrence	  of	  psychosis	  with	  
common	  mental	  health	  disorders,	  none	  of	  which	  could	  be	  distinguished	  based	  on	  the	  
presented	  data	  but	  should	  be	  explored	  in	  future	  studies.	  The	  onset	  of	  psychosis	  is	  now	  
widely	  attributed	  to	  epigenetic	  mechanisms,	  such	  that	  the	  presence	  of	  particular	  genes	  may	  
make	  someone	  more	  vulnerable	  to	  the	  development	  of	  psychosis,	  but	  additional	  
environmental	  exposures	  are	  necessary	  for	  the	  expression	  of	  these	  genes	  and	  the	  
consequent	  presentation	  of	  symptoms	  (van	  Os,	  Rutten,	  &	  Poulton,	  2008).	  Similar	  gene-­‐
environment	  interactions	  are	  believed	  to	  explain	  a	  broad	  range	  of	  mental	  health	  conditions	  
(Rutter,	  Moffitt,	  &	  Caspi,	  2006),	  thereby	  explaining	  the	  paradox	  that	  1)	  environmental	  
exposures	  are	  known	  to	  lead	  to	  onset	  of	  certain	  mental	  health	  conditions,	  yet	  2)	  not	  
everyone	  exposed	  to	  these	  factors	  develops	  a	  mental	  health	  condition	  (Caspi	  &	  Moffitt,	  
2006).	  Recent	  evidence	  has	  shown	  that	  diagnostically	  disparate	  mental	  health	  conditions	  
(i.e.	  schizophrenia,	  autism,	  attention-­‐deficit	  hyperactivity	  disorder,	  bipolar	  disorder,	  and	  
major	  depressive	  disorder)	  share	  genetic	  risk-­‐loci	  (Cross-­‐Disorder	  Group	  of	  the	  Psychiatric	  
Genomics	  Consortium,	  2013),	  confirming	  through	  genetic	  analysis	  what	  had	  previously	  
been	  concluded	  from	  research	  with	  twins	  (Kendler,	  Prescott,	  Myers,	  &	  Neale,	  2003).	  As	  
such,	  inherited	  genes	  may	  exert	  pleiotropic	  effects	  such	  that	  a	  common	  set	  of	  ‘risk’	  genes	  
may	  lead	  to	  different	  and	  seemingly	  disparate	  phenotypic	  expressions	  (Weiser,	  van	  Os,	  &	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Davidson,	  2005),	  which	  may	  then	  be	  more	  or	  less	  consistent	  with	  particular	  diagnostic	  
criteria.	  	  
In	  addition	  to	  shared	  genetic	  vulnerabilities,	  psychosis	  and	  common	  mental	  health	  
conditions	  also	  share	  environmental	  risk	  factors.	  For	  example,	  childhood	  trauma	  may	  lead	  
to	  post-­‐traumatic	  stress	  disorder	  (e.g.	  Cloitre	  et	  al.,	  2009),	  but	  is	  also	  more	  prevalent	  
among	  people	  with	  depressive	  and	  anxiety	  disorders	  (Douglas	  et	  al.,	  2010;	  Hovens	  et	  al.,	  
2010),	  substance	  abuse	  disorders	  (Douglas	  et	  al.,	  2010;	  Ducci	  et	  al.,	  2009;	  Medrano,	  Zule,	  
Hatch,	  &	  Desmond,	  1999;	  Wilsnack,	  Vogeltanz,	  Klassen,	  &	  Harris,	  1997),	  and	  notably	  among	  
people	  with	  psychotic	  experiences	  (Arseneault	  et	  al.,	  2011;	  Galletly	  et	  al.,	  2011;	  Mackie,	  
Castellanos-­‐Ryan,	  &	  Conrod,	  2011;	  Soosay	  et	  al.,	  2012).	  Similar	  non-­‐specific	  associations	  
are	  found	  with	  social	  support,	  employment	  status,	  socioeconomic	  status,	  and	  other	  known	  
risk	  factors	  for	  psychotic	  experiences	  (Linscott	  &	  van	  Os,	  2013).	  	  
Psychosis	  and	  common	  mental	  disorders	  also	  share	  substrates	  of	  neural	  
dysfunction,	  which	  may	  mediate	  the	  relationship	  between	  genetic	  and	  environmental	  risk	  
factors	  and	  symptom	  presentation.	  For	  example,	  the	  dysfunction	  of	  the	  hypothalamic-­‐
pituitary-­‐adrenal	  (HPA)	  axis	  plays	  a	  critical	  role	  in	  the	  onset	  of	  schizophrenia	  in	  the	  
neurobiological	  diathesis-­‐stress	  model,	  in	  that	  chronic	  activation	  of	  the	  HPA-­‐axis	  (possibly	  
due	  to	  impaired	  inhibition	  from	  the	  hippocampus	  and	  prefrontal	  cortex)	  may	  lead	  to	  
sensitization	  of	  the	  dopamine	  system,	  behaviorally	  manifested	  as	  psychotic	  symptoms	  
(Corcoran	  et	  al.,	  2003;	  Walker	  &	  DiForio,	  1997).	  However,	  PTSD	  is	  likewise	  characterized	  
by	  sensitization	  of	  the	  HPA	  axis	  (Yehuda,	  2001),	  and	  alcohol	  use	  disorders	  are	  
characterized	  by	  impaired	  inhibition	  of	  the	  HPA	  axis	  (Thayer	  et	  al.,	  2006).	  HPA	  axis	  
dysfunction	  is	  also	  present	  in	  major	  depression	  (Pariante	  &	  Lightman,	  2008)	  and	  anxiety	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disorders	  (Kallen	  et	  al.,	  2008),	  including	  panic	  disorder	  (Abelson	  et	  al.,	  2007)	  and	  social	  
phobia	  (Condren	  et	  al.,	  2002),	  among	  others.	  Other	  potential	  shared	  neural	  substrates	  
across	  psychosis	  and	  common	  disorders	  may	  include	  prefrontal	  cortex	  function,	  
hippocampal	  damage,	  and	  abnormalities	  in	  dopamine	  circuits.	  	  
It	  is	  also	  conceivable	  that	  psychiatric	  disorders	  can	  causally	  lead	  from	  one	  to	  
another.	  For	  example,	  an	  ongoing	  debate	  regarding	  schizophrenia	  etiology	  focuses	  on	  the	  
role	  of	  substance	  abuse	  (particularly	  cannabis)	  in	  the	  onset	  of	  symptoms	  (Casadio,	  
Fernandes,	  Murray,	  &	  Di	  Forti,	  2011).	  Similarly,	  anxiety	  disorders	  may	  lead	  to	  the	  
subsequent	  onset	  of	  depressive	  disorder,	  or	  vice-­‐versa	  (Lamars	  et	  al.,	  2011).	  Although	  it	  is	  
parsimonious	  to	  assume	  that	  multi-­‐morbidity	  is	  caused	  by	  shared	  risk	  factors,	  it	  is	  possible	  
that	  it	  is	  caused	  by	  shared	  risk	  factors	  in	  addition	  to	  interactive	  effects	  between	  diagnoses	  
(or	  dimensions	  of	  symptoms).	  Pilot	  analysis	  of	  temporal	  order	  of	  diagnoses	  and	  psychotic	  
experiences	  in	  this	  sample	  based	  on	  retrospective	  estimates	  of	  age	  of	  onset	  did	  not	  appear	  
reliable	  or	  consistent	  across	  data	  sets	  (data	  not	  shown),	  leaving	  this	  an	  open	  question	  that	  
would	  be	  better	  answered	  using	  prospective	  cohort	  data.	  	  
Clinical	  significance	  of	  psychotic	  experiences	  
Psychotic	  experiences	  occurring	  in	  the	  context	  of	  diagnosable	  mental	  disorders	  
increase	  risk	  for	  suicide	  attempts	  across	  all	  samples	  studied	  except	  the	  Asian	  sample,	  for	  
which	  there	  was	  likely	  insufficient	  statistical	  power	  given	  the	  lower	  prevalence	  of	  both	  
psychotic	  experiences	  and	  suicide	  attempts	  among	  this	  ethnic	  group.	  Several	  studies	  have	  
now	  supported	  a	  link	  between	  sub-­‐threshold	  psychosis	  and	  suicidal	  ideation	  (Nishida	  et	  al.,	  
2010;	  Saha	  et	  al.,	  2011)	  and	  attempts	  (Fisher	  et	  al.,	  2013;	  Kelleher	  et	  al.,	  2012b;	  2013b;	  
Saha	  et	  al.,	  2011).	  This	  finding	  is	  therefore	  unsurprising,	  but	  is	  notable	  as	  the	  first	  study	  to	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find	  this	  association	  specifically	  in	  respondents	  with	  co-­‐occurring	  disorders.	  Wigman	  and	  
colleagues	  (2012)	  tested	  for	  an	  association	  between	  psychotic	  experiences	  and	  suicidal	  
ideation	  among	  respondents	  with	  major	  depression	  or	  anxiety	  disorders	  but	  found	  no	  
association.	  This	  discrepancy	  may	  be	  explained	  by	  the	  difference	  in	  measures	  of	  suicidality;	  
Kelleher	  and	  colleagues	  (2013a)	  recently	  suggested	  that	  psychotic	  experiences	  may	  be	  
related	  to	  attempts	  but	  not	  ideation	  because	  they	  primarily	  affect	  the	  more	  severe	  range	  of	  
the	  suicidality	  spectrum;	  this	  is	  likewise	  supported	  by	  the	  analysis	  in	  paper	  1	  of	  this	  
dissertation.	  	  
Psychotic	  experiences	  were	  likewise	  associated	  with	  cognitive	  impairment	  in	  all	  
data	  sets	  except	  the	  NLAAS	  Asian	  sample.	  Cognitive	  impairment	  is	  a	  well-­‐known	  
component	  of	  threshold	  psychosis	  (Heinrichs	  &	  Zakzanis,	  1998)	  as	  early	  as	  the	  first	  
psychotic	  episode	  (Mesholam-­‐Gately	  et	  al.,	  2009)	  and	  the	  antecedent	  prodromal	  period	  
(Fusar-­‐Poli	  et	  al.,	  2012b),	  and	  has	  been	  proposed	  as	  a	  causal	  agent	  contributing	  to	  the	  
onset	  of	  psychotic	  symptoms	  (Garety,	  Kuipers,	  Fowler,	  Freeman,	  &	  Bebbington,	  2001).	  The	  
presence	  of	  cognitive	  impairment	  at	  and	  prior	  to	  first	  episode	  psychosis	  would	  suggest	  that	  
it	  is	  a	  component	  of	  the	  broader	  psychosis	  phenotype	  and	  therefore	  should	  be	  present	  
among	  respondents	  with	  sub-­‐threshold	  psychosis,	  as	  was	  shown	  here.	  	  Cognitive	  
remediation	  therapies	  have	  been	  effective	  in	  reducing	  cognitive	  impairment,	  symptom	  
severity,	  and	  functional	  impairment	  in	  schizophrenia	  (McGurk,	  Twamley,	  Sitzer,	  McHugo,	  &	  
Mueser,	  2007)	  and	  likewise	  may	  benefit	  individuals	  with	  sub-­‐threshold	  psychotic	  
experiences,	  particularly	  when	  they	  occur	  in	  the	  context	  of	  common	  mental	  disorders.	  	  
Other	  forms	  of	  clinical	  significance	  are	  difficult	  to	  determine	  in	  these	  data,	  given	  the	  
generally	  inconsistent	  findings	  across	  data	  sets.	  Treatment-­‐seeking	  was	  only	  marginally	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more	  common	  among	  people	  with	  psychotic	  experiences,	  in	  contrast	  to	  a	  prior	  study	  with	  
these	  data	  showing	  that	  treatment-­‐seeking	  was	  substantially	  more	  common	  among	  those	  
with	  psychotic	  experiences	  when	  including	  respondents	  without	  co-­‐occurring	  disorders	  
(DeVylder	  et	  al.,	  in	  press).	  The	  association	  between	  sub-­‐threshold	  psychosis	  and	  treatment-­‐
seeking	  behavior	  has	  been	  debated	  in	  the	  field.	  Studies	  controlling	  for	  co-­‐occurring	  
diagnoses	  have	  found	  significant	  relationships	  between	  psychosis	  and	  service	  utilization	  
(DeVylder	  et	  al.,	  in	  press;	  Murphy	  et	  al.,	  2012),	  whereas	  a	  study	  controlling	  for	  severity	  of	  
co-­‐occurring	  psychopathology	  did	  not	  find	  a	  relationship	  between	  psychosis	  and	  treatment	  
(Kobayashi	  et	  al.,	  2011).	  Time	  out	  of	  role	  is	  similarly	  difficult	  to	  interpret,	  as	  it	  is	  only	  
significantly	  associated	  with	  psychosis	  among	  the	  Asian	  and	  Latino	  samples.	  Psychotic	  
experiences	  may	  therefore	  be	  associated	  with	  additional	  role	  function	  impairment	  above	  
and	  beyond	  that	  associated	  with	  the	  primary	  diagnoses,	  although	  this	  should	  be	  replicated	  
in	  future	  studies.	  	  
Psychosis	  co-­‐morbidities	  across	  ethnic	  groups	  
The	  four	  data	  sets	  examined	  in	  this	  paper	  all	  were	  drawn	  from	  the	  same	  source	  
country	  using	  similar	  methods,	  with	  ethnicity	  as	  the	  primary	  factor	  distinguishing	  each	  
sample.	  No	  single	  prior	  study	  has	  attempted	  to	  replicate	  findings	  with	  psychotic	  
experiences	  across	  ethnic	  groups.	  In	  this	  analysis,	  findings	  were	  largely	  consistent,	  
particularly	  in	  that	  psychotic	  experiences	  were	  associated	  1)	  with	  all	  classes	  of	  
psychopathology	  in	  bivariate	  analyses	  and	  2)	  with	  multi-­‐morbidity	  in	  a	  dose-­‐response	  
fashion,	  across	  all	  four	  samples.	  Findings	  pertaining	  to	  clinical	  outcomes	  were	  more	  
variable,	  most	  notably	  that	  psychotic	  experiences	  were	  not	  associated	  with	  suicide	  
attempts	  or	  cognitive	  impairment	  among	  Asians,	  as	  they	  were	  across	  all	  other	  samples.	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Prior	  research	  on	  psychotic	  experience	  among	  Asian-­‐Americans	  is	  essentially	  non-­‐existent	  
with	  the	  exception	  of	  one	  study	  showing	  that	  psychosis	  prevalence	  is	  related	  to	  the	  
experience	  of	  acculturative	  stress	  (DeVylder	  et	  al.,	  2013a),	  making	  it	  difficult	  to	  interpret	  
this	  cross-­‐ethnic	  difference.	  The	  association	  between	  psychosis	  and	  suicide	  attempts	  is	  
similar	  in	  terms	  of	  effect	  size	  across	  all	  ethnic	  groups,	  and	  may	  only	  be	  insignificant	  among	  
Asians	  due	  to	  insufficient	  power	  (i.e.	  prevalence	  rates	  of	  suicide	  attempts,	  psychotic	  
experiences,	  and	  common	  mental	  disorders	  are	  all	  lower	  in	  Asians).	  	  This	  would	  not	  
explain	  the	  absence	  of	  associations	  with	  cognitive	  dysfunction	  or	  treatment	  seeking	  in	  the	  
Asian	  sample,	  however.	  The	  only	  other	  study	  to	  show	  a	  lack	  of	  association	  between	  
psychotic	  experiences	  and	  service	  utilization	  was	  conducted	  in	  Tokyo,	  Japan	  (Kobayashi	  et	  
al.,	  2011).	  More	  research	  is	  needed	  to	  determine	  whether	  psychotic	  experiences,	  or	  more	  
precisely,	  the	  subjective	  experiences	  prompting	  a	  respondent	  to	  respond	  positively	  to	  a	  
psychosis	  screen,	  are	  qualitatively	  different	  among	  Asians	  or	  Asian-­‐Americans	  compared	  to	  
other	  ethnic	  groups,	  particularly	  in	  terms	  of	  their	  clinical	  significance.	  	  
Strengths,	  limitations,	  and	  conclusions	  
The	  primary	  strength	  of	  this	  study	  is	  the	  use	  of	  four	  large	  general	  population	  data	  
sets	  with	  varying	  ethnic	  composition,	  allowing	  multiple	  replications	  and	  cross-­‐cultural	  
validation	  within	  a	  single	  study.	  Further,	  diagnoses	  and	  the	  presence	  of	  psychotic	  
experiences	  were	  both	  determined	  using	  the	  WHO-­‐CIDI	  interview,	  widely	  considered	  a	  
valid	  measure	  for	  use	  in	  general	  population	  survey	  samples.	  However,	  despite	  validation	  
with	  clinical	  interviews	  (Haro	  et	  al.,	  2006),	  which	  themselves	  may	  be	  fallible,	  the	  
assessment	  of	  psychiatric	  diagnoses	  and	  psychosis	  using	  lay	  interviews	  may	  be	  subject	  to	  
misclassification.	  Epidemiologists	  have	  intermittently	  argued	  for	  the	  use	  of	  psychometric	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measures	  of	  psychopathology	  rather	  than	  categorical	  diagnoses	  (e.g.	  Dohrenwend,	  1990),	  
which	  may	  produce	  more	  valid	  measured	  when	  administered	  by	  lay-­‐interviewers,	  and	  
indeed	  would	  have	  been	  consistent	  with	  the	  assumption,	  inherent	  in	  studying	  sub-­‐
threshold	  psychosis,	  that	  psychopathology	  is	  continuously	  distributed	  in	  the	  population.	  
Controversy	  over	  the	  validity	  of	  single	  diagnoses	  in	  lay-­‐administered	  surveys	  is	  offset	  by	  
the	  use	  of	  subgroups	  of	  disorders,	  rather	  than	  individual	  diagnoses.	  A	  further	  potential	  
limitation	  is	  that	  PTSD	  and	  anxiety	  disorders	  are	  separated	  based	  on	  DSM-­‐5	  guidelines,	  
although	  the	  diagnoses	  in	  the	  surveys	  utilized	  DSM-­‐IV	  criteria.	  This	  was	  done	  to	  test	  the	  
alternative	  hypothesis	  that	  psychotic	  experiences	  may	  be	  specifically	  related	  to	  PTSD	  
(Fisher	  et	  al.,	  2013),	  and	  to	  be	  consistent	  with	  current	  conventions	  (American	  Psychiatric	  
Association,	  2013).	  Overall,	  concerns	  over	  measurement	  are	  partially	  allayed	  by	  the	  study	  
design,	  which	  allowed	  up	  to	  four	  replications	  of	  any	  significant	  findings;	  measurement	  
limitations,	  which	  would	  generally	  introduce	  random	  error,	  are	  unlikely	  to	  sufficiently	  
explain	  several	  replications	  of	  a	  statistical	  association.	  	  
	   This	  study	  provides	  strong	  evidence	  that	  psychotic	  experiences	  are	  associated	  with	  
multi-­‐morbidity	  of	  common	  mental	  health	  conditions,	  both	  in	  the	  general	  population	  of	  the	  
United	  States	  and	  across	  specific	  ethnic	  groups.	  Associations	  between	  psychotic	  
experiences	  and	  clinical	  outcomes	  were	  more	  tenuous	  and	  are	  in	  need	  of	  replication,	  
particularly	  given	  the	  substantial	  clinical	  importance	  of	  the	  association	  between	  psychotic	  
experiences	  and	  both	  suicide	  attempts	  and	  cognitive	  impairment	  among	  individuals	  with	  
common	  mental	  health	  conditions.	  	  
	  




The	  Persistence	  of	  Psychotic	  Experiences	  
The	  prevalence	  of	  sub-­‐threshold	  psychotic	  experiences	  in	  the	  general	  population	  is	  
known	  to	  far	  surpass	  that	  of	  threshold	  psychotic	  disorders,	  such	  as	  schizophrenia,	  
consistent	  with	  a	  population-­‐level	  continuum	  model	  of	  psychosis	  (Linscott	  &	  van	  Os,	  2010;	  
2013;	  van	  Os	  et	  al.,	  2009).	  Despite	  not	  being	  of	  sufficient	  severity	  to	  meet	  categorical	  
diagnostic	  criteria,	  these	  symptoms	  may	  nonetheless	  cause	  impairment.	  Previous	  studies	  
have	  shown	  that	  they	  are	  associated	  with	  psychological	  distress	  (Armando	  et	  al.,	  2010;	  
Cohen	  &	  Marino,	  2013;	  Saha	  et	  al.,	  2011b;	  Yung	  et	  al.,	  2006),	  pathological	  co-­‐morbidities	  
(Johns	  et	  al.,	  2004;	  Kelleher	  et	  al.,	  2012a;	  Saha	  et	  al.,	  2012;	  Scott	  et	  al.,	  2007;	  van	  Nierop	  et	  
al.,	  2009;	  Varghese	  et	  al.,	  2011;	  Wigman	  et	  al.,	  2012;	  Fisher	  et	  al.,	  2013),	  suicidal	  thoughts	  
(Fisher	  et	  al.,	  2013;	  Kelleher	  et	  al.,	  2012b;	  2013b;	  Nishida	  et	  al.,	  2010;	  Saha	  et	  al.,	  2011),	  
need	  for	  care	  (Bak	  et	  al.,	  2005;	  DeVylder	  et	  al.,	  in	  press),	  and	  treatment-­‐seeking	  (DeVylder	  
et	  al.,	  in	  press;	  Murphy	  et	  al.,	  2012).	  As	  such,	  these	  psychotic	  experiences	  constitute	  a	  high-­‐
risk	  exposure	  for	  a	  broad	  range	  of	  negative	  outcomes,	  and	  persistence	  of	  these	  experiences	  
can	  be	  interpreted	  as	  prolonged	  exposure	  to	  this	  risk	  state.	  In	  addition,	  prospective	  
longitudinal	  studies	  have	  shown	  that	  persistence	  of	  psychotic	  experiences	  predict	  later	  
severe	  mental	  health	  outcomes,	  including	  schizophrenia,	  post-­‐traumatic	  stress	  disorder,	  
substance	  use,	  and	  suicidal	  behavior	  (Cougnard	  et	  al.,	  2007;	  Dhossche,	  Ferdinand,	  Van	  der	  
Ende,	  Hofstra,	  &	  Verhulst,	  2002;	  Dominguez	  et	  al.,	  2011;	  Fisher	  et	  al.,	  2013;	  Werbeloff	  et	  al.,	  
2012).	  	  
	   Risk	  factors	  associated	  with	  the	  lifetime	  prevalence	  of	  psychotic	  experiences	  are	  
reasonably	  well-­‐established,	  and	  generally	  consistent	  with	  known	  risk	  factors	  for	  threshold	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psychotic	  disorders	  (Linscott	  &	  van	  Os	  2010;	  van	  Os	  et	  al.,	  2009),	  with	  the	  most	  consistent	  
risk	  factors	  across	  studies	  including	  belonging	  to	  an	  ethnic	  minority	  group,	  being	  
unmarried,	  and	  using	  alcohol	  or	  other	  substances	  (Linscott	  &	  van	  Os,	  2013).	  However,	  it	  
cannot	  be	  assumed	  that	  factors	  associated	  with	  onset	  of	  a	  mental	  health	  condition	  are	  also	  
associated	  with	  its	  persistence,	  an	  assumption	  violated	  even	  in	  disorders	  of	  seemingly	  clear	  
etiology	  such	  as	  post-­‐traumatic	  stress	  disorder	  (Dohrenwend,	  Yager,	  Wall,	  &	  Adams,	  2013).	  
Psychotic	  experiences	  appear	  to	  be	  transient	  and	  short-­‐lived	  among	  adults	  in	  the	  
population	  (De	  Loore	  et	  al.,	  2011;	  Hanssen	  et	  al.,	  2005),	  with	  most	  symptom	  subtypes	  
declining	  in	  prevalence	  with	  increasing	  age	  (Rössler	  et	  al.,	  2007),	  although	  relatively	  few	  
studies	  have	  directly	  examined	  factors	  related	  to	  persistence	  versus	  remission	  of	  psychotic	  
experiences	  over	  time.	  Prospective	  cohort	  and	  population	  studies	  have	  linked	  persistence	  
of	  psychotic	  experiences	  to	  psychological	  factors	  such	  as	  daily	  life	  stress	  reactivity	  (Collip	  
et	  al.,	  2013),	  environmental	  and	  sociodemographic	  factors	  including	  substance	  use,	  ethnic	  
minority	  status,	  trauma	  exposure,	  and	  victimization	  (Mackie	  et	  al.,	  2011;	  Wigman	  et	  al.,	  
2011),	  as	  well	  as	  financial,	  judicial,	  and	  relationship	  problems	  (Rössler	  et	  al.,	  2007),	  and	  
characteristics	  of	  the	  psychotic	  experiences	  themselves,	  with	  the	  co-­‐occurrence	  of	  
hallucinations	  and	  delusions	  associated	  with	  greater	  risk	  for	  persistence	  (De	  Loore	  et	  al.,	  
2011;	  Smeets	  et	  al.,	  2012;	  2013).	  	  
In	  addition	  to	  associations	  with	  the	  onset	  of	  threshold	  psychotic	  disorder	  (Hanssen	  
et	  al.,	  2005),	  persistent	  psychotic	  experiences	  have	  also	  been	  associated	  with	  clinical	  and	  
functional	  outcomes.	  Specifically,	  Rössler	  and	  colleagues	  (2007)	  found	  a	  wide	  range	  of	  poor	  
functional	  outcomes	  among	  the	  respondents	  with	  persistent	  psychotic	  experiences,	  
including	  unemployment	  and	  other	  occupational	  problems,	  financial	  problems,	  marital	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issues	  and	  separation,	  and	  police	  intervention	  and	  incarceration.	  Clinical	  outcomes	  
associated	  with	  persistent	  psychotic	  experiences	  include	  depressive	  symptoms,	  emergence	  
of	  novel	  psychotic	  experiences	  (i.e.	  delusions	  among	  respondents	  with	  hallucinations	  at	  
baseline),	  and	  general	  psychological	  distress	  among	  adolescents	  (De	  Loore	  et	  al.,	  2011),	  as	  
well	  as	  current	  mental	  health	  treatment	  (Wigman	  et	  al.,	  2011).	  	  
	   Because	  the	  persistence	  of	  psychotic	  experiences	  over	  time	  may	  lead	  to	  
psychological	  distress,	  role	  impairment,	  and	  severe	  mental	  health	  conditions,	  it	  would	  be	  of	  
clinical	  interest	  to	  understand	  what	  factors	  are	  associated	  with	  their	  remission	  in	  the	  
general	  population.	  In	  this	  study,	  I	  have	  selected	  respondents	  from	  the	  Collaborative	  
Psychiatric	  Epidemiology	  Surveys	  (CPES;	  Alegría	  et	  al.,	  2007a)	  who	  reported	  psychotic	  
experiences	  with	  a	  prior	  to	  past	  year	  (PPY)	  onset	  and,	  among	  these	  respondents,	  tested	  for	  
demographic	  and	  clinical	  predictors	  of	  persistence.	  The	  aims	  of	  this	  study	  are	  to	  distinguish	  
the	  relative	  importance	  of	  sociodemographic	  factors	  and	  clinical	  factors,	  including	  
characteristics	  of	  the	  psychotic	  experiences	  themselves,	  in	  determining	  the	  course	  of	  these	  
symptoms	  overtime.	  A	  secondary	  aim	  is	  to	  test	  the	  hypothesis	  that	  persistent	  psychotic	  
experiences	  would	  be	  associated	  with	  clinical	  outcomes,	  including	  current	  treatment,	  
suicidality,	  and	  impaired	  function.	  Finally,	  all	  analyses	  were	  tested	  separately	  with	  a	  
limited	  subsample	  consisting	  of	  respondents	  with	  PE	  onset	  at	  least	  10	  years	  prior	  to	  the	  
date	  of	  the	  interview,	  to	  specifically	  examine	  predictors	  and	  outcomes	  associated	  with	  
long-­‐term	  persistence,	  which	  may	  have	  greater	  clinical	  significance	  due	  to	  the	  prolonged	  





	   The	  Collaborative	  Psychiatric	  Epidemiology	  Surveys	  (CPES;	  Alegría	  et	  al.,	  2007a)	  
consist	  of	  data	  from	  three	  one-­‐time	  cross-­‐sectional	  surveys	  conducted	  in	  the	  United	  States	  
with	  similar	  methodologies	  and	  content:	  1)	  the	  National	  Comorbidity	  Survey-­‐Replication	  
(Alegría	  et	  al.,	  2007b;	  Kessler	  et	  al.,	  2004),	  2)	  the	  National	  Latino	  and	  Asian	  American	  Study	  
(Alegría	  et	  al.,	  2004;	  Alegría	  &	  Takeuchi,	  2007),	  and	  3)	  the	  National	  Survey	  of	  American	  Life	  
(Jackson	  et	  al.,	  2004;	  2007).	  All	  surveys	  utilized	  multi-­‐stage	  sampling	  designs,	  and	  were	  
conducted	  February	  2001	  to	  December	  2003.	  The	  total	  CPES	  data	  set	  included	  20,013	  
respondents.	  Only	  those	  who	  experienced	  psychotic	  experiences	  PPY	  were	  included	  in	  this	  
study.	  Participants	  were	  excluded	  if	  they	  had	  a	  lifetime	  diagnosis	  of	  a	  psychotic	  disorder	  or	  
if	  they	  were	  age	  65	  or	  older,	  to	  be	  consistent	  with	  prior	  studies	  of	  psychotic	  experiences	  
(van	  Os	  et	  al.,	  2009).	  The	  final	  sample	  included	  921	  participants,	  all	  of	  whom	  had	  reported	  
psychotic	  experiences	  with	  onset	  more	  than	  one	  year	  prior	  to	  the	  interview.	  
Measures	  
	   Demographic	  variables	  (age,	  sex,	  race,	  immigration	  status,	  education,	  employment	  
status,	  and	  marital	  status)	  were	  self-­‐reported	  by	  respondents.	  Respondents	  were	  assessed	  
for	  lifetime	  DSM-­‐IV	  axis	  I	  disorders	  using	  the	  World	  Mental	  Health	  Composite	  International	  
Diagnostic	  Interview	  (WHO-­‐CIDI),	  a	  widely	  used	  and	  reliable	  structured	  interview	  
assessment	  for	  diagnosis	  (Wittchen,	  1994).	  Participants	  were	  coded	  positive	  for	  lifetime	  
affective	  disorders	  if	  they	  met	  criteria	  for	  major	  depressive	  disorder	  or	  dysthymia;	  for	  
lifetime	  anxiety	  disorders	  if	  they	  met	  criteria	  for	  generalized	  anxiety	  disorder,	  agoraphobia	  
with	  and	  without	  panic	  disorder,	  panic	  disorder,	  or	  social	  phobia;	  for	  lifetime	  substance	  
use	  disorders	  if	  meeting	  criteria	  for	  abuse	  or	  dependence	  of	  alcohol	  or	  other	  substances;	  
and	  individually	  for	  lifetime	  post-­‐traumatic	  stress	  disorder.	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Respondents	  were	  also	  asked	  to	  report	  on	  clinical	  outcomes	  including	  suicidality	  
and	  treatment-­‐seeking	  behavior.	  Suicidality	  was	  recorded	  as	  the	  presence	  or	  absence	  of	  
current	  (past	  12-­‐months)	  suicide	  attempts.	  Treatment-­‐seeking	  was	  defined	  as	  having	  seen	  
a	  mental	  health	  professional	  (past	  12-­‐months),	  with	  mental	  health	  professional	  broadly-­‐
defined	  as	  a	  psychiatrist,	  psychologist,	  clinical	  social	  worker,	  or	  other	  medical	  (e.g.	  general	  
practitioner,	  nurse	  practitioner)	  or	  counseling	  professional	  (e.g.	  counselor,	  
psychotherapist,	  spiritual	  advisor)	  seen	  for	  mental	  health	  reasons.	  WHO-­‐DAS	  scales	  were	  
used	  to	  assess	  current	  function,	  in	  the	  domains	  of	  cognitive,	  social,	  mobility,	  self-­‐care,	  role	  
performance,	  and	  time	  out	  of	  role.	  WHO-­‐DAS	  items	  were	  highly	  skewed	  and	  were	  therefore	  
recoded	  into	  dichotomous	  variables	  indicating	  high	  impairment	  (as	  close	  as	  possible	  to	  the	  
top	  20%	  of	  impairment	  on	  that	  measure	  among	  the	  sample),	  in	  accordance	  with	  past	  
studies	  of	  psychosis	  in	  these	  data	  (Kessler	  et	  al.,	  2005a).	  
All	  participants	  had	  endorsed	  lifetime	  presence	  of	  at	  least	  one	  psychotic	  experience	  
from	  the	  WHO-­‐CIDI	  3.0	  psychosis	  screen,	  which	  included	  1)	  visual	  hallucinations,	  2)	  
auditory	  hallucinations,	  3)	  thought	  insertion,	  4)	  thought	  control,	  5)	  telepathy,	  and	  6)	  
delusions	  of	  persecution.	  Psychotic	  experiences	  were	  excluded	  if	  the	  experience	  took	  place	  
in	  the	  context	  of	  falling	  asleep,	  dreaming,	  or	  substance	  use.	  A	  similar	  set	  of	  questions	  
inquired	  the	  presence	  or	  absence	  of	  psychotic	  experiences	  over	  the	  12-­‐mont	  period	  prior	  
to	  the	  interview,	  with	  those	  who	  endorsed	  any	  of	  the	  six	  symptoms	  over	  the	  past	  12	  
months	  being	  grouped	  as	  have	  persistent	  psychotic	  experiences	  and	  those	  without	  
psychotic	  experiences	  over	  the	  past	  12	  months	  having	  remitted	  psychotic	  experiences.	  Age	  




	   All	  analyses	  were	  conducted	  using	  the	  complex	  sample	  features	  of	  SPSS	  version	  21.	  
All	  statistical	  estimates	  were	  weighted	  using	  CPES	  sampling	  weights	  to	  account	  for	  
individual-­‐level	  sampling	  factors	  including	  non-­‐response	  and	  unequal	  probabilities	  of	  
selection.	  Design-­‐based	  analyses	  were	  used	  to	  estimate	  standard	  errors	  that	  accounted	  for	  
the	  complex	  multistage	  clustered	  design	  of	  the	  CPES	  sample.	  All	  logistic	  regression	  
analyses	  were	  adjusted	  a	  priori	  for	  age	  and	  sex.	  	  
The	  analytic	  design	  of	  this	  case-­‐control	  study	  was	  planned	  such	  that	  cases	  were	  
defined	  as	  those	  who	  experienced	  at	  least	  one	  instance	  of	  psychotic	  experiences	  over	  the	  
past	  12-­‐months	  (the	  persistent	  group),	  and	  controls	  defined	  as	  those	  who	  have	  not	  
experienced	  symptoms	  in	  the	  past	  12-­‐months	  (the	  remitted	  group).	  Differences	  in	  
demographic	  (age,	  sex,	  ethnicity,	  foreign-­‐birth,	  marital	  status,	  employment	  status,	  
education),	  clinical	  (lifetime	  DSM-­‐IV	  diagnoses	  of	  affective,	  anxiety,	  substance	  use	  
disorders,	  post-­‐traumatic	  stress	  disorder),	  and	  psychosis-­‐related	  (e.g.	  specific	  symptoms,	  
number	  of	  different	  psychotic	  experience	  subtypes)	  variables	  between	  those	  with	  and	  
without	  current	  psychotic	  experiences	  were	  tested	  using	  Wald	  chi-­‐square	  tests,	  with	  two-­‐
tailed	  alpha	  set	  at	  0.05.	  Analyses	  were	  carried	  out	  separately	  for	  1)	  the	  entire	  sample	  and	  
2)	  respondents	  with	  >	  10	  years	  (relative	  to	  the	  interview)	  since	  initial	  psychotic	  experience	  
onset,	  in	  order	  to	  identify	  general	  predictors	  of	  persistence	  as	  well	  as	  predictors	  of	  long-­‐
term	  (10+	  year)	  persistence	  of	  psychotic	  experiences.	  	  
All	  variables	  that	  were	  significantly	  associated	  with	  current	  psychotic	  experiences	  
in	  bivariate	  analysis	  were	  entered	  into	  a	  multiple	  logistic	  regression	  model	  to	  test	  their	  
adjusted	  associations	  with	  12-­‐month	  psychotic	  experiences,	  both	  in	  the	  total	  sample	  and	  in	  
	  
	  86	  
the	  long-­‐term	  persistence	  subsample.	  For	  all	  the	  multiple	  logistic	  regression	  analyses,	  
significance	  was	  tested	  using	  Wald	  chi-­‐square	  tests,	  with	  two-­‐tailed	  alpha	  set	  at	  0.05.	  	  
A	  second	  set	  of	  analyses	  compared	  the	  groups	  with	  persistent	  versus	  remitted	  
psychotic	  experiences	  on	  several	  outcomes	  related	  to	  current	  function.	  Groups	  were	  
compared	  on	  current	  (12-­‐month)	  treatment	  seeking,	  suicidal	  ideation,	  and	  suicide	  
attempts,	  and	  on	  six	  WHODAS	  scales	  assessing	  function	  over	  the	  past	  30-­‐days	  (self-­‐care,	  
cognitive,	  mobility,	  role	  impairment,	  social	  interaction,	  and	  time	  out	  of	  role).	  	  Odds	  ratios	  
for	  all	  outcomes	  were	  derived	  using	  logistic	  regression	  analyses,	  adjusted	  for	  age	  and	  sex,	  
with	  significance	  tested	  using	  Wald	  chi-­‐square	  tests,	  with	  two-­‐tailed	  alpha	  set	  at	  0.05.	  	  
Table 18. Bivariate comparison of sociodemographics between participants reporting persistence or remission of 
psychotic experience  
 Entire sample (N= 921) > 10 years since onset (N= 577) 








OR [95% CI] 
Age (mean, SE) 921 36.4 (0.8) 38.9 (0.6) 0.98 [0.97-1.00] 577 38.1 (0.8) 42.7 (0.6) 0.97 [0.95-0.98] 
         
Sex         
   Male 341 45.6 (4.0) 39.9 (2.9) - 220 38.5 (4.7) 42.0 (3.2) - 
   Female 580 54.4 (4.0) 60.1 (2.9) 0.79 [0.53-1.17] 357 61.5 (4.7) 58.0 (3.2) 1.16 [0.69-1.93] 
         
Race         
   White, non-Latino 133 40.4 (4.7) 44.9 (3.8) - 85 34.4 (4.3) 46.4 (4.1) - 
   Black, non-Latino 432 28.7 (3.1) 25.1 (2.3) 1.23 [0.75-2.01] 265 32.0 (3.3) 24.0 (2.6) 1.70 [1.00-2.91] 
   Latino 254 24.4 (4.7) 2.7 (2.4) 1.08 [0.52-2.24] 158 25.2 (3.8) 21.7 (2.9) 1.34 [0.62-2.88] 
   Asian 97 6.2 (1.5) 6.8 (1.1) 0.89 [0.40-2.02] 68 8.0 (2.8) 7.9 (1.5) 1.10 [0.35-3.44] 
   Other 5 0.2 (0.2) 0.5 (0.3) 0.46 [0.05-4.71] 1 0.5 (0.0) 0.0 (0.0) na1 
         
Foreign         
   No 636 81.5 (2.5) 81.5 (2.2) - 373 79.9 (3.5) 79.0 (2.8) - 
   Yes 281 18.5 (2.5) 18.5 (2.2) 0.93 [0.58-1.50] 202 20.1 (3.5) 21.0 (2.8) 0.82 [0.41-1.65] 
         
Marital status         
   Married 422 39.3 (4.0) 56.1 (3.2) - 294 44.7 (4.6) 63.3 (3.9)  
   Single 293 40.1 (4.4) 24.5 (3.0) 2.12 [1.17-3.84] 135 25.4 (3.3) 15.9 (2.8) 1.67 [1.01-2.78] 
   Previously married 206 20.6 (2.6) 19.4 (2.6) 1.59 [1.00-2.55] 148 29.9 (4.6) 20.8 (3.4) 2.34 [1.25-4.39] 
         
Employment         
   Employed 602 72.1 (3.0) 66.2 (2.3) - 396 75.3 (3.7) 67.5 (2.9) - 
   Unemployed 99 8.3 (2.1) 7.4 (1.2) 0.97 [0.50-1.89] 45 3.4 1.2) 5.7 (1.4) 0.42 [0.16-1.12] 
   Not in labor force 219 19.6 (2.9) 26.3 (2.3) 0.74 [0.49-1.12] 136 21.3 (3.7) 26.8 (2.9) 0.84 [0.51-1.38] 
         
Education         
   No college 475 57.0 (3.9) 47.0 (2.8) - 274 53.9 (4.8) 42.6 (3.5) - 
   > some college 445 43.0 (3.9) 53.0 (2.8) 0.68 [0.48-0.95] 303 46.1 (4.8) 57.4 (3.5) 0.61 [0.40-0.91] 
Note:  
Bold font indicates significance 






Table 19. Bivariate comparison of clinical variables between participants reporting persistence or remission of 
psychotic experience  
 Entire sample (N= 921) > 10 years since onset (N= 577) 








OR [95% CI] 
         
Affective disorder         
   No 686 70.5 (4.0) 69.9 (2.9) - 444 67.7 (4.2) 72.2 (4.2) - 
   Yes 235 29.5 (4.0) 30.1 (2.9) 1.01 [0.60-1.71] 133 32.3 (4.2) 27.8 (4.2) 1.27 [0.68-2.36] 
         
Anxiety disorder         
   No 663 69.1 (4.0) 69.6 (2.1) - 423 61.2 (4.7) 71.2 (2.0) - 
   Yes 258 30.9 (4.0) 30.4 (2.1) 1.08 [0.69-1.69] 154 38.8 (4.7) 28.8 (2.0) 1.77 [1.07-2.92] 
         
PTSD         
   No 780 84.6 (3.0) 85.9 (1.9) - 497 80.9 (5.4) 85.3 (2.3) - 
   Yes 141 15.4 (3.0) 14.1 (1.9) 1.16 [0.75-1.80] 80 19.1 (5.4) 14.7 (2.3) 1.39 [0.71-2.69] 
         
Substance disorder         
   No 756 77.1 (3.8) 75.8 (3.6) - 479 75.6 (4.5) 75.3 (4.3) - 
   Yes 165 22.9 (3.8) 24.2 (3.6) 0.92 [0.52-1.61] 98 24.4 (4.5) 24.7 (4.3) 1.08 [0.49-2.39] 
Note: Bold font indicates significance 
	  
Results	  
Among	  the	  entire	  sample	  (N=921),	  28.1%	  (se=2.5)	  experienced	  persistent	  psychotic	  
experiences,	  while	  21.3%	  (se=2.0)	  experienced	  long-­‐term	  persistence	  in	  the	  group	  with	  
initial	  onset	  of	  more	  than	  10	  years	  prior	  to	  the	  interview.	  Demographic	  variables	  were	  
associated	  with	  total	  persistence	  and	  long-­‐term	  persistence,	  with	  greater	  odds	  for	  
persistence	  associated	  with	  being	  unmarried	  or	  previously	  married,	  and	  lower	  odds	  
associated	  with	  older	  age	  and	  college	  education;	  black	  respondents	  were	  also	  at	  greater	  
odds	  of	  long-­‐term	  persistence,	  but	  not	  in	  the	  total	  sample	  (Table	  18).	  Increased	  risk	  for	  
long-­‐term	  persistence	  was	  associated	  with	  lifetime	  diagnosis	  of	  an	  anxiety	  disorder	  (Table	  
19).	  Finally,	  odds	  for	  both	  total	  and	  long-­‐term	  persistence	  were	  greater	  for	  respondents	  
experiencing	  auditory	  hallucinations	  (hearing	  voices)	  and	  those	  experiencing	  multiple	  
symptom	  subtypes;	  one	  delusional	  experience,	  thought	  control,	  was	  additionally	  associated	  
with	  persistence	  in	  the	  long-­‐term	  subgroup	  but	  not	  in	  the	  total	  sample	  (Table	  20).	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Table 20. Bivariate comparison of psychosis-related variables between participants reporting persistence or 
remission of psychotic experience  
 Entire sample (N= 921) > 10 years since onset (N= 577) 








OR [95% CI] 
Auditory 
hallucinations 
        
   No 533 44.6 (4.9) 61.7 (2.4) - 340 45.8 (5.1) 63.3 (2.5) - 
   Yes 388 55.4 (4.9) 38.3 (2.4) 2.13 [1.38-3.30) 237 54.2 (5.1) 36.7 (2.5) 2.43 [1.53-3.87] 
         
Visual 
hallucinations 
        
   No 265 34.5 (3.4) 30.4 (3.0) - 136 27.6 (3.8) 25.2 (3.1) - 
   Yes 656 65.5 (3.4) 69.6 (3.0) 0.83 [0.55-1.24) 441 72.4 (3.8) 74.8 (3.1) 0.74 [0.48-1.14] 
         
Thought insertion         
   No 878 93.3 (2.2) 97.0 (1.1) - 549 88.1 (3.2) 97.6 (0.8) - 
   Yes 43 6.7 (2.2) 3.0(1.1) 2.16 [0.79-5.92) 28 11.9 (3.2) 2.4 (0.8) 6.15 [2.37-15.97] 
         
Thought control         
   No 293 97.7 (0.7) 98.7 (0.5) - 562 97.7 (0.9) 98.6 (0.2) - 
   Yes 28 2.3 (0.7) 1.3 (0.5) 1.66 [0.65-4.21) 15 2.3 (0.9) 1.4 (0.2) 1.58 [0.77-3.23] 
         
Telepathy         
   No  851 88.3 (3.4) 93.0 (1.4) - 541 88.9 (3.0) 94.7 (1.2) - 
   Yes 70 11.7 (3.4) 7.0 (1.4) 1.55 [0.64-3.73) 36 11.1 (3.0) 5.3 (1.2) 2.09 [0.90-4.86] 
         
Persecutory 
delusions 
        
   No 847 89.0 (2.7) 92.5 (1.4) - 547 94.7 (1.0) 94.5 (1.0) - 
   Yes 74 11.0 (2.7) 7.5 (1.4) 1.44 [0.63-3.27) 30 5.3 (1.0) 5.5 (1.0) 1.12 [0.65-1.91] 
         
# of different PE         
   1 667 63.3 (4.6) 78.8 (2.1) - 420 58.7 (5.2) 80.2 (2.2) - 
   2 200 24.1 (3.0) 17.7 (2.1) 1.68 [1.04-2.72) 125 29.4 (3.7) 15.8 (2.7) 2.68 [1.42-5.07] 
   3+ 54 12.6 (4.1) 3.5 (1.2) 4.20 [1.38-12.79) 32 11.9 (2.7) 4.0 (1.6) 4.19 [1.55-11.38] 
Linear trend    χ² (df=1)=6.51, p=0.11    χ² (df=1)=8.18, p=0.004 
Note: Bold font indicates significance 
	  
	   Significant	  bivariate	  predictors	  (of	  either	  long-­‐term	  or	  total	  persistence)	  were	  
entered	  into	  two	  separate	  multiple	  logistic	  regression	  models	  (including	  the	  same	  
predictor	  variables),	  which	  significantly	  predicted	  persistence	  among	  both	  the	  total	  sample	  
and	  the	  long-­‐term	  subgroup	  (Table	  21).	  Specifically,	  persistence	  was	  associated	  with	  
auditory	  hallucinations	  and	  remission	  was	  associated	  with	  being	  married.	  Among	  the	  total	  
sample	  only,	  at	  least	  some	  college	  education	  was	  additionally	  associated	  with	  remission.	  
Among	  the	  long-­‐term	  subsample	  only,	  age	  was	  additionally	  associated	  with	  persistence	  of	  
psychotic	  experiences	  such	  that	  odds	  of	  persistence	  decreased	  with	  increasing	  age.	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Table	  21.	  Logistic	  regression	  models	  of	  persistence	  versus	  remission	  for	  the	  total	  sample	  and	  the	  long-­‐term	  
persistence	  subsample.	  	  
	   Total	  sample	   Long-­‐term	  persistence	  
Variable	   OR	  [95%	  CI]	   Statistics	   OR	  [95%	  CI]	   Statistics	  
	  	  	  Gender	  (female)	   ns	   ns	   ns	   ns	  
	  	  	  Ethnicity	  (black)	   ns	   ns	   ns	   ns	  
	  	  	  Age	  (10	  years)*	  	   ns	   ns	   0.68	  [0.54-­‐0.86]	   χ²(df=1)=11.13,	  p=0.001	  
	  	  	  Marital	  status	  (married)	   0.53	  [0.35-­‐0.82]	   χ²(df=1)=8.53,	  p=0.005	   0.53	  [0.30-­‐0.93]	   χ²(df=1)=5.08,	  p=0.024	  
	  	  	  College	   0.66	  [0.49-­‐0.89]	   χ²(df=1)=7.50,	  p=0.006	   ns	   ns	  
	  	  	  Anxiety	  disorder	   ns	   ns	   ns	   ns	  
	  	  	  Hearing	  voices	   1.82	  [1.12-­‐2.92]	   χ²(df=1)=6.23,	  p=0.013	   1.64	  [1.11-­‐2.45]	   χ²(df=1)=6.21,	  p=0.013	  
	  	  	  Mind	  control	  experience	   ns	   ns	   ns	   ns	  
	  	  	  Multiple	  PE	  subtypes	   ns	   ns	   ns	   ns	  
Intercept	   	   ns	   	   ns	  
Model	   	   χ²(df=12)=34.62,	  p<0.001	   	   χ²(df=10)=26.17,	  p=0.004	  
Note:	  All	  listed	  variables	  were	  included	  in	  both	  models,	  data	  presented	  for	  significant	  variables	  only.	  	  
Odds	  ratios	  for	  age	  are	  calculated	  based	  on	  change	  in	  odds	  of	  persistence	  for	  every	  10	  year	  increase	  in	  age.	  	  
ns	  =	  not	  statistically	  significant.	  	  
	  
	   The	  persistent	  and	  remitted	  groups	  did	  not	  significantly	  vary	  on	  any	  of	  the	  six	  WHO-­‐
DAS	  function	  scales	  (self-­‐care,	  cognitive,	  mobility,	  role	  impairment,	  social	  interaction,	  time	  
out	  of	  role)	  or	  on	  current	  suicidal	  ideation,	  whether	  tested	  using	  the	  entire	  sample	  or	  the	  
long-­‐term	  subsample	  (data	  not	  shown).	  However,	  respondents	  with	  persistent	  symptoms	  
were	  significantly	  more	  likely	  to	  report	  a	  recent	  suicide	  attempt	  (Figure	  5),	  both	  in	  the	  total	  
sample,	  Wald	  χ²(df=1)=5.28,	  p=0.022,	  OR[95%	  CI]=3.92	  [1.21-­‐12.72],	  and	  the	  long-­‐term	  
subsample,	  Wald	  χ²(df=1)=8.87,	  p=0.003,	  OR[95%	  CI]=30.85	  [3.12-­‐305.24].	  Persistent	  
symptoms	  were	  likewise	  associated	  with	  current	  (past	  12-­‐month)	  treatment	  seeking	  
(Figure	  6),	  in	  both	  the	  total	  sample,	  Wald	  χ²(df=1)=11.81,	  p=0.001,	  OR[95%	  CI]=2.23	  [1.40-­‐





Figure 5. Prevalence of past-year suicide attempts among respondents with persistent and remitted psychotic 
experiences.  
	   	  






























Persistence	  versus	  remission	  of	  psychotic	  experiences	  
The	  persistence	  of	  sub-­‐threshold	  psychotic	  experiences	  over	  time	  is	  of	  significant	  
clinical	  interest	  as	  it	  may	  cause	  prolonged	  psychological	  distress	  and	  increased	  risk	  for	  
severe	  mental	  health	  outcomes.	  In	  this	  population	  sample,	  psychotic	  experiences	  persisted	  
for	  a	  sizable	  minority	  of	  respondents	  (28.1%),	  with	  more	  than	  one	  in	  five	  reporting	  long-­‐
term	  persistence	  of	  greater	  than	  ten	  years.	  This	  level	  of	  persistence	  is	  generally	  in	  
concurrence	  with	  prospective	  cohort	  studies,	  which	  have	  found	  that	  psychotic	  experiences	  
decline	  in	  prevalence	  with	  age	  (Rössler	  et	  al.,	  2007)	  and	  therefore	  tend	  to	  remit	  over	  time.	  
Of	  incident	  cases	  of	  psychotic	  experiences	  among	  adults,	  only	  8%	  still	  reported	  sub-­‐
threshold	  psychosis	  1	  year	  later	  with	  an	  additional	  8%	  with	  clinical	  psychotic	  outcomes	  
(Hanssen	  et	  al.,	  2005).	  Persistence	  may	  be	  somewhat	  greater	  in	  adolescents,	  with	  27%	  of	  
adolescents	  reporting	  auditory	  hallucinations	  at	  baseline	  still	  reporting	  symptoms	  two	  
years	  later	  (De	  Loore	  et	  al.,	  2011),	  although	  this	  may	  reflect	  the	  elevated	  overall	  prevalence	  
of	  psychotic	  experiences	  in	  this	  age	  group	  (Kelleher	  et	  al.,	  2011).	  	  
Sociodemographic	  predictors	  of	  psychosis	  persistence	  
Marital	  status	  is	  the	  most	  notable	  sociodemographic	  predictor	  of	  psychosis	  
persistence	  in	  this	  sample,	  with	  married	  respondents	  having	  approximately	  one	  half	  the	  
odds	  of	  persistence	  compared	  to	  those	  who	  are	  previously	  (i.e.	  divorced,	  separated,	  or	  
widowed)	  or	  never	  married.	  Being	  unmarried	  was	  likewise	  linked	  to	  both	  the	  lifetime	  
prevalence	  and	  annual	  incidence	  of	  psychotic	  experiences	  in	  meta-­‐analyses	  (Linscott	  &	  van	  
Os,	  2013),	  and	  has	  been	  associated	  with	  the	  onset	  (Agerbo,	  Byrne,	  Eaton,	  &	  Mortensen,	  
2004;	  Tien	  &	  Eaton,	  1992)	  and	  course	  (Farina,	  Garmezy,	  &	  Barry,	  1963)	  of	  schizophrenia,	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potentially	  explained	  by	  a	  combination	  of	  both	  social	  causation	  (lack	  of	  marital	  support	  
increasing	  risk	  for	  psychosis)	  and	  social	  selection	  (psychosis	  typically	  onsets	  during	  
adolescents	  or	  young	  adult	  hood	  and	  may	  disrupt	  relationships).	  Rössler	  and	  colleagues	  
(2007)	  previously	  identified	  associations	  between	  persistent	  psychotic	  experiences	  and	  
separation	  from	  a	  partner,	  as	  well	  as	  conflict	  within	  the	  household,	  which	  the	  authors	  
attributed	  to	  being	  a	  consequence	  of	  prolonged	  mental	  health	  difficulties.	  The	  association	  
between	  marriage	  and	  psychosis	  may	  also	  be	  consistent	  with	  a	  social	  causation	  
explanation,	  such	  that	  symptoms	  may	  be	  more	  likely	  to	  remit	  among	  individuals	  with	  
consistent	  social	  support.	  Marriage	  can	  be	  considered	  a	  form	  of	  social	  support,	  which	  can	  
protect	  against	  the	  effect	  of	  stress	  on	  symptom	  exacerbation,	  as	  articulated	  in	  the	  diathesis-­‐
stress	  model	  (Corcoran	  et	  al.,	  2003;	  Nuechterlein	  &	  Dawson,	  1984).	  Prospective	  studies	  
have	  supported	  a	  causal	  relationship	  between	  social	  support	  and	  recovery	  from	  psychotic	  
disorders	  (Pernice-­‐Duca	  &	  Onaga,	  2009)	  and,	  conversely,	  between	  insufficient	  support	  and	  
readmission	  to	  inpatient	  treatment	  (Bergen,	  Hunt,	  Armitage,	  &	  Bashir,	  1998;	  Norman	  et	  al.,	  
2005).	  It	  is	  likely	  therefore	  that	  a	  reciprocal	  relationship	  consisting	  of	  social	  causation	  and	  
social	  selection	  exists	  between	  marital	  status	  and	  psychosis	  persistence.	  These	  
explanations,	  however,	  cannot	  be	  distinguished	  using	  a	  retrospective	  analysis	  of	  cross-­‐
sectional	  data.	  	  
Remission	  of	  psychotic	  experiences	  was	  also	  associated	  with	  having	  at	  least	  some	  
college	  education,	  although	  this	  was	  not	  true	  for	  long-­‐term	  persistence,	  suggesting	  that	  
higher	  education	  may	  have	  some	  protective	  effect	  against	  transient	  psychotic	  symptoms	  
but	  may	  have	  declining	  influence	  over	  longer	  periods.	  	  Age	  was	  associated	  specifically	  with	  
the	  long-­‐term	  persistence	  of	  psychotic	  experiences,	  with	  a	  decline	  in	  risk	  for	  ongoing	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persistence	  (of	  >	  10	  years)	  as	  respondents	  aged,	  consistent	  with	  the	  known	  peak	  in	  
psychosis	  risk	  in	  younger	  adulthood	  (Rössler	  et	  al.,	  2007;	  Thompson	  et	  al.,	  2004).	  	  
Clinical	  predictors	  of	  psychosis	  persistence	  
Self-­‐reported	  psychotic	  experiences	  in	  the	  population	  vary	  in	  terms	  of	  the	  specific	  
symptoms	  experienced	  and	  in	  terms	  of	  their	  profile	  of	  psychiatric	  co-­‐morbidity.	  Although	  
depressive,	  anxiety,	  and	  substance	  use	  disorders	  are	  common	  among	  individuals	  with	  
psychotic	  experiences	  (Fisher	  et	  al.,	  2013;	  Johns	  et	  al.,	  2004;	  Kelleher	  et	  al.,	  2012a;	  Saha	  et	  
al.,	  2012;	  Scott	  et	  al.,	  2007;	  van	  Nierop	  et	  al.,	  2009;	  Varghese	  et	  al.,	  2011;	  Wigman	  et	  al.,	  
2012),	  none	  of	  these	  disorders	  were	  independently	  associated	  with	  persistence	  of	  
psychotic	  experiences	  over	  time.	  Instead,	  persistence	  was	  predicted	  by	  the	  presence	  
specifically	  of	  sub-­‐threshold	  auditory	  hallucinations.	  Psychotic	  experiences	  typically	  remit	  
over	  time,	  in	  these	  data	  as	  well	  as	  prior	  studies	  (De	  Loore	  et	  al.,	  2011;	  Hanssen	  et	  al.,	  2005;	  
Rössler	  et	  al.,	  2007),	  making	  it	  useful	  to	  know	  which	  symptom	  subtypes	  are	  more	  likely	  to	  
persist	  and	  therefore	  more	  likely	  to	  lead	  to	  or	  indicate	  prolonged	  impairment	  in	  terms	  of	  
co-­‐morbidities,	  psychological	  distress,	  or	  suicide	  risk.	  Further,	  persistent	  hallucinations	  
may	  be	  particularly	  clinically	  relevant	  as	  they	  potentially	  lead	  to	  threshold	  psychotic	  
disorder	  (Smeets	  et	  al.,	  2012).	  
Psychosis	  persistence	  and	  suicide	  risk	  
Ongoing	  persistence	  of	  psychotic	  experiences	  was	  associated	  with	  greater	  risk	  for	  a	  
recent	  suicide	  attempt,	  in	  concurrence	  with	  several	  past	  studies	  (Fisher	  et	  al.,	  2013;	  
Kelleher	  et	  al.,	  2012b;	  2013b;	  Nishida	  et	  al.,	  2010;	  Saha	  et	  al.,	  2011).	  Earlier	  in	  this	  
dissertation	  it	  was	  demonstrated	  that	  12-­‐month	  psychotic	  experiences	  are	  associated	  with	  
concurrent	  suicidal	  ideation	  and	  suicide	  attempts,	  particularly	  those	  with	  intent	  to	  die.	  This	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expands	  on	  that	  finding	  by	  showing	  that,	  even	  among	  those	  with	  psychotic	  experiences,	  
those	  with	  persistent	  psychotic	  experiences	  are	  at	  elevated	  risk	  for	  suicidal	  behavior,	  even	  
more	  than	  10	  years	  after	  initial	  onset.	  Fisher	  and	  colleagues	  (2013)	  likewise	  showed,	  using	  
a	  prospective	  cohort	  design,	  that	  psychotic	  experiences	  are	  associated	  with	  future	  risk	  for	  
suicide	  attempts.	  	  
Treatment	  seeking	  
	   Persistence	  of	  psychotic	  symptoms	  among	  adults	  was	  associated	  with	  treatment-­‐
seeking	  over	  the	  12-­‐month	  period	  prior	  to	  the	  interview,	  as	  had	  previously	  been	  shown	  in	  
a	  population	  cohort	  of	  adolescents	  in	  the	  Netherlands	  (Wigman	  et	  al.,	  2011).	  Twelve-­‐month	  
psychotic	  experiences	  have	  previously	  been	  shown	  to	  be	  associated	  with	  increased	  service	  
utilization	  and	  need	  for	  care	  among	  this	  sample	  (DeVylder	  et	  al.,	  in	  press)	  and	  in	  a	  similar	  
population	  sample	  in	  the	  United	  Kingdom	  (Murphy	  et	  al.,	  2012);	  this	  expands	  the	  prior	  
finding	  to	  show	  that	  respondents	  with	  current	  psychotic	  experiences	  are	  more	  than	  twice	  
as	  likely	  to	  seek	  care	  compared	  not	  only	  to	  the	  general	  population	  (as	  previously	  shown)	  
but	  even	  when	  compared	  to	  others	  who	  have	  remitted	  psychotic	  experiences.	  This	  further	  
supports	  an	  interpretation	  that	  it	  is	  the	  psychotic	  experiences	  themselves	  (or	  other	  
temporally	  concurrent	  difficulties,	  such	  as	  consequent	  impairments	  in	  function)	  that	  lead	  
to	  treatment	  seeking.	  	  
Practice	  implications	  
Psychotic	  experiences	  are	  associated	  with	  a	  broad	  range	  of	  clinical	  outcomes,	  
supporting	  the	  need	  for	  clinical	  guidelines	  regarding	  assessment	  and	  treatment	  of	  these	  
symptoms.	  Assuming	  that	  persistent	  psychotic	  symptoms	  carry	  greater	  clinical	  need	  due	  to	  
prolonged	  exposure	  of	  the	  risk	  state,	  this	  analysis	  suggests	  that	  auditory	  hallucinations	  and	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thought	  control	  experiences	  should	  be	  given	  particular	  clinical	  attention.	  Brief	  screening	  
tools	  for	  clinical	  purposes	  may	  be	  more	  efficient	  if	  focus	  is	  limited	  to	  these	  experiences.	  The	  
finding	  that	  marital	  status	  influences	  the	  odds	  of	  remission	  may	  guide	  intervention	  for	  
people	  with	  sub-­‐threshold	  auditory	  hallucinations.	  This	  tentatively	  suggests	  that	  
encouragement	  of	  positive	  familial	  relationships	  other	  forms	  of	  social	  support	  may	  provide	  
similar	  effects.	  Psychotic	  experiences	  tend	  to	  be	  associated	  with	  social	  withdrawal	  
(Kelleher	  et	  al.,	  2013a)	  and	  other	  factors	  that	  may	  limit	  social	  support	  (approximating	  
negative	  symptoms	  in	  schizophrenia).	  This	  can	  be	  addressed	  clinically	  by	  building	  familial	  
support	  through	  interventions	  such	  as	  family	  psychoeducation	  (Lukens	  &	  Thorning,	  2010),	  
or	  by	  buttressing	  non-­‐familial	  social	  support	  through	  social	  skills	  training	  (Kurtz	  &	  Mueser,	  
2008).	  Treatment	  should	  also	  address	  the	  elevated	  suicide	  risk	  among	  persons	  with	  
persistent	  psychotic	  experiences,	  potentially	  through	  regular	  screenings	  (Mann	  et	  al.,	  
2005),	  which	  are	  known	  to	  be	  safe	  even	  in	  high-­‐risk	  populations	  (Gould	  et	  al.,	  2005).	  For	  
those	  with	  substantial	  ideation	  or	  suicide	  plans,	  cognitive	  behavioral	  therapy	  may	  be	  an	  
efficacious	  approach	  to	  suicide	  prevention	  (Stanley	  et	  al.,	  2009).	  Directed	  interventions	  for	  
psychotic	  experiences	  are	  feasible	  even	  though	  these	  symptoms	  do	  not	  meet	  diagnostic	  
thresholds,	  given	  that	  those	  with	  persistent	  psychotic	  experiences	  are	  nonetheless	  
significantly	  more	  likely	  to	  be	  in	  treatment.	  	  
Limitations	  &	  conclusions	  
	   The	  primary	  limitation	  of	  this	  paper	  is	  the	  analysis	  of	  retrospective	  reports	  of	  
psychosis	  onset	  based	  on	  cross-­‐sectional	  data,	  which	  is	  not	  ideal	  for	  assessing	  predictors	  of	  
change	  over	  time.	  Recall	  biases	  may	  influence	  the	  estimated	  onset	  of	  psychotic	  experiences,	  
as	  well	  as	  other	  lifetime	  variables	  that	  were	  entered	  as	  predictors	  in	  the	  models.	  The	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primary	  concern	  is	  that	  experiences	  reported	  as	  having	  onset	  “prior	  to	  the	  past	  year”	  may	  
be	  misreported,	  particularly	  for	  respondents	  with	  an	  initial	  onset	  approximately	  at	  that	  
one-­‐year	  point,	  or	  those	  with	  unclear	  onset	  (e.g.	  gradual	  increase	  in	  severity	  of	  sub-­‐
threshold	  symptoms	  over	  time).	  This	  is	  alleviated	  somewhat	  by	  looking	  only	  at	  those	  with	  
long-­‐term	  persistence,	  who	  are	  less	  likely	  to	  be	  misclassified	  due	  to	  recall	  errors.	  Given	  the	  
limited	  availability	  of	  prospective	  longitudinal	  data	  on	  psychotic	  experiences	  in	  the	  general	  
population,	  particularly	  in	  the	  United	  States,	  this	  approximation	  of	  a	  longitudinal	  analysis	  
may	  nonetheless	  provide	  useful	  guidance	  in	  the	  development	  of	  future	  prospective	  cohort	  
studies.	  	  
A	  second	  limitation	  is	  the	  low	  prevalence	  of	  delusional	  experiences	  relative	  to	  
hallucinations,	  which	  has	  previously	  been	  attributed	  to	  differences	  in	  threshold	  of	  severity	  
between	  these	  dichotomous	  items	  (Kessler	  et	  al.,	  2005a),	  although	  a	  study	  using	  clinical	  
interviews	  with	  a	  different	  sample	  likewise	  found	  elevated	  prevalence	  of	  hallucinatory	  
experiences	  (Zammit	  et	  al.,	  2013).	  If	  delusional	  items	  are	  of	  greater	  severity	  then	  the	  
analysis	  may	  be	  biased	  towards	  identifying	  delusional	  experiences	  as	  predictors	  of	  
persistence.	  	  This	  is	  unlikely	  to	  explain	  these	  findings	  because,	  first,	  delusional	  experiences	  
were	  not	  uniformly	  predictive	  of	  persistence,	  and	  second,	  auditory	  hallucinations	  were	  the	  
primary	  predictor	  of	  persistence.	  Nonetheless,	  limitations	  in	  lay-­‐administered	  assessment	  
of	  psychotic	  experiences	  should	  be	  considered	  when	  interpreting	  these	  and	  other	  survey	  
results.	  	  
An	  additional	  limitation	  is	  the	  exclusion	  of	  notable	  psychological	  predictors	  such	  as	  
impaired	  tolerance	  to	  daily	  stress,	  which	  has	  also	  been	  linked	  to	  persistence	  of	  psychotic	  
experiences	  (Collip	  et	  al.,	  2013).	  Stress	  sensitivity	  was	  not	  measured	  across	  all	  surveys	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included	  in	  the	  present	  data	  set,	  although	  heightened	  stress	  sensitivity	  is	  generally	  
correlated	  with	  several	  clinical	  variables	  included	  in	  the	  present	  model,	  including	  
depressive	  and	  anxiety	  disorders	  (Caspi	  et	  al.,	  2003;	  Salmon,	  2001).	  	  
The	  presented	  results	  confirm	  past	  findings	  from	  prospective	  cohort	  studies	  that	  
psychotic	  experiences	  tend	  to	  remit	  over	  time	  (De	  Loore	  et	  al.,	  2011;	  Hanssen	  et	  al.,	  2005;	  
Rössler	  et	  al.,	  2007),	  while	  specifying	  that	  auditory	  hallucinations	  bestow	  particular	  risk	  for	  
long-­‐term	  persistence.	  The	  analysis	  also	  builds	  on	  Rössler	  and	  colleagues’	  (2007)	  finding	  
that	  marital	  status	  is	  associated	  with	  psychosis	  persistence,	  although	  it	  remains	  unclear	  if	  
this	  is	  due	  to	  social	  causation	  or	  social	  selection.	  Surprisingly,	  lifetime	  psychiatric	  co-­‐
morbidities	  had	  no	  effect	  on	  persistence,	  despite	  their	  frequent	  co-­‐occurrence	  in	  this	  
sample	  and	  in	  others	  (Fisher	  et	  al.,	  2013;	  Johns	  et	  al.,	  2004;	  Kelleher	  et	  al.,	  2012a;	  Saha	  et	  
al.,	  2012;	  Scott	  et	  al.,	  2007;	  van	  Nierop	  et	  al.,	  2009;	  Varghese	  et	  al.,	  2011;	  Wigman	  et	  al.,	  
2012).	  As	  predicted,	  persistence	  does	  appear	  to	  be	  related	  to	  greater	  clinical	  need	  in	  terms	  
of	  treatment-­‐seeking	  and	  suicide	  risk.	  Future	  studies	  therefore	  should	  continue	  to	  identify	  
predictors	  of	  persistence	  versus	  remission	  and	  further	  explore	  clinical	  services	  for	  those	  
with	  persistent	  psychotic	  experiences,	  with	  a	  particular	  emphasis	  on	  suicide	  prevention.	  	  
	  
	  




Conclusions:	  The	  Significance	  of	  Psychotic	  Experiences	  for	  	  
Social	  Work,	  Public	  Health,	  and	  Health	  Care	  Policy	  
Main	  findings	  of	  the	  dissertation	  
The	  goal	  of	  this	  dissertation	  was	  to	  address	  three	  broad	  aims:	  1)	  to	  determine	  the	  
risk	  for	  suicidal	  behavior	  associated	  with	  psychotic	  experiences;	  2)	  to	  examine	  psychosis	  
comorbidity	  and	  multi-­‐morbidity	  with	  common	  mental	  health	  conditions,	  and	  describe	  the	  
clinical	  significance	  of	  these	  symptoms	  when	  occurring	  in	  the	  context	  of	  common	  mental	  
disorders;	  and	  3)	  to	  evaluate	  factors	  associated	  with	  the	  persistence	  or	  remission	  of	  
psychotic	  experiences	  in	  the	  general	  population.	  	  
As	  predicted,	  psychotic	  experiences	  were	  associated	  with	  both	  increased	  risk	  and	  
increased	  severity	  of	  suicidal	  behavior.	  Suicide	  risk	  appears	  to	  be	  a	  part	  of	  the	  broader	  
psychosis	  phenotype	  and	  not	  simply	  a	  reaction	  to	  the	  onset	  of	  threshold	  psychotic	  
disorder.	  The	  finding	  that	  psychosis	  is	  linked	  especially	  to	  severe	  attempts	  with	  intent	  to	  
die	  highlights	  the	  potential	  public	  health	  significance	  of	  screening	  for	  these	  experiences	  
among	  people	  reporting	  suicidal	  ideation.	  	  
Likewise	  as	  predicted,	  psychotic	  experiences	  were	  associated	  with	  extensive	  co-­‐
morbidities	  across	  diagnoses,	  supporting	  the	  notion	  of	  broad	  etiological	  and	  clinical	  
overlap	  between	  psychosis	  and	  common	  mental	  health	  conditions.	  This	  argues	  against	  the	  
notion	  that	  psychosis	  is	  associated	  with	  or	  predicts	  a	  constrained	  set	  of	  closely	  related	  
mental	  health	  conditions,	  but	  is	  in	  concurrence	  with	  recent	  epidemiological	  studies	  and	  
with	  genetic	  evidence	  for	  overlapping	  diagnostic	  categories.	  Non-­‐specific	  associations	  with	  
mental	  health	  conditions	  would	  suggest	  that	  psychosis	  may	  be	  the	  product	  of	  increasingly	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severe	  psychopathology	  rather	  than	  specific	  types	  of	  psychopathology,	  which	  was	  indeed	  
found	  to	  be	  the	  case.	  This	  was	  notably	  replicated	  across	  multiple	  ethnic	  groups,	  several	  of	  
which	  have	  previously	  received	  minimal	  attention	  in	  the	  research	  literature	  on	  sub-­‐
threshold	  psychosis.	  	  	  
Interestingly,	  none	  of	  these	  comorbidities	  were	  predictive	  of	  the	  long-­‐term	  
persistence	  of	  sub-­‐threshold	  psychosis,	  which	  was	  better	  explained	  by	  the	  type	  of	  
symptoms	  (auditory	  hallucinations)	  and	  marital	  status.	  While	  this	  is	  consistent	  with	  the	  
diathesis	  stress	  model	  and	  the	  known	  importance	  of	  social	  support	  in	  schizophrenia	  and	  in	  
mental	  health	  in	  general,	  it	  stands	  in	  contrast	  to	  the	  relatively	  stronger	  emphasis	  on	  
biological	  and	  clinical	  factors	  (i.e.	  co-­‐occurring	  conditions	  and	  symptoms)	  in	  the	  literature.	  
As	  expected	  based	  on	  findings	  from	  the	  first	  study,	  the	  relationship	  between	  psychosis	  and	  
suicide	  attempts	  was	  again	  present	  for	  respondents	  with	  persistent	  psychotic	  experiences	  
compared	  to	  remitted	  psychotic	  experiences,	  and	  grew	  in	  magnitude	  when	  looking	  
exclusively	  at	  those	  with	  long-­‐term	  persistence.	  Treatment-­‐seeking	  behavior,	  on	  the	  other	  
hand,	  appeared	  to	  remain	  stably	  associated	  with	  psychotic	  experiences	  regardless	  of	  
duration.	  	  
Implications	  for	  clinical	  social	  work	  practice	  
	   Adults	  with	  psychotic	  experiences	  are	  more	  than	  twice	  as	  likely	  to	  seek	  treatment	  
relative	  to	  the	  general	  population,	  and	  are	  more	  likely	  to	  report	  an	  unmet	  need	  for	  care	  
(DeVylder	  et	  al.,	  in	  press).	  It	  is	  therefore	  likely	  that	  a	  substantial	  portion	  of	  adults	  with	  
psychotic	  experiences	  are	  already	  in	  some	  way	  involved	  in	  the	  mental	  health	  system,	  
regardless	  of	  the	  extent	  to	  which	  these	  experiences	  are	  reported	  to	  their	  treating	  clinicians.	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Interventions	  for	  sub-­‐threshold	  psychosis	  can	  therefore	  be	  directed	  towards	  clinical	  
populations	  with	  presently	  undetected	  or	  untreated	  psychotic	  experiences.	  	  
	   The	  first	  step	  in	  this	  process	  is	  detection.	  Psychosis	  screens	  have	  typically	  been	  
developed	  for	  epidemiological	  and	  other	  research	  studies,	  although	  attempts	  have	  been	  
made	  more	  recently	  to	  develop	  screens	  for	  clinical	  use	  (Liu	  et	  al.,	  2013).	  Screening	  for	  
psychotic	  experiences	  can	  identify	  clients	  with	  high	  clinical	  need,	  regardless	  of	  any	  distress	  
associated	  with	  the	  experiences	  themselves.	  Multi-­‐morbidity	  and	  suicide	  are	  both	  highly	  
relevant	  clinical	  phenomena	  that	  should	  be	  given	  highest	  priority	  in	  treatment.	  A	  single	  
brief	  screen	  (for	  example,	  see	  Kelleher	  et	  al.,	  2011;	  Liu	  et	  al.,	  2012)	  can	  efficiently	  indicate	  
the	  need	  to	  assess	  for	  and	  potentially	  intervene	  with	  these	  significant	  conditions.	  
	   Further	  research	  will	  be	  needed	  to	  maximize	  the	  clinical	  utility	  of	  assessing	  for	  sub-­‐
threshold	  psychosis,	  particular	  in	  regards	  to	  identifying	  moderating	  and	  mediating	  factors	  
relating	  psychosis	  to	  suicide	  risk.	  An	  initial	  attempt	  was	  made	  in	  this	  dissertation,	  showing	  
that	  risk	  was	  heightened	  among	  college-­‐educated	  and	  female	  respondents,	  particularly	  
those	  experiencing	  a	  concurrence	  of	  auditory	  and	  visual	  hallucinations.	  It	  is	  likely	  that	  
there	  are	  additional	  undetected	  moderators,	  both	  for	  suicide	  and	  multi-­‐morbidity,	  which	  
can	  be	  used	  to	  identify	  clients	  at	  maximal	  clinical	  risk	  
	   The	  extensive	  multi-­‐morbidity	  between	  sub-­‐threshold	  psychosis	  and	  every	  subtype	  
of	  and	  nearly	  every	  individual	  mental	  health	  condition	  tested	  argues	  for	  dimensional	  
models	  of	  mental	  health	  and	  illness.	  The	  clinical	  corollary	  of	  such	  models	  would	  be	  non	  
diagnosis-­‐specific	  treatment,	  where	  interventions	  are	  tailored	  to	  clusters	  of	  symptoms	  or	  
distressing	  experiences	  rather	  than	  to	  treating	  individual	  diagnostic	  entities	  (Barnett	  et	  al.,	  
2012).	  This	  is	  very	  much	  in	  tune	  with	  social	  work	  ideals	  of	  person-­‐centered	  care	  and	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engagement	  based	  on	  concerns	  of	  the	  individuals	  in	  treatment,	  even	  when	  intervening	  with	  
severe	  and	  persistent	  mental	  illness	  (Rapp,	  1998).	  Categorical	  diagnostic	  constructs	  have	  
limited	  utility	  if	  they	  overlap	  so	  extensively	  with	  each	  other	  that	  interventions	  cannot	  
meaningfully	  be	  tailored	  to	  one	  diagnosis	  at	  the	  exclusion	  of	  others.	  A	  feasible	  alternative	  is	  
to	  focus	  on	  symptom	  dimensions	  or	  clusters,	  including	  psychosis	  but	  also,	  for	  example,	  
internalizing	  symptoms,	  externalizing	  symptoms,	  and	  the	  continuum	  of	  substance	  use.	  
Prior	  research	  has	  suggested	  that	  psychotic	  experiences	  may	  enhance	  the	  severity	  and	  
clinical	  need	  among	  individuals	  with	  specific	  diagnoses	  of	  major	  depressive	  disorder	  or	  an	  
anxiety	  disorder,	  in	  terms	  of	  more	  persistent	  course,	  more	  observable	  illness	  behavior,	  
greater	  utilization	  of	  services,	  and	  greater	  co-­‐occurrence	  of	  substance	  use	  (Wigman	  et	  al.,	  
2012).	  It	  may	  therefore	  be	  more	  clinically	  appropriate	  to	  approach	  psychosis	  as	  a	  relatively	  
independent	  dimension	  of	  mental	  health	  and	  illness	  that	  permeates	  across	  diagnostic	  
categories.	  	  	  
	   Psychosocial	  interventions	  currently	  utilized	  by	  social	  workers	  tend	  to	  be	  more	  
focused	  on	  the	  subjective	  needs	  of	  the	  person	  in	  care	  rather	  than	  specific	  symptoms	  or	  
diagnoses.	  Cognitive	  behavioral	  therapy	  may	  be	  useful	  in	  addressing	  factors	  that	  are	  
associated	  with	  the	  exacerbation	  of	  sub-­‐threshold	  psychosis,	  such	  as	  heightened	  stress	  
sensitivity	  (DeVylder	  et	  al.,	  2013b),	  and	  may	  serve	  the	  dual	  purpose	  of	  addressing	  
psychotic	  symptoms	  (van	  der	  Gaag	  et	  al.,	  2012)	  and	  suicidal	  behavior	  (Stanley	  et	  al.,	  2009).	  
Psychoeducation	  likewise	  improves	  outcomes	  in	  threshold	  psychosis	  (Lukens	  &	  Thorning,	  
2010;	  McFarlane	  et	  al.,	  1995),	  and	  may	  be	  particularly	  valuable	  in	  supporting	  individuals	  
with	  psychotic	  experiences	  and	  their	  families,	  given	  the	  paucity	  of	  public	  information	  on	  
sub-­‐threshold	  psychosis.	  In	  contrast,	  pharmaceutical	  interventions	  known	  to	  be	  efficacious	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among	  people	  with	  psychotic	  disorders,	  particularly	  antipsychotic	  medications,	  are	  known	  
to	  be	  poorly	  tolerated	  in	  people	  with	  sub-­‐threshold	  symptoms.	  Specifically,	  they	  are	  met	  
with	  high	  rates	  of	  non-­‐adherence,	  discontinuation,	  and	  outright	  refusal	  to	  initiate	  
treatment,	  and	  have	  not	  been	  conclusively	  shown	  to	  prevent	  the	  progression	  of	  psychosis	  	  
(Addington	  &	  Heinssen,	  2012).	  	  
Implications	  for	  public	  health	  
	   The	  practice	  implications	  described	  above	  have	  potential	  to	  meaningfully	  impact	  
public	  health	  in	  the	  area	  of	  suicide	  prevention.	  It	  is	  notoriously	  difficult	  to	  predict	  suicide	  
attempts	  using	  common	  clinical	  measures	  and	  assessment	  techniques	  (Roos,	  Sareen,	  &	  
Bolton,	  2013),	  although	  the	  predictive	  validity	  of	  assessment	  tools	  may	  be	  improving	  
(Posner	  et	  al.,	  2011).	  In	  this	  dissertation	  analysis,	  psychotic	  experiences	  were	  the	  primary	  
predictor	  of	  severe	  suicide	  attempts	  among	  respondents	  with	  suicidal	  ideation,	  surpassing	  
the	  positive	  predictive	  value	  of	  depressive	  disorders,	  substance	  use	  disorders,	  and	  anxiety	  
disorders.	  This	  information	  can	  be	  used	  either	  1)	  to	  further	  improve	  the	  predictive	  validity	  
of	  existing	  suicide-­‐risk	  assessments	  by	  including	  items	  related	  to	  psychotic	  experiences,	  or	  
2)	  to	  justify	  the	  use	  of	  direct	  assessments	  of	  psychotic	  experiences	  as	  a	  proxy	  for	  suicide	  
risk	  among	  those	  with	  ideation.	  Either	  approach	  has	  potential	  to	  significantly	  reduce	  the	  
prevalence	  of	  suicide	  attempts	  in	  the	  general	  population,	  particularly	  attempts	  with	  intent	  
to	  die.	  Brief	  screening	  tools,	  which	  tend	  to	  be	  self-­‐report	  and	  completed	  in	  several	  minutes	  
(Kelleher	  et	  al.,	  2011;	  Liu	  et	  al.,	  2012),	  may	  provide	  invaluable	  information	  on	  suicide	  risk.	  
Considerations	  when	  intervening	  with	  sub-­‐threshold	  psychosis	  
	   It	  is	  clear	  based	  on	  the	  results	  presented	  here	  as	  well	  as	  prior	  studies	  that	  psychotic	  
experiences	  carry	  clinical	  significance,	  even	  when	  considered	  to	  be	  at	  a	  “sub-­‐threshold”	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level	  of	  severity.	  Their	  assessment	  in	  the	  clinical	  setting	  may	  allow	  detection	  of	  individuals	  
at	  elevated	  risk	  for	  some	  of	  the	  most	  severe	  mental	  health	  outcomes,	  including	  multiple	  
comorbid	  conditions,	  schizophrenia,	  and	  suicide.	  However,	  the	  potential	  benefits	  of	  
intervention	  are	  accompanied	  by	  potential	  costs,	  particularly	  when	  a	  condition	  or	  set	  of	  
symptoms	  carries	  a	  label	  related	  to	  psychosis.	  	  	  
	   There	  has	  been	  little	  discussion	  in	  the	  field	  regarding	  how	  to	  best	  approach	  
psychotic	  experiences	  clinically.	  However,	  the	  closely	  related	  construct	  of	  “clinical	  high-­‐
risk”	  for	  psychosis	  (i.e.	  sub-­‐threshold	  psychotic	  symptoms	  in	  addition	  to	  age	  range	  
requirements	  and	  recent	  decline	  in	  function)	  has	  received	  considerable	  attention	  as	  a	  hotly	  
debated	  diagnosis	  considered	  for	  inclusion	  in	  the	  DSM-­‐5	  (e.g.	  Carpenter,	  2009;	  Corcoran,	  
First,	  &	  Cornblatt,	  2010;	  Ruhrmann,	  Schultze-­‐Lutter,	  &	  Klosterkötter,	  2010;	  Woods,	  Walsh,	  
Saksa,	  &	  McGlashan,	  2010).	  A	  primary	  concern	  is	  that	  sub-­‐threshold	  psychosis	  would	  be	  
used	  as	  an	  “at-­‐risk”	  syndrome	  for	  schizophrenia,	  despite	  the	  lack	  of	  a	  significant	  evidence	  
base	  regarding	  prevention	  of	  schizophrenia	  among	  this	  population	  (Corcoran	  et	  al.,	  2010).	  
Although	  many	  youth	  meeting	  clinical	  high-­‐risk	  criteria	  experience	  significant	  impairment	  
and	  distress	  (Ruhrmann	  et	  al.,	  2010),	  as	  with	  people	  with	  psychotic	  experiences	  (Bak	  et	  al.,	  
2005;	  DeVylder	  et	  al.,	  in	  press),	  it	  is	  likely	  that	  clinicians	  will	  interpret	  these	  designations	  
as	  risk	  syndromes	  rather	  than	  as	  clinically	  meaningful	  conditions	  in	  themselves.	  In	  other	  
words,	  clinicians	  may	  focus	  on	  trying	  to	  prevent	  schizophrenia	  rather	  than	  addressing	  
distress	  associated	  with	  the	  sub-­‐threshold	  psychosis	  syndrome.	  The	  most	  significant	  
problem	  that	  may	  arise,	  then,	  is	  over-­‐prescription	  of	  anti-­‐psychotic	  medications	  to	  a	  
population	  that	  is	  at	  relatively	  low	  risk	  of	  developing	  schizophrenia,	  regardless	  of	  
intervention	  (Corcoran	  et	  al.,	  2005;	  2010).	  This	  problem	  is	  of	  some	  concern	  for	  clinical	  
	  
	  104	  
high-­‐risk	  populations	  who	  truly	  are	  at	  notably	  elevated	  risk	  for	  schizophrenia,	  but	  may	  be	  
of	  extensively	  greater	  significance	  if	  it	  likewise	  affected	  people	  with	  psychotic	  experiences,	  
who	  are	  at	  notably	  lower	  risk	  (Werbeloff	  et	  al.,	  2012).	  	  
	   These	  concerns	  will	  be	  minimized	  if	  alternative	  treatments	  are	  developed	  for	  sub-­‐
threshold	  psychosis	  that	  do	  not	  include	  prescription	  of	  potentially	  dangerous	  medications.	  
Several	  steps	  have	  been	  taken	  towards	  this	  goal,	  with	  promising	  results	  for	  the	  efficacy	  of	  
psychosocial	  interventions	  including	  cognitive	  behavioral	  therapy	  and	  supportive	  therapy	  
(Addington	  et	  al.,	  2011b;	  Morrison	  et	  al.,	  2004;	  2007),	  as	  well	  as	  mild	  pharmacological	  
agents	  including	  Omega-­‐3	  tablets	  (Amminger	  et	  al.,	  2010).	  However,	  even	  with	  the	  
development	  of	  effective	  psychosocial	  treatments,	  it	  is	  possible	  that	  these	  time-­‐	  and	  
resource-­‐intensive	  treatments	  may	  be	  differentially	  accessible	  to	  people	  of	  higher	  
socioeconomic	  status	  and	  less	  accessible	  to	  ethnic	  minority	  groups	  that	  tend	  to	  have	  
restrained	  access	  to	  health	  and	  mental	  health	  resources	  (Phelan	  &	  Link,	  2005).	  This	  in	  
particular	  may	  include	  African-­‐Americans,	  who	  are	  more	  likely	  to	  believe	  that	  mental	  
health	  treatment	  is	  unnecessary	  (Anglin,	  Alberti,	  Link,	  &	  Phelan,	  2008),	  further	  
exacerbating	  existing	  ethnic	  disparities	  in	  psychosis	  prevalence	  (Bresnahan	  et	  al.,	  2007).	  	  
	   The	  word	  ‘psychosis’	  is	  not	  only	  loaded	  with	  implications	  for	  treatment	  but	  also	  
implications	  for	  acceptability	  within	  the	  general	  population.	  Any	  potential	  benefit	  of	  social	  
work	  intervention	  must	  be	  weighed	  against	  the	  potential	  harm	  of	  stigmatization.	  Whether	  
stigma	  is	  prominent	  for	  psychosis	  risk	  states	  remains	  a	  largely	  unanswered	  question,	  
although	  there	  is	  evidence	  that	  similar	  “risk”	  syndromes	  are	  associated	  with	  familial	  stigma	  
and	  discrimination	  from	  insurance	  carriers	  (Yang,	  Wonpat-­‐Borja,	  Opler,	  &	  Corcoran,	  2010).	  	  
However,	  people	  that	  hold	  the	  belief	  that	  psychosis	  occurs	  on	  a	  continuum	  are	  reported	  to	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have	  reduced	  feelings	  of	  stigma	  towards	  those	  with	  mental	  illness,	  specifically	  less	  need	  for	  
social	  distance	  (Schomerus	  et	  al.,	  2013).	  It	  is	  conceivable	  that	  acceptance	  of	  continuum	  
models	  of	  psychosis	  may	  attenuate	  feelings	  of	  stigma	  in	  the	  general	  population	  in	  such	  a	  
way	  that	  may	  provide	  some	  counterbalance	  to	  the	  stigma	  felt	  by	  individuals	  with	  sub-­‐
threshold	  psychotic	  symptoms.	  	  
Policy	  recommendations	  
Taking	  into	  account	  these	  potential	  benefits	  for	  social	  work	  practice	  and	  public	  
health,	  while	  likewise	  considering	  the	  potential	  downside	  to	  recognizing	  and	  acting	  on	  
these	  sub-­‐threshold	  symptoms,	  several	  policy	  recommendations	  can	  be	  made.	  First,	  
support	  for	  dimensional	  models	  of	  psychopathology	  encourage	  an	  expansion	  of	  primary	  
care	  for	  mental	  health.	  Psychotic	  experiences	  are	  clinically	  meaningful	  even	  when	  they	  do	  
not	  meet	  DSM-­‐5	  thresholds	  for	  psychotic	  disorders.	  Proactive	  services	  would	  allow	  these	  to	  
be	  addressed	  as	  part	  of	  routine	  treatment.	  Mental	  health	  parity,	  proposed	  by	  Bill	  Clinton	  
(Sturm	  &	  McCullough,	  1998)	  and	  implemented	  by	  Barack	  Obama	  through	  the	  Affordable	  
Care	  Act	  (Barry	  &	  Huskamp,	  2011),	  provides	  the	  structural	  foundation	  for	  the	  expansion	  of	  
primary	  care	  in	  mental	  health.	  However,	  the	  Supreme	  Court	  ruling	  striking	  down	  the	  state	  
mandated	  expansion	  of	  Medicaid	  (Jost	  &	  Rosenbaum,	  2012),	  along	  with	  the	  subsequent	  
refusal	  of	  25	  states	  to	  expand	  their	  Medicaid	  programs	  leaves	  a	  substantial	  gap	  in	  coverage	  
for	  lower	  income	  Americans	  in	  those	  states.	  Accessibility	  to	  care,	  therefore,	  will	  continue	  to	  
be	  strongly	  related	  to	  socioeconomic	  status	  in	  much	  of	  the	  country.	  Even	  an	  expansion	  of	  
mental	  health	  primary	  care	  would	  be	  disproportionately	  available	  to	  higher	  income	  
Americans	  across	  much	  of	  the	  United	  States,	  reinforcing	  existing	  socioeconomic	  disparities	  
in	  psychosis-­‐related	  care.	  Further	  attempts	  need	  to	  be	  made	  to	  ensure	  that	  any	  efficacious	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treatment	  are	  not	  available	  only	  for	  those	  who	  are	  white,	  male,	  college-­‐educated,	  or	  of	  
higher	  SES,	  all	  of	  which	  were	  associated	  with	  reduced	  risk	  for	  psychotic	  experiences	  in	  
these	  data.	  	  
	   Once	  interventions	  have	  been	  tested	  and	  have	  been	  made	  available	  for	  people	  with	  
sub-­‐threshold	  psychosis,	  policies	  should	  be	  put	  in	  place	  to	  ensure	  that	  these	  individuals	  
have	  access	  to	  evidence-­‐based	  treatments	  and	  to	  prevent	  them	  from	  being	  improperly	  
prescribed	  anti-­‐psychotic	  medications.	  The	  overuse	  of	  anti-­‐psychotics	  among	  people	  who	  
do	  not	  meet	  criteria	  for	  threshold	  psychosis	  and	  who	  likely	  will	  not	  develop	  a	  psychotic	  
disorder	  is	  a	  central	  concern	  as	  psychotic	  experiences	  become	  recognized	  as	  independent	  
clinical	  phenomena	  (Corcoran	  et	  al.,	  2005;	  2010).	  	  This	  would	  be	  considered	  an	  ‘off-­‐label’	  
use	  of	  such	  medications,	  given	  that	  they	  have	  not	  been	  specifically	  tested	  among	  people	  
with	  sub-­‐threshold	  psychosis,	  which	  is	  being	  increasingly	  targeted	  and	  prosecuted	  by	  the	  
federal	  government.	  Most	  notably,	  the	  pharmaceutical	  company	  Johnson	  &	  Johnson	  agreed	  
to	  pay	  over	  $2	  billion	  for	  actively	  promoting	  the	  off-­‐label	  use	  of	  Risperdal,	  a	  common	  anti-­‐
psychotic	  medication,	  among	  several	  vulnerable	  populations	  (Thomas,	  2013).	  Stricter	  
policies	  and	  continued	  enforcement	  of	  existing	  policies	  around	  the	  misuse	  of	  prescription	  
medications,	  particularly	  anti-­‐psychotics,	  would	  alleviate	  much	  of	  the	  concern	  regarding	  
improper	  treatment	  for	  people	  with	  sub-­‐threshold	  psychosis.	  	  
	   Concerns	  of	  stigma	  related	  to	  a	  “sub-­‐threshold	  psychosis”	  label	  likewise	  may	  be	  
addressed	  through	  policy	  change.	  More	  research	  is	  needed	  to	  support	  the	  relationship	  
between	  continuum	  beliefs	  and	  stigma;	  specifically,	  we	  do	  not	  know	  if	  educating	  people	  on	  
continuums	  of	  mental	  health	  would	  lead	  to	  reductions	  in	  stigma	  (as	  a	  causal	  relationship),	  
or	  if	  people	  who	  tend	  to	  hold	  such	  beliefs	  likewise	  hold	  less	  stigmatizing	  attitudes	  (as	  an	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association).	  	  However,	  this	  does	  provide	  a	  potential	  avenue	  for	  public	  education	  as	  a	  
means	  to	  reduce	  stigma	  related	  to	  treatment	  for	  sub-­‐threshold	  psychosis	  while	  likewise	  
alleviating	  public	  stigma	  towards	  people	  with	  psychotic	  disorders.	  Strides	  may	  also	  be	  
made	  by	  eliminating	  and	  replacing	  highly-­‐stigmatized	  terminology	  altogether.	  	  For	  
example,	  van	  Os	  (2009)	  recommended	  the	  term	  “salience	  syndrome”	  to	  capture	  the	  entire	  
psychosis	  continuum,	  both	  as	  a	  more	  accurate	  term	  based	  on	  current	  knowledge	  of	  
psychosis	  etiology,	  and	  as	  a	  term	  that	  is	  not	  associated	  with	  iatrogenic	  stigma.	  It	  has	  also	  
been	  argued	  that	  changing	  the	  name	  to	  a	  more	  biologically-­‐based	  and	  readily	  translatable	  
term	  or	  phrase,	  such	  as	  “neuro-­‐emotional	  integration	  disorder”	  may	  improve	  cross-­‐cultural	  
validity	  and	  facilitate	  public	  education	  (Levin,	  2006).	  In	  Japan,	  the	  name	  was	  changed	  from	  
“mind-­‐split-­‐disease”	  to	  “integration	  disorder”	  following	  similar	  logic	  (Sato,	  2006),	  which	  
appeared	  to	  attenuate	  the	  implicit	  stereotype	  associating	  schizophrenia	  with	  criminality	  
(Takahashi	  et	  al.,	  2009).	  This	  remains	  a	  debated	  issue,	  with	  changes	  in	  terminology	  argued	  
by	  some	  to	  be	  premature	  (Lieberman	  &	  First,	  2007).	  
Future	  research	  directions	  
	   There	  are	  many	  unanswered	  questions	  regarding	  the	  phenomenology	  of	  sub-­‐
threshold	  psychosis,	  its	  associated	  clinical	  significance,	  and	  appropriate	  approaches	  to	  
prevention,	  intervention,	  and	  treatment.	  A	  central	  problem	  in	  this	  dissertation	  and	  all	  other	  
studies	  of	  psychotic	  experiences	  to	  date	  is	  the	  lack	  of	  qualitative	  data	  regarding	  the	  true	  
nature	  of	  the	  experience	  underlying	  a	  ‘yes’	  response	  to	  items	  on	  psychosis	  screens.	  This	  
population	  is	  predominantly	  known	  from	  large	  epidemiological	  datasets;	  determining	  the	  
true	  clinical	  significance	  of	  these	  psychotic	  experiences	  will	  require	  a	  further	  
understanding	  of	  what	  the	  experiences	  actually	  mean	  to	  the	  person	  that	  reports	  them.	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Quantitative	  methods	  of	  psychosis	  assessment	  may	  also	  be	  improved,	  particularly	  those	  
that	  account	  for	  false	  positive	  due	  to	  reporting	  of	  culturally	  normative	  phenomena	  or	  
experiences	  that	  are	  merely	  odd	  or	  unusual	  (Kessler	  et	  al.,	  2005a).	  	  
	   Perhaps	  the	  most	  important	  finding	  in	  this	  dissertation	  is	  the	  strong	  and	  robust	  
association	  between	  psychotic	  experiences	  and	  suicidal	  behavior,	  particularly	  severe	  
suicide	  attempts.	  Like	  many	  rare	  behaviors,	  suicide	  attempts	  with	  intent	  to	  die	  are	  difficult	  
to	  predict.	  Having	  a	  new	  indicator	  for	  incipient	  risk	  of	  such	  behaviors	  can	  be	  invaluable,	  if	  
shown	  to	  be	  reliable	  and	  implementable	  in	  social	  work	  practice.	  	  It	  would	  be	  useful	  to	  test	  
the	  association	  between	  psychotic	  experiences	  and	  suicidal	  behavior	  in	  a	  prospective	  study	  
to	  help	  determine	  whether	  there	  is	  a	  causal	  relationship.	  It	  would	  also	  be	  useful	  to	  
distinguish	  those	  with	  psychotic	  experiences	  who	  do	  make	  attempts	  from	  those	  who	  do	  
not,	  as	  has	  previously	  been	  done	  for	  schizophrenia	  (Harkavy-­‐Friedman	  et	  al.,	  1999).	  In	  
addition,	  putative	  shared	  risk	  factors	  can	  continue	  to	  be	  explored,	  including	  exposure	  to	  
bullying	  and	  emotional	  reactivity	  to	  stressful	  life	  events.	  	  
	   Finally,	  usefulness	  of	  findings	  regarding	  clinical	  significance	  is	  entirely	  dependent	  
on	  their	  application	  in	  the	  clinical	  setting.	  This	  will	  require	  the	  modification	  of	  existing	  
psychosis	  screens,	  developed	  and	  used	  primarily	  in	  research,	  for	  efficient	  and	  reliable	  use	  
in	  the	  clinical	  setting.	  Stigma	  regarding	  treatment	  for	  sub-­‐threshold	  psychosis	  would	  need	  
to	  be	  better	  understood	  and	  addressed	  as	  a	  potential	  barrier	  to	  intervention.	  In	  particular,	  
it	  should	  be	  tested	  whether	  educating	  the	  general	  population	  on	  continuum	  models	  of	  
psychopathology	  reduces	  stigmatizing	  attitudes	  towards	  people	  that	  fall	  anywhere	  on	  the	  
psychosis	  spectrum.	  Finally,	  efficacious	  interventions	  need	  to	  be	  developed	  that	  can	  best	  
serve	  individuals	  with	  psychotic	  experiences.	  Many	  people	  with	  psychotic	  experiences	  in	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this	  dataset	  were	  already	  in	  treatment	  or	  expressed	  the	  need	  to	  seek	  help	  (DeVylder	  et	  al.,	  
in	  press).	  Psychotic	  experiences	  therefore	  occur	  frequently	  in	  social	  work	  settings,	  
regardless	  of	  whether	  or	  not	  they	  are	  presently	  being	  detected,	  and	  are	  associated	  with	  a	  
range	  of	  severe	  mental	  health	  outcomes.	  Individuals	  deserve	  efficacious	  treatments	  that	  
can	  alleviate	  distress	  associated	  with	  these	  experiences	  and	  prevent	  the	  onset	  of	  more	  
severe	  conditions,	  efforts	  that	  may	  in	  turn	  improve	  the	  health	  of	  the	  population	  by	  
reducing	  the	  occurrence	  of	  multi-­‐morbidities	  and	  by	  reducing	  the	  prevalence	  of	  suicidal	  
thoughts	  and	  behavior.	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